Synthesis and Biological Activity of Macrocyclic Diesters of Synthanecine A by Barbour, Robert Howie
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
SYNTHESIS AND BIOLOGICAL ACTIVITY 
OF MACROCYCLIC DIESTERS 
OF SYNTHANECINE A
A thesis in part fulfilment of the 
requirement for the Degree of 
Doctor of Philosophy
by
Robert Howie Barbour
Department of Organic Chemistry
June 19 8 6
University of Glasgow
ProQuest Number: 10991874
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10991874
Published by ProQuest LLO (2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
Acknowledgements
I wish to express my sincere thanks to my supervisor,
Dr D.J. Robins, for his help, advice and encouragement 
during the course of this work and in the preparation of 
this thesis.
I should also like to thank Dr K. Brown and Dr M. Burton 
for their assistance and helpful discussions.
Thanks go to the chemistry department analytical 
services. To Dr D.J. Rycroft, Mr J. Gall and Mr R. Sharp 
for n.m.r. spectra; to Mr A. Ritchie and Mr P. Stewart for 
mass spectra; to Mrs W . Harkness and Mrs K. Coombe for 
microanalyses; and to Mrs F. Lawrie, Miss E. Gill and Linda 
for i.r. spectra.
I am grateful to Prof. G . Sim and Dr A.A. Freer for 
X-ray analyses.
For their assistance during my time at the MRC Toxicology 
Unit, Carshalton, I should like to thank Dr A.R. Mattocks and 
Miss J. Brown.
Financial support from the SERC and MRC is gratefully 
acknowledged.
Thanks also go to Mrs M. Palmer for typing this thesis.
Finally, thanks go to my mother and father for their 
encouragement and to my wife, Linda, for her endless 
assistance and encouragement throughout this period.
CHAPTER 1
1.1 
1.2
1.3
1.14
1.5
1.5
TABLE OF CONTENTS
INTRODUCTION 
Pyrrolizidine Alkaloids 
Synthanecine A
Health and Economic Hazards of 
Pyrrolizidine Alkaloids
Metabolism of Pyrrolizidine Alkaloids
Therapeutic Properties of Pyrrolizidine 
Alkaloids
Conformational Aspects of Macrocyclic 
Diester Pyrrolizidine Alkaloids
PAGE
1
3
5
6
11
13
CHAPTER 2 SYNTHESIS OF PYRROLIZIDINE
■ ALKALOIDS AND ANALOGUES
2.1 Introduction
2.2 Synthesis of Monoesters and Diesters
2.3 Synthesis of Macrocyclic Diesters
2 . M- Synthesis of Pyrrolizidine Alkaloid
Analogues
17
17
31
59
CHAPTER 3 SYNTHESIS OF TEN AND ELEVEN MEMBERED
MACROCYCLIC DIESTERS OF SYNTHANECINE A 
BY THE COREY-NICOLAOU METHOD
3.1 Introduction
3.2 Synthesis of Synthanecine A
3.3 Synthesis of 11-membered Dilactones
3.4 Synthesis of 10-membered Dilactones
3.5 Chromatographic Analysis of this 
Synthetic route
3.6 Spectroscopic Analysis of these 
Macrocycles
63
64 
6 6 
76
79
82
PAGE
3.7 Conformational Aspects of
Synthanecine A Dilactones
3.8 Conclusions
89
97
CHAPTER 4
4.1
4.2
4.3
4.4
4.5
SYNTHESIS OF A SERIES OF 
ALIPHATIC, OLEFINIC AND AROMATIC 
SYNTHANECINE A DILACTONES VIA 
THE ALLYLIC CHLORIDE (200)
Introduction
Synthesis of 3-Chloromethyl-2- 
hydroxymethy1-1-methyl-3- 
pyrrolinium chloride (200)
Synthesis of Macrocyclic Diesters 
of Synthanecine A
Chromatographic Analysis of this 
Route
Conclusions
98
100
103
117
118
CHAPTER 5
5.1
5.2
5 . 3
5.4
SYNTHESIS OF 12-MEMBERED AND 
LARGER MACROCYCLIC DIESTERS OF 
SYNTHANECINE A
Introduction
Attempted Synthesis of Macrocyclic 
Diesters with 12-Membered and 
Larger Rings
Synthesis of Macrocyclic Diesters 
with 12-Membered and Larger Rings
Conclusions
119
120
137
143
CHAPTER 5 BIOLOGICAL ACTIVITY OF MACROCYCLIC 
DIESTERS OF SYNTHANECINE A
IV .
6.1 Introduction
6.2 Experimental Discussion
6.3 Results and Discussion
6.4 Toxicity Tests
6.5 Hydrolysis of 11-Membered 
Synthanecine A Dilactones under 
Aqueous Alkaline Conditions
6.6 Conclusions
PAGE
144
145 
149 
152
153
156
CHAPTER 7
7.1
7.2
7.3
EMILINE
Introduction
Results and Discussion
Conclusions
157
158 
162
CHAPTER 8
8.1
8.2
8.3
8.4
8.5 
8 . 6
EXPERIMENTAL 
General Notes 
Experimental to Chapter 3 
Experimental to Chapter 4 
Experimental to Chapter 5 
Experimental to Chapter 6 
Experimental to Chapter 7
163
164 
182 
192 
207 
209
REFERENCES 211
V .
Summary
This thesis covers three areas of research relating to 
pyrrolizidine alkaloids, (a) Synthesis of macrocyclic 
pyrrolizidine alkaloid analogues based on synthanecine A;
(b) Biological activity of these pyrrolizidine alkaloid 
analogues, and (c) Structural studies.
(a) Synthesis of macrocyclic pyrrolizidine alkaloid 
analogues based on synthanecine A . The synthesis of 
macrocyclic pyrrolizidine alkaloid analogues based on 
synthanecine A [(±)-2,3-bishydroxymethyl-l-methyl-3-pyrroline] 
has been achieved by three routes. In the first, treatment 
of synthanecine A with various succinic and glutaric 
derivatives selectively yielded 6-monoester hydroxy acids 
which were lactonised via their corresponding pyridine-2- 
thiol esters (Corey-Nicolaou lactonisation). The macrocyclic 
nature of these 10- and 11-membered pyrrolizidine alkaloid 
analogues was established by spectroscopic studies.
In the second route, (±)-3-chloromethyl-2-hydroxymethyl-
1-methyl-3-pyrrolinium chloride, prepared by the reaction of 
synthanecine A and thionyl chloride, was treated with a 
series of aliphatic, olefinic and aromatic 5- and 6-membered 
anhydrides, in the presence of base, to yield macrocyclic 
diesters. Lactonisation was effected by the intramolecular 
nucleophilic substitution of the allylic chloride by 
carboxylate anion. This simple and efficient procedure 
resulted in higher yields of the 10- and 11-membered 
pyrrolizidine alkaloid analogues than by the first procedure.
In the final route, macrocyclic diesters of synthanecine
A with 12- to 15-inembered rings were prepared by a 
combination of the above two methods. Treatment of (±)-3- 
chloromethyl-2-hydroxymethy1-1-methyl-3-pyrrolinium chloride 
with the appropriate diacid, in the presence of base, gave a 
monoester hydroxy acid which was lactonised by the Corey- 
Nicolaou method. Attempts to prepare these analogues via the 
non-hydrolytic conversion of an intermediate monoester phenyl 
ester into a monoester N-acylimidazolide failed; oligomeric 
products were probably formed.
(b) Biological activity of pyrrolizidine alkaloid 
analogues. The biological activity of a series of these 
analogues based on synthanecine A was examined. Dilactones 
of synthanecine A are metabolised in a similar manner to 
pyrrolizidine alkaloids and thus are hepatotoxic if they are 
resistant to esterase hydrolysis. The structure of the diacid 
moiety was seen to have a significant influence on the 
metabolic rate of these macrocyclic diesters.
(c) Structural analysis. The structure of emiline, a 
macrocyclic pyrrolizidine alkaloid, has been revised. The 
original structure proposed, containing an 11-membered ring, 
was inconsistent with and n.m.r. spectroscopic data.
The use of advanced n.m.r. spectroscopic techniques was 
invaluable in this structural revision, which showed that 
emiline contains a 12-membered ring.
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CHAPTER 1 
INTRODUCTION
1.1 Pyrrolizidine Alkaloids
Pyrrolizidine alkaloids constitute a large class of 
natural products.^ Over 200 have now been isolated.
Alkaloids of this type have grown in importance over the 
years due to their widespread occurrence and known hepato- 
toxicity.^ The health and economic hazards of pyrrolizidine 
alkaloids will be discussed in Chapter 1.3 and the likely 
mechanism for toxicity is detailed in Chapter 1. M-. 
Pyrrolizidine alkaloid containing plants are widespread both 
geographically and botanically. They occur on all continents 
and are represented in at least 60 genera (the three most 
important being Senecio, Crotalaria, and Heliotropium) in 
around twelve plant families.  ^ In fact it has been estimated 
that 3% of the world’s flowering plants contain pyrrolizidine 
alkaloids.^
As their name implies these alkaloids contain the
1-azabicyclo[3,3,0]octane (pyrrolizidine) nucleus (1), or a 
closely related system (2). This nucleus is often found as 
part of a diol system, as in retronecine (3).
Me
(2)
HO
(3)
2 .
Me Me Me
CH2OCO Me Me COO
macrophylLine sar racine
(4 ) (5 )
Me
Me
CHOHMe
cronaburmine
yO\ ISHMe
LoLine
(7 )
(6)
HQ
Me
anacrotine
(8)
3 *
The most common pyrrolizidine alkaloids are esters.^ 
These may be monoesters [such as (M-)], diesters [like (5)] 
or macrocyclic diesters [like (5)]. The amino alcohol 
portions (necines ) differ in the number and position of 
alcohol substituents, stereochemistry and degree of 
unsaturation in the right hand ring. The acid moiety of the 
alkaloids, the necic acids, contain various branched chains 
and are often hydroxylated and unsaturated. They normally 
have five to ten carbon atoms and include mono- and 
dicarboxylic acids. A small collection of simple non-ester 
pyrrolizidine alkaloids, such as loline (7), have also been 
isolated.
Macrocyclic diester pyrrolizidine alkaloids in which a 
pyrrolizidine diol [e.g. retronecine (3)] is esterified with 
a diacid, have attracted most attention since they are the 
most hepatotoxic."* The most common ring sizes in these 
macrocyclic dilactones are 11- (6) and 12-membered (8). 
However, a few examples with 13-^ and 14-membered rings* 
have also been isolated.
For further information on the occurrence,^ ’ ^ chemistry,® 
and pharmacology"*’  ^ of pyrrolizidine alkaloids a number of 
reviews are available. A comprehensive book by Bull et al.^
and the annual reviews presented in the Specialist Periodical
10 % 1 
Reports and Natural Product Reports are also recommended.
1. 2 Synthanecine A
Synthanecine A (9) is a monocyclic analogue of the most 
common base portion of pyrrolizidine ester alkaloids, namely
4.
retronecine (3). (±)-Synthanecine A was originally
prepared by Mattocks^^^* to further his investigations
( t ) -  synthanecine A
into the structural features required for the hepatotoxicity
4 14
of pyrrolizidine alkaloids. ’
This necine analogue (9) has been employed in our
studies because of its structural similarities to retronecine 
(3) and its ease of synthesis (see Chapter 2.4). Since 
synthanecine A (9) can be obtained in reasonable quantities, 
the synthesis of a range of macrocyclic diester analogues 
could be envisaged. Methods available for the synthesis 
of macrocyclic diester pyrrolizidine alkaloids are discussed 
in Chapter 2.3. The synthesis of a number of pyrrolizidine 
alkaloid analogues with a range of ring sizes, containing 
synthanecine A is described in Chapters 3-5.
The metabolic fate and hepatotoxicity of a series of
synthanecine A dilactones were assessed at the M.R.C. 
Toxicology Unit in Carshalton. The results from the dm vivo 
studies are presented in Chapter 6. The susceptibility of 
these dilactones to basic hydrolysis has also been studied 
and these results are included in Chapter 6. A detailed 
account of the main routes of metabolism and the hazards of
5.
hepatotoxic pyrrolizidine alkaloids can be found in 
Chapter 1.4 and 1.3 respectively.
Macrocyclic diesters adopt specific conformations, 
which may have an effect on their hepatotoxicity.
Information on the conformation of these systems can be 
obtained from n.m.r. spectral data and X-ray measurements 
as discussed in Chapter 1.5.
Attempts will be made to relate metabolism and toxicity 
to the structure and conformation of the macrocyclic diester 
analogues prepared.
1.3 Health and Economic Hazards of Pyrrolizidine Alkaloids
Livestock owners in some countries recognised that 
poisoning of their animals by fodder from meadows, was due 
to certain weeds and it was during a chemical investigation 
of one of these weeds that the first pyrrolizidine alkaloids 
were isolated.^* When tested on animals these alkaloids 
were shown to produce liver degradation characteristic of 
the disease.^* Other investigations have shown that the 
symptoms observed for pyrrolizidine alkaloid poisoning 
depend upon the animal species involved, the plant species 
ingested and the duration of exposure.^ However, the main 
lesion in each case is cirrhosis of the liver. Other 
organs affected are the lungs, heart, and occasionally the 
kidneys. The characteristic feature of pyrrolizidine 
poisoning is a megalocytosis of the liver in which the liver 
becomes composed of a small number of giant cells. In 
addition to this hepatotoxic activity some pyrrolizidine
6 .
alkaloids are believed to be carcinogenic.^^
Due to the complexity of this poisoning it has been 
’rediscovered' on a number of occasions and is described 
under a variety of names (e.g. Missouri River Bottom 
Disease, Pictou Disease, Winton Disease etc.).^
Ingestion of pyrrolizidine alkaloids is a major human 
health hazard. Human poisoning can occur by two methods.
(1) Deliberate ingestion. In Jamaica^* and other 
countries,  ^® plants containing pyrrolizidine alkaloids are 
often used in herbal remedies and in the preparation of bush 
teas. (2) Accidental contamination. Pyrrolizidine alkaloid 
poisoning epidemics in Afghanistan^® and India^^ in 1975 
were due to the consumption of bread prepared from grain 
contaminated with seeds which contained pyrrolizidine 
alkaloids. The transfer of pyrrolizidine alkaloids from 
plants into the milk of cows and goats, and the honey
2 3
collected by bees, could also affect man.
The extent of this poisoning is not yet fully 
appreciated and to this day remains a serious health and 
economic problem.
1.4 Metabolism of Pyrrolizidine Alkaloids
Early experimental studies showed that some 
pyrrolizidine alkaloids are relatively non toxic, while 
others are potent hepatotoxins. This led Schoental^** to 
suggest that the structural requirements for hepatotoxicity 
are a double bond in the 1,2-position and the presence of
7 .
the ester function, as indicated in Figure 1.
N
\
\;
/
/
/
Figure 1
Culvenor*^ then proposed that the way in which the 
hepatotoxic pyrrolizidine alkaloids act on cell nuclei is 
an alkylation process. This was based on the known tendency 
of the allylic ester group to undergo alkyl-oxygen fission. 
However, it was the outstanding results obtained by 
Mattocks^^^^ which finally provided evidence for the 
mechanism of toxicity and the toxic species involved. 
Mattocks proposed that the alkaloids themselves were not 
responsible for the toxicity, and suggested that the active 
toxins were pyrrolic derivatives (10) (dihydropyrrolizines). 
During his investigations, Mattocks found evidence for these 
pyrrole metabolites in several organs, primarily the liver, 
and in the urine of animals dosed with pyrrolizidine 
alkaloids. Dihydropyrrolizines were also produced from 
pyrrolizidine alkaloids vitro using liver slices, giving 
further evidence that the metabolic activation occurs in 
the liver.
It is now known that the pyrroles are produced by
the action of a hepatic microsomal oxidase enzyme on the 
alkaloid. This is believed to occur by a hydroxylation - 
dehydration process, as shown in Scheme 1.
OCOROCORRCOO
RCOO OCOROCORRCOO
H 00)
SCHEME 1
Furthermore, Mattocks proposed that the likely toxic 
mechanism is an alkylation between the pyrrole metabolites 
and nucleophilic tissue constituents such as nucleic acids 
or the sulphydryl groups of proteins. The pyrroles can act 
as bifunctional alkylating agents through the activation of 
the two ester groups by conjugation with the lone pair of 
electrons on the pyrrole nitrogen (see Scheme 2). Therefore,
9 .
CORRCOO OCOR
OCOR
r
CH Y
SCHEME 2
this confirms that the structural features required for
2 4
hepatotoxicity are, as suggested by Schoental, a double 
bond in the 1,2-position and estérification of one or more 
of the alcohols.
Previously, Schoental and Mattocks had proposed that a 
branched chain necic acid, which they believed might cause 
the alkaloids to interfere with steroid synthesis, was 
necessary for hepatotoxicity.  ^^ However, it is now clear 
that this feature has only a secondary effect on the toxicity.
29
10 .
Chain branching, especially on the a-position of the acid, 
is reported to cause steric hindrance around the ester 
groups.  ^ This enhances the toxicity of alkaloids by 
reducing their susceptibility to detoxification by esterase 
h y d r o l y s i s . F o r  this reason macrocyclic diesters are 
generally more toxic than simple diester alkaloids.
The water solubility and base strength of the alkaloid 
also has an effect on its hepatotoxicity.
The three principal metabolic processes of pyrrolizidine 
alkaloids are pyrrole formation and N-oxidation by 
microsomal oxidases, and hydrolysis by esterases (see 
Figure 2).** The first process produces toxic metabolites, as
pyrrole formation
N -oxidation
hydrolysis
Figure
described previously, while the other two are detoxifying, as 
the highly water soluble products are rapidly excreted.
Mattocks has shown that compounds containing a single 
pyrrole ring with appropriate substitution, such as in (11), 
can exhibit hepatotoxic properties.**’ *^* This indicates that
11
the saturated left hand ring of the necine portion is not 
a structural requirement for hepatotoxicity. Simple 
pyrroline esters like (12) should therefore be hepatotoxic 
provided that their ester groups are resistant to hydrolysis
OAc
Me
RCOO OCOR
(11) (12)
1.5 Therapeutic Properties of Pyrrolizidine Alkaloids
The pyrrolizidine nucleus is not solely associated 
with hepatotoxicity as some of its derivatives display 
therapeutic properties.
Indicine N-oxide (13) was shown to be the antitumour 
constituent of Heliotropium indicum.^  ^ As this 
pyrrolizidine monoester N-oxide (13) does not exhibit the 
hepatotoxicity normally associated with pyrrolizidine 
alkaloids it has been used in clinical trials. These 
showed that it is effective against advanced gastro­
intestinal c a n c e r , a n d  in cases of leukaemia and 
melanoma. A semi-synthetic pyrrolizidine alkaloid (14),
12 .
3 3
prepared by Zalkow ^  al, was shown to be a more active 
antitumour agent than indicine N-oxide (13).
HO
OH
HO
Me
0—
HO
Me
0.
(13) (14)
In the U.S.S.R. platyphylline (15) is widely used for 
the treatment of hypertension and internal ulcers.^ Since 
this macrocyclic diester does not contain a 1,2-double bond 
it should not be hepatotoxic.
HO
Me
Me
(15)
A series of semi-synthetic quaternary pyrrolizidine 
derivatives have been the subject of pharmacological
3 4
studies. The quaternary ammonium derivatives (16) and 
(17) were shown to exhibit ganglion and neuromuscular 
blocking activities respectively. Atal et al. also showed
13 .
CH(Me).
(16)
Me
(17)
that the diester (18) of platynecine has a local 
anaesthetic activity.
Me
Me
(18)
1.6 Conformational Aspects of Macrocyclic Diester 
Pyrrolizidine Alkaloids
Knowledge of the preferred conformation of macrocyclic 
pyrrolizidine alkaloids might lead to a better understanding 
of the precise structure/activity relationships involved in 
their metabolism. X-Ray crystallographic and n.m.r. 
spectral data^ ^ have provided information on the 
conformation of these alkaloids in the solid state and
organic solution respectively. ’1 , 2 3
14
Examination of X-ray data on a series of 11- and 12- 
membered macrocyclic diesters containing retronecine has 
led to some interesting generalisations. All of the 
natural 11-membered dilactones which have been analysed, 
except trichodesmine, contain ester carbonyl groups which 
are syn-parallel and directed downward from the macro-ring 
as shown in Figure 3 for monocrotaline (19). However, in 
all of the 12-membered dilactones which have been subjected 
to X-ray analysis, the ester carbonyl groups are anti­
parallel with the C-11 carbonyl directed above the macro­
ring [c.f. Figure 3, senecionine (20)].
(19) (20)
Crystal structures of m onocrotaline(19) ancj senecionine (20)
Figure 3
^H N.m.r. spectral data have provided information on 
the conformations of macrocyclic diester alkaloids in 
organic solutions. In these alkaloids rotation of the 
C ^ “C H 2”C^  °-C ^ ^ OR sections is limited and the conformation 
of this part of the molecule can be deduced from the 
chemical shift differences of the diastereotopic C-9 protons.
15 .
AôH-9. This value has been observed to range from ^0 -1.53 
p.p.m. (see Table 1). When A6H-9 is large, as for 
senecionine (20), the downfield proton is subjected to near
Chemical shift differences of the diastereotopic C-9 
protons (A5H-9) of macrocyclic pyrrolizidine alkaloids
11-membered macrocycles
AÔH-9 (p.p.m.) 
crispatine 0.32
fulvine 0.73
monocrotaline 0.15 
retusamine 0.9 2
Table 1
12-membered macrocycles
AÔH-9 (p.p.m.) 
integerrimine 1.2 5
jacobine 1.53
otosenine 1.14
senecionine 1.47
maximum deshielding from the 1,2-double bond and the ester 
carbonyl, and therefore lies in the plane of these 
unsaturated bonds (see Figure 3). When the A6H-9 value is 
small [e.g. monocrotaline (19) 0.16 p.p.m.] the C-9 protons 
must be more symmetrically placed about the plane of the 
carbonyl group and the more downfield proton is closer to 
the 1,2-double bond.
Further conformational data have been obtained by 
examining the allylic and homoallylic couplings between the 
C-2, C-3 and C-9 protons.^
The conformations derived from the ^H n.m.r. spectral 
data for monocrotaline (19) and senecionine (20) appear to 
be consistent with the crystal structures shown in Figure 3 
Therefore  ^H n.m.r. spectroscopy is a useful technique when
15 .
considering the conformational aspects of macrocyclic 
diesters.
It must however be noted that the conformations adopted 
by the alkaloids in the solid state and in organic solutions 
are not necessarily the same as those present when the 
alkaloid is metabolised vivo, i.e. in dilute aqueous 
media.
A rough guide to the ring size of a macrocyclic diester 
containing retronecine can also be obtained from the A6H-9 
values (see Table 1). For 11-membered macrocycles, the 
difference in chemical shifts is typically 0-0.73 p.p.m. 
whereas for 12-membered macrocycles, the range is usually 
from 1.25-1.53 p.p.m.
17 .
CHAPTER 2
SYNTHESIS OF PYRRQLIZIDINE ALKALOIDS AND ANALOGUES
2.1 Introduction
Although a great many syntheses of necines and necic 
acids have been reported, the following chapter is primarily 
concerned with the combination of these moieties to prepare 
pyrrolizidine ester alkaloids. The synthesis of semi­
synthetic and synthetic analogues will also be considered.
The most outstanding achievement in this area has been 
the synthesis of diester alkaloids of the macrocyclic type. 
This has been achieved, so far, by three groups and will be 
discussed in section 2.3. This section will include details 
on lactonisation methods and some recent developments in 
this area. Most of the early synthetic studies were focussed 
on the preparation of monoester and simple diester alkaloids, 
and this will be considered in section 2.2. Another area of 
research which is of synthetic as well as toxicological 
interest is the preparation of semi-synthetic and synthetic 
analogues. The semi-synthetic analogues will be considered 
in their relevant sections whereas the totally synthetic 
analogues will be dealt with separately in section 2.4.
2.2 Synthesis of Monoesters and Diesters 
(a) Estérification by Conventional Methods
One of the earliest examples of pyrrolizidine alcohol 
acylation was the synthesis of retronecine diacetate (21).
In their attempts to elucidate the structure of retronecine
1 8 .
(3), Barger et aly^*prepared the diacetate (21) using 
acetic anhydride. A similar investigation by Konovalova and 
Orekhov^^ showed that platynecine (22) formed mono- (23) 
and dibenzoate (24) derivatives when treated with benzoyl 
.chloride.
o r 2
(22) R’ = R2=H
(23) R '=H,R^= PhCO
(24) R' = R^= PhCO
AcO OAc
(21)
The first deliberate synthesis of a pyrrolizidine 
monoester analogue was by Gurevich and Men'shikov.^^  They 
prepared the hydrochloride salts of the benzoate (25) and 
p-aminobenzoate (26) of trachelanthamidine (27) using acid 
chlorides, as shown in Scheme 3, for subsequent 
pharmacological studies. The benzoate (25) is a feeble 
anaesthetic whereas the p-aminobenzoate (26) has comparable 
potency to cocaine.
OCOPhOH
PhCOCl
CHCL3
(27)
(2 5 )
Fe/AcOH
HCL H Ct (2 6 )
SCHEME 3
19
Not surprisingly, acid chlorides were used on 
numerous occasions for the preparation of pyrrolizidine 
ester alkaloids and analogues. For example, method (a) 
(Scheme 3) was employed by Hart and Lamberton to prepare 
laburnine benzoate (28), for spectroscopic and chromato­
graphic comparison with the natural product.
•OCOPh
(28)
The tetraacetyl derivative (29) of malaxine (30), an 
alkaloid isolated from Liparis species, was synthesised by 
Tanino et al. The final step in this synthesis involved 
the treatment of laburnine (31), in dry pyridine, with the 
acid chloride (32), as shown in Scheme 4.
Laburnine (31), obtained by the reductive cleavage of 
malaxine (30), was acetylated by Lindstrom and Tuning**^ 
using ketene (see Scheme 4). Both products, tetraacetyl- 
malaxine (29) and laburnine acetate (33), were prepared to 
characterise these new alkaloids.
20
AcQ OAc
OR
OR
32) CHoOR
OCL
CzO
(31)
LAH
OAc
(29) R=Ac
(30) R=H
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Mattocks**^ and Culvenor et also employed acid
chlorides to prepare semi-synthetic ester alkaloids for 
subsequent toxicological studies. Mattocks prepared a 
series of diesters of (+)-retronecine (3) by heating 
retronecine hydrochloride wdth various acid chlorides, as 
shown in Scheme 5. Monoester and diester derivatives of 
heliotridine (34) were prepared by Culvenor e^ al. 
7-Acetylheliotridine (35) was prepared by treating 
heliotridine with acetyl chloride at room temperature
21.
HO OH
RCOCl
(excess)
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(Scheme 6a). However,when a solution of heliotridine, in 
dry chloroform, was treated with a molar equivalent of 
pivaloyl chloride (36), at room temperature, a mixture of 
the 7-(37) monoester, 9-(38) monoester and 7,9-diester (39) 
products was obtained (see Scheme 6b). 7,9-Diester 
analogues were obtained exclusively by heating heliotridine 
hydrochloride with various acid chlorides (c.f. Scheme 5).
AcCL
HO
AcÇ OH
(35)
OR
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(37) R’=COC(Me)3,R2 = H
(38) r’ = H, R2 = COC(Me)3
(39) rU  r2= COC(Me),
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(b) Nucleophilic Displacement
(i) Nucleophilic Displacement of Allylic Chlorides.
This method relies upon the high reactivity of allylic 
chlorides towards nucleophiles. If the nucleophilic species 
is a carboxylate anion the product is an allylic ester, 
which is a functionality commonly observed in pyrrolizidine 
ester alkaloids.
if
Culvenor et devised this method to prepare some
naturally occurring 9-monoesters of the unsaturated 
hydroxy necines; heliotridine (34), supinidine (40) and 
retronecine (3). These bases were transformed into the 
hydrochloride salts of their 1-chloromethyl derivatives, 
(41), (42) and (43) respectively, using thionyl chloride at 
0 °C. The required ester alkaloids were then prepared by 
heating these allylic chlorides with the appropriate sodium 
carboxylate at reflux in aqueous ethanol, as shown in Scheme 
7. Poor yields of the products were obtained, especially 
when using saturated bases, owing to the strong tendency of 
the chloro compound to form quaternary ammonium derivatives.
Heliotrine (44) from heliotridine (34) and supinine 
(45) from supinidine (40), were the first two monoester 
alkaloids prepared by this method. In 1966, Culvenor et 
al.**^  reported the first formal synthesis of hepatotoxic 
pyrrolizidine alkaloids, namely intermidine (46) and 
lycopsamine (47). These diastereomeric 9-monoesters of 
retronecine were prepared via the 1-chloromethyl derivative 
(43) of retronecine (see Scheme 7). 9-Angelylretronecine
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(36) r’ = 0 H ,r 2=H
(40) r1= r 2= H 
(3  ) r’ = H ,r 2=0H
Cl
(41) R^=0 H , r 2=H
(42) r1=r 2=H
(43) Rl = H, r 2 = 0H
r3c 02 Na*
alcohol (aq)
OCOR
(44) r1 = 0 H ,  R%H, R^. C(CHNe2)(0H)CH(0H)Me
(45) r 1 = r 2 = h ,  r3= C(CHMe2)(0 H )C H (0 Me)Me
(46 )a n d (47 ) R'' = H ,r2 = 0 H , r3 =  C(CHMe2)(0 H)CH(0 H)Me
SCHEME 7
Me
Me
24.
N-oxide (48) was prepared similarly, to confirm the 
structure of this new alkaloid.
(ii) Nucleophilic Displacement of Secondary Mesylates.
7
Glinski and Zalkow have reported an efficient method
for the transformation of retronecine (3) into heliotridine
(34), utilising the reactivity of secondary mesylates
 ^8
towards displacement by cesium carboxylates. This route 
also permitted the first syntheses of diester pyrrolizidine 
alkaloids containing different ester groups.
The conversion of retronecine into heliotridine requires 
the inversion of configuration of a secondary alcohol. This 
was achieved as outlined in Scheme 8. 9-Benzoylretronecine 
(49) was synthesised by the site specific coupling of 
retronecine with benzoic acid, using N,N-carbonyldiimidazole 
(GDI) (50) (see Chapter 2.2d). This monoester was in turn 
converted into the key intermediate (51) using methane- 
sulphonyl chloride and triethylamine at -2 ^C. The stereo­
chemical inversion was then accomplished by the nucleophilic 
displacement of the mesylate (51) with various cesium 
carboxylates in N,N-dimethylformamide (DMF). Cesium 
propionate was found to give the most promising result. 
Finally, heliotridine (34) was obtained by the basic 
hydrolysis or reductive cleavage of the diester (52).
The naturally occurring diesters, 7-acetylechinatine
(53) and 7 - a n g e l y l - 9 -(viridifloryl)heliotridine (54), were 
prepared by an analogous route (see Scheme 8). Estérification 
of retronecine at C-9 with the acetonide of (-)-viridifloric
25,
OH
(3 )
(49) R^=H, R2=C0Ph 
(51) RlcMeSO; ,R2=C0Ph
(55) r' = H, r2= viridifloryl
acetonide
(56) R^=MeS02 , p2= ••
HO OH
(3 4 )
(52) Rl=COCH2Me,R2 = COPh
(53) R^ = COMe , R 2=vlrld ifloryl
(54) R^=ang«lyl , r2=
(57)r’ = ■■ , r2=H
REAGENTS
i PhC02H(1eq) , G D I (M  eq),THF,r.t.,16h. , 95%  ,
ii MeS02C( (1-3eq), EtjNdSeq). CH2CI2 , -2°C , T5h .
iii RCO2 Cs (4eq) , D M F  .
iv Ba(0H)23q , r t .  , 8 7 %  .
Me
\
•CO Me
angelyl
-C O
HO­
MO
iPr
H
Me
vindifloryl
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acid, using GDI, produced the monoester (55) which was then 
converted into the 7-mesylate (55). Nucleophilic 
substitution of (56) with cesium acetate or cesium angelate 
and deprotection, yielded the required products (53) and
(54) respectively. Oxidative cleavage of (54) or its 
acetonide with periodic acid gave 7-angelylheliotridine (57)
(c) Transestérification.
The first total syntheses of pyrrolizidine monoester
 ^9
alkaloids were accomplished by Kochetov et These
syntheses included the preparation of optically active 
necines, the synthesis of optically active acids and 
estérification of the necines with the corresponding acids. 
Trachelanthamine (58) and viridiflorine (59) were prepared 
by the combination of (-)-trachelanthamidine (60) with 
(+)-trachelanthic acid (61) and (-)-viridifloric acid (62) 
respectively. Lindelofine (63) was prepared from 
lindelofidine (64) and (+)-trachelanthic acid (61), as 
shown in Scheme 9.
The optically active acids were esterified and 
converted into their di-O-benzylether derivatives, which 
were then subjected to base catalysed transestérification 
with the appropriate 1-hydroxymethylpyrrolizidines.
Removal of the benzyl ethers, by hydrogenolysis over 
palladium on charcoal, afforded the required products (58), 
(59) and (63).
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CH 2— CH— C— COoH —  
R> r 2
(61) R^=OH , r2z CHMe2
(62) r ’ = r 2=0 H. r3=CHM€2
i C H2 N2 .
i PhCH2 CL, Na H , DMF ;
IJI
(60) R ^ = H , r 3  = CH2ÛH 
(64) R^=CH20H , r 5 = H  
iv H2 , P(^\C
R'
000-i.
R-
'ÇH—CH3
Ri
(58) R^ = r3= oh , r2^ CH.Me2
(59) r ’ =r2=QH , r3 =  CHMe2
(63)
CHMeo OH
I /
OCO-C--------CH—CH3
OH
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(d ) Dicyclohexylcarbodiimide (DCC) (65) and 
N^M-carbonyIdiiïïiidazole (CDD (50)
5 0
Hoskins and Crout assessed the potential or DCC (65) 
and CDI (50) as reagents for the selective esrerification
28 .
of dihydroxynecine bases, such as retronecine. They also 
investigated the estérification of necines with a,6- 
unsaturated acids and with hindered a-hydroxyacids.
Estérification by DCC provided a reasonably selective 
route for the formation of 9-monoesters of retronecine. The 
amount of diester formation was roughly inversely proportional 
to the magnitude of the acid, presumably because the 
increasing steric hindrance makes the remaining hydroxyl less 
susceptible to further estérification. Synthesis of 9- 
angelylretronecine (66), as shown in Scheme 10, gave low 
yields [due to competing rearrangement to the N-acylurea (67)] 
and partial geometrical isomérisation giving 9-tiglylretro- 
necine (68). This indicated that DCC was not a suitable 
reagent for the estérification of retronecine with a,3“ 
unsaturated acid.
OHHO
Me
Me
(65)
Me Me
CO
y — 6 — N
^  (67)
(6 6 ) R^= Me
(6 8 ) RbMe,R 2 =H
SCHEME 10
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Estérification using GDI, or with previously formed 
N-acylimidazolides, provided regiospecific routes to 9- 
monoesters of retronecine. Treatment of retronecine with 
equimolar amounts of N-acylimidazolides (69) for 24 h gave 
9-monoesters (38) directly, in good yields. Comparable 
yields were obtained by adding retronecine directly to a 
solution of the carboxylic acid and CDI in ethanol free 
chloroform (see Scheme 11).
RCO2H
coi; CHCL3
9
R—C—N. _ I (69)
THF
SCHEME 11
retronecine (3)
nL OCOR
(38) R= CMeg
This method permitted the synthesis of the a ,g 
unsaturated ester, 9-tiglylretronecine (88), in reasonable 
yield. Furthermore, the unsymmetrical diester (70) of 
retronecine was prepared by esterifying the allylic alcohol 
using pivaloylimidazole and subsequent estérification of the 
remaining alcohol with the appropriate acid chloride. 
Finally, the diesterification of retronecine with a 
carboxylic acid (71) having a-hydroxy-a,a-dialkyl 
substitution was also achieved using CDI. This substitution 
pattern is commonly observed in naturally occurring necic 
acids.
30
0 —c— CM©C — 0
(70)
More recently, Zalkow and co-workers^^ employed GDI to 
prepare the 9-monoester (72). 9-0-[(±)-2-hydroxy-2-phenyl-
butyryl]retronecine (72) was formed by the addition of 
retronecine (3) directly to a solution of the appropriate 
acid (73) and CDI in dry chloroform (see Scheme 12). The 
N-oxide (1M-) of the monoester (72) was shown to be a more 
active anti-tumour agent than indicine N-oxide (13) (see 
Chapter 1.5).
0 — ^— C M© 2 0 H
(71)
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OH 
C H 3 C H 2— Ç— C O 2H 
(73)
i C D I  , T H F
0
II
0— (
HO—
- 0
H----- — H
Me
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2.3 Synthesis of Macrocyclic Diesters
(a) Eleven membered macrocyclic diesters
Macrocyclic diester pyrrolizidine alkaloids have proved 
to be formidable synthetic targets. In fact it was not 
until the beginning of this decade that the first promising 
results were published. Robins and Sakderat^^ reported the 
synthesis of an eleven membered macrocyclic diester (74) of 
retronecine.
The key step of this synthesis involved the Corey-Nicolaou
32 .
"double activation" method for lactonisation.^^ This 
method requires the formation of a pyridine-2-thiol ester, 
which is doubly activated towards lactonisation by the 
internal transfer of a proton from the hydroxyl to the 
carbonyl as shown in figure M-. The transfer of this proton
n  - n
Figure ^
is facilitated by the basic nitrogen of the pyridine nucleus,
Full details of the synthesis of (74) and of a series 
of similar alkaloid analogues [(75)-(78)] were published 
soon after (see Scheme 13). Treatment of (+)-retronecine
(3) with an equimolar amount of 3,3-dimethylglutaric 
anhydride (79) in chloroform gave a quantitative mixture of 
the corresponding 7-(80) and 9-monoesters (81). 
Estérification occurred predominantly at the primary allylic 
hydroxyl and no 7,9-diester formation was observed because 
the initial zwitterionic monoester products had precipitated, 
The 7- and 9-monoester hydroxyacids were converted into 
their pyridine-2-thiol ester derivatives, (82) and (83) 
respectively, with triphenylphosphine (84) and 2,2'- 
dithiopyridine (85) at room temperature. Vigorous stirring 
was required to effect the dissolution of the zwitterionic 
monoesters. Slow addition of the pyridine-2-rhiol esters
33
OH
(3 )
Me
i
(85)
ii
(84)
(80) R' = C0 CH2CMe2CH2C02H , r 2=H
(81) R^=H , R^= C0 CH2CMC2CH2C02H
(82) R1= CO CH2Ole2CH2C0SPy , r2=H  
( 83) = H , r2= CO CH2CM«2CH2COSPy
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(75) (CH2
(76) H H
(77) Ph Ph
(78)
Me
H
(88) OH Me
(89) Me OH
(86)
+  0 -7  isomer 
(87)
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(82) and (83) to refluxing chloroform, followed by 12 hours 
heating at reflux yielded the required product (7M-). 
Macrocyclic diesters [(75)-(78)] were prepared similarly 
using the appropriately substituted glutaric anhydrides. 
When N,N-dimethylformamide (DMF) was used instead of 
chloroform, to solubilise the 7- and 9-zwitterionic mono­
esters, by products (86) and (87) were isolated. These 
N ,N-dimethylamides were presumed to be formed by the 
reaction of dimethylamine (from the breakdown of DMF) with 
pyridine-2-thiol esters.
Soon after, Robins ^   ^^ successfully employed this
route for the first synthesis of a macrocyclic diester 
pyrrolizidine alkaloid. Dicrotaline (88), the simplest of 
the eleven membered macrocyclic diesters of (+)-retronecine 
(3), and its C-13 epimer (89), were prepared from the 
trimethylsilylether of 3-hydroxy-3-methylglutaric anhydride 
and (+)-retronecine in a similar manner to that described 
above (see Scheme 13). No deprotection step was required . 
as the protecting group was removed in the work-up. The 
mixture- of diastereomers was separated by preparative Thin 
layer chromatography, and the absolute configuration at 
C-13 in both compounds was established by a sequence of 
selective reactions on each epimer, yielding optically 
active mevalonolactone.
The Corey-Nicolaou procedure for lactonisation has 
been applied successfully in a number of other syntheses of
5 6
natural products.
Another procedure, developed by Masamune,^^ utilises
35
t-butylthiol esters to effect lactonisation, as shown in 
Scheme 14. The soft thiophilic mercury(ll)ion (as its
0
B - s - <
OH
6— 0
(91)(90)
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trifluoroacetate or methanesulphonate) is required to 
catalyse the conversion of the thiol ester (90) into the 
lactone (91). The mechanism for this conversion is 
thought to proceed through the intermediate shown in 
Figure 5. Other thiophilic cations such as Cu(I), Cu(II) 
and Ag(I) can also be used. This procedure provides an
P ~ s :
Figure 5
attractive means for protecting and subsequently activating 
a carboxyl group.
The 0-acetyl derivative (92) of crobarbatine (93), 
another eleven membered macrocyclic diester of (+)- 
retronecine, and a diastereomer have been synthesised by 
Huang and Meinwald^^ employing this strategy (see Scheme 15)
Crobarbatic acid lactone (94), shown to be the trans­
36.
isomer, was converted into the methylene chloride soluble 
dimethylaluminium salt (95) which was subsequently treated 
with dimethylaluminium t-butylsulphide affording the 
required t-butylthiol ester (96). Protection of the 
tertiary hydroxyl of compound (96), as the acetate, was 
followed by activation of the free acid as the acylimidazolide
(97). The suitably derivatised crobarbatic acid (97) was 
coupled with retronecine, using a catalytic amount of sodium 
hydride, yielding a mixture of diastereomeric monoesters
(98). Various attempts to lactonise (98) failed. When 6 
equivalents or less of mercuric trifluoroacetate or a 
mixture of mercuric chloride and cadmium carbonate
were used,starting material was recovered and when a large 
excess of mercuric trifluoroacetate or copper(I) trifluoro­
acetate was used,the carboxylic acid (99) was isolated. 
Finally, copper(I) trifluoromethanesulphonate - benzene complex 
was found to effect the crucial lactonisation in good yield. 
The mixture of diastereomeric cyclic diesters (92), obtained 
in 6 2% yield, was separated by column chromatography.
The configurations of the acid portions of the 
dilactones (92a) and (92b) were established by acid 
hydrolysis of each diastereomer, and analysis of the Cotton 
effect exhibited by each lactonic acid (see Figure 6).
Attempts to deacetylate (92a) and (92b) by base catalysed 
hydrolysis, even under mildly basic conditions, produced 
retronecine. Under acid catalysed conditions only (92a) 
yielded the deacetylated product (9 3a) in low yield. How­
ever, the authors could not prove that (93a) corresponded to 
natural crobarbatine.
37.
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Vedejs and Larsen attempted both Corey-Nicolaou 
(pyridine-2-thiol ester) and Masamune (t-butylthiol ester) 
procedures for lactonisation, while trying to prepare 
(±)-crispatine (100) and (±)-fulvine (101),without much 
success.
A strategy similar to that applied by Robins et al. 
for the synthesis of dicrotaline was initially 
attempted by Vedejs (see Scheme 16). Suitably protected
TMSQ
ArCH2Û
Me.
A
(102)
.Me
Me Me
(103)
i deprolection
i i  C o re y -N ic o la o u  L a c to n is a t io n
HO lyte
Me
Me
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(±)-fulvinic anhydride (102) and (± )-retronecine (3) were 
combined affording the required monoester (10 3) and a
39 .
diastereomer. Deprotection of the monoesters followed by 
lactonisation by the Corey-Nicolaou method yielded the 3- 
lactone (10M-) instead of the macrocyclic dilactone (101).
A low yield of the required product (101) was obtained by 
treating the monoester (104) with potassium hydride.
Improved syntheses of (±)-crispatine. (100) and (±)- 
fulvine (101), reported by Vedejs and La rs en,invol ve d a 
simple alternative cyclisation.method, based on the high 
reactivity of allylic mesylates towards carboxylate anions 
(see Scheme 17). A similar method had been used earlier, by 
Culvenor et al., to prepare 9-monoesters of unsaturated 
necine bases (see Section 2.2.b.i).
Crispatic anhydride (106), prepared from crispatic acid 
(105), was protected as its methoxymethylether (107)
Opening of the anhydride afforded the carboxyl protected 
crispatic derivative (108), and activation of the free acid 
was achieved by preparing the mixed phosphoric anhydride 
(109). Coupling of the activated acid (109) with the lithium 
alkoxide (110) of synthetic monosilylated (±)-retronecine 
gave a 1:1 mixture of the monoester (Ilia) and a diastereomer. 
Lactonisation was accomplished by the following deprotection, 
activation and deprotection sequence. Desilylation of the 
monoesters (111) liberated the primary allylic hydroxyl 
(112) which was then transformed into the mesylate (113).
This mesylate was not isolated but diluted with acetonitrile 
and added, over a period of approximately 3 hours, to excess 
tetra-n-butylammonium fluoride hydrate in acetonitrile. 
Lactonisation occurred spontaneously to give diasteromers
t o .
Me OH 
Me. 4. ,Me
Me OR
DCC
P2P5/(MeO)2CH2
.Me
Me;AL0CH2CH25iMe3
OH 0 - \ q ^ 0
(105)
'Me OCHoOMe 
\  /
Me V  M e
° ^ 0 r2
(106) R=H
(107) R=CH2ÛMe
(108) R^=H , r2= CH2CH2Si Meg
(109) r1 = P0(0Et)2 . R2 = CH2CH2 SiM23
(109) and
Me
I I
(110)
ITBDMS
i DMAP
0<  A  XC>2CH2CH2SiMe3 
MeOCHp Me 
D  u ^ O R
ii H2O-HF, THF
iii MeS02CL,Et3N,CH2C(2
(tlla) R = TBDMS 
(112a) R= H
(113a) R= S02Me 
« a diastereoisomer ' b
Me
Me.Me
0
. 7
II BF3.Et20 -EtSH ^  1
(IK ) R=CH20Me
(100) R= H
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(115) R= CHjDMe
(116) R= H
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(114) and (115) which were separated. Quantitative 
deprotection of (114) gave (±)-crispatine (100) which was 
chromatographically and spectroscopically identical with a 
sample of the natural product. Deprotection of (115) gave 
(i)-isocrispatine (116). An analogous route was used to 
prepare (±)-fulvine (1 0 1 ) and (±)-isofulvine.
(b) Twelve membered macrocyclic diesters
Integerrimine (130) is the only twelve membered macro- 
cyclic diester pyrrolizidine alkaloid which has been 
synthesised. The synthesis, accomplished by Narasaka et al. , 
includes a novel lactonisation procedure which employs a 
methylthiomethyl ester (CO2CH2SCH3 ) as a protecting group 
which can be readily activated.
The methylthiomethyl group is a well known protecting 
group for alcohols and carboxylic acids. Deprotection is 
generally carried out with heavy metal salts or oxidising 
agents. The latter converts the methylthiomethyl group into 
a methylsulphonylmethyl group which is readily hydrolysed by 
aqueous alkali (see Scheme 18). The authors expected that an 
ester (117) would be formed if the methylsulphonylmethyl ester 
was treated with a metal alkoxide instead of aqueous alkali.
R - C - 0 C H 2 S C H 3
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The synthesis of integerrimine (130) includes the 
preparation of suitably protected retronecine and integer- 
rinecic acid, coupling of these moieties followed by 
lactonisation.
Retronecine was prepared by a modification of the 
Geissman route and selectively protected as the t-butyl- 
dimethylsilyl ether (1 1 0 ).
(±)-Integerrinecic acid, prepared as reported,*^ was 
suitably derivatised as shown in Scheme 19a. Firstly, the 
tertiary carboxylic acid of integerrinecic acid lactone
(118) was protected as the trimethylsilylethyl ester (1 2 0 ) 
using the Mukaiyama reagent, l-chloro-2 -methylpyridinium 
iodide (119). Selective hydrolysis of the 5-lactone, 
followed by protection of the free acid, as the methyl­
thiomethyl ester, and of the tertiary hydroxyl as the 
methoxymethyl ether, afforded compound (121). Desilylation 
of this intermediate (1 2 1 ) preceded the oxidation of the 
sulphide to the sulphone (122). Protection of the tertiary 
acid, as the methylthiomethyl ester, followed by 
hydrolysis of the sulphone yielded the required derivatised 
integerrinecic acid (123). This was transformed into the 
acid anhydride (124) by treatment with the coupling reagent
(119) .
The necine and necic acid moieties were coupled by 
treating the lithium alkoxide (1 1 0 ) of the silylated 
retronecine with the acid anhydride (124), in the presence 
of a catalytic amount of N,N-4-dimethylaminopyridine (DMAP).
^3
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The following sequence of reactions' was carried out on the 
diastereomeric mixture of products (125). The monoesters 
(125) were desilylated and oxidation of the sulphides (126) 
gave the corresponding sulphones (127). Lactonisation of 
the activated acids (12 7) was achieved by the intramolecular 
nucleophilic displacement of the methanesulphonylmethyl 
group to afford the dilactones (128). Reduction of the N- 
oxides (128) yielded a diastereomeric mixture of bases 
[(129a) and (129b)] which were separated. Removal of the 
methoxymethyl ether from (129a) afforded (±)-integerrimine 
(130) which was spectroscopically and chromatographically 
identical to a natural sample (see Scheme 19b).
A pyrrolizidine alkaloid analogue (132) with a 12- 
membered macrocycle has been prepared, by Drewes and 
Pitchford,^^ by the reaction of 2,6-bis(bromomethyl)pyridine 
with the dipotassium salt of the C^ ^ necic acid, retronecic 
acid (see Scheme 20). The authors claim that the macrocyclic
Me
I Q|_|
V '  'f "  Me 9"2
-(|—ch2'”Ch— — CH2OH y y
v=o r
2K DMF  ^ / d
8 o®c 48 h \ ^
BrCH2^ N ^ ^ C H 2 6 r ' CH2.^N\^2
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diester (132) causes cytotoxic effects similar to 
pyrrolizidine alkaloids although it is difficult to see how 
such an analogue could be metabolised to produce these 
effects.
(c) Ten-membered macrocyclic diester analogue
Macrocyclic pyrrolizidine diesters generally have 11- 
or 12-membered rings. No 10-membered macrocyclic diesters 
have been isolated, although succinic acid derivatives are 
common plant constituents.
A series of 10-membered macrocyclic diesters [(133)- 
(135)] of (+)-retronecine have been prepared by Robins and 
B u r t o n . T h e  compounds (133)-(135) were prepared by the 
treatment of (+)-retronecine with succinic anhydride,
(±)-trans-cyclohexane-1 ,2-dicarboxylic anhydride and phthalic 
anhydride respectively. The resulting monoester hydroxy- 
acids were lactonised via their pyridine-2-thiol esters.
The diastereomers (134) were not separated, but were shown 
to be present in a ratio of approximately 4:1, by n.m.r. 
spectroscopy. X-ray data for the succinate dilactone (133) 
showed that the 1 0 -membered macrocycle adopts a solid state 
conformation in which the carbonyl groups are antiparallel.
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Lactonisation
Synthetic methodology for the construction of large 
ring lactones has been developed over recent years due to 
the discovery of macrolide natural products with antibiotic 
and other therapeutic properties.
In this subsection the principles of,and commonly used 
procedures for,lactonisation will be discussed. Some recent 
advances in this area will also be detailed. However, for 
a more comprehensive review of lactonisation procedures, the 
listed publications are recommended.^
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Lactonisation is the process by which a hydroxy- 
carboxylic acid is intramolecularly esterified producing a 
cvclic ester (lactone), as shown in Scheme 21. The rate
HO—(*CH2 )n—CO2 H
SCHEME 21
of this and other cyclisations depends upon the following 
two factors. Firstly, the atoms at the end of the chain have 
to come within reacting distance (entropy factor) and 
secondly, steric and stereoelectronic interactions may hinder 
the ring closure when the two ends meet (enthalpy factor).
Specific structural features can enhance the rate of 
cyclisation. For example, the presence of unsaturation in a 
medium sized carbon chain will reduce the rotational 
possibilities available and eliminate transannular inter­
actions, thereby promoting an intramolecular process.*^
The rate of cyclisation is also dependent on the length 
of carbon chain involved as shown in Figure 7. From this 
graph, based on the work of Illuminati et  ^^ it can be
seen that 5-membered lactones are formed 1 0 ® times more 
readily than 8 -membered lactones.
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Macrocyclic lactones are prepared by the lactonisation 
of long chain hydroxycarboxylic acids. Although the steric 
and stereoelectronic interactions involved may be negligible 
this process is disfavoured on the basis of the entropy 
factor. A competing intermolecular process (estérification) 
exists from which oligomeric products are formed (see Scheme 
2 2 ).
HO—fCH 2 )n—CO2 H
SCHEME 22
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This process is favoured when long chain w-hydroxycarboxylic 
acids are reacted under normal.reaction conditions. How­
ever, since lactonisation is a unimolecular process and 
estérification a bimolecular process, the former process can 
be enhanced and the latter minimised by reacting the w- 
hydroxyacid under dilute conditions.
The preparation of a macrocyclic lactone from a long 
chain hydroxyacid is generally achieved by the following 
procedure (see Scheme 23).
HO—("CH2 )n—CO2 H
0
1 II
R k ) HO-C
—(CHzIn
(136)
HO C-OR^
J•fCH2  In
(1 37 )
0
C— 0
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Firstly the hydroxyacid is converted into a hydroxyl (136) 
or carboxyl (137) activated intermediate by treatment with 
suitable reagents. Lactonisation is then effected by 
adding a solution of the reactive intermediate [(136) or 
(137)] dropwise, over a period of time, to solvent heated at 
reflux.
A number of lactonisation reagents have been developed
5 2
over the past dozen years. The widely used Corey and 
Masamune methods which utilize intermediate thiol esters 
to promote lactonisation, have already been discussed in 
the preceding subsection. Other commonly used procedures 
are
1. Modifications to the Corey Method
In the syntheses of two macrolide pheromones (141) and 
(142), published by Oehlschlager ^   ^° the crucial
lactonisation steps were effected by modified Corey methods 
as shown in Schemes 24 and 25. In the first, the hydroxy­
acid (138) was transformed into the thiol ester (139) by 
treatment with the disulphide (140) and triphenylphosphine 
(84) (c.f. preparation of dicrotaline, Scheme 13). 
Cyclisation to the required lactone was promoted through 
the double activation of the thiol ester. Imidazolethiol 
esters, such as (139), are reported^^ to be more reactive
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Ph]P
(141)
SCHEME 24
intermediates than the corresponding pyridine analogues, as 
lactonisation can occur at room temperature. In the second, 
the lactone (lM-2) was prepared via a pyridine-2-thiol ester
:-0H
i i  A g  CIO.: Me
(142)
SCHEME 25
in the presence of silver ions (as the perchlorate). Silver
7 2
ions are used to activate the thiol ester by complexation.
53
2. Mukaiyama Method
The cyclisation of w-hydroxyacids using l-methyl-2- 
chloropyridinium iodide (119) in the presence of triethyl' 
amine (TEA), was reported by M u k a i y a m a . T h e  proposed 
mechanism is shown in Scheme 26. Nucleophilic attack of
H0“4"CH 2 )n— CO2  H
Et,N
Cl
Me
(119)
I
Et]N
0 ,
HQ
(143)
4
Me
(144)
SCHEME 26
the carboxylate ion on the chloropyridinium salt (119) 
generates an active acylating agent (143) which rapidly 
cyclises as a result of the intramolecular attack of the 
hydroxyl group. The 2-pyridone (144) is the by-product.
The macrolide (146) was prepared, by Oehlschlager et 
in a 49% yield, using this method (see Scheme 27).
A solution of the hydroxyacid (145) and TEA in acetonitrile 
was added dropwise to a solution of the Mukaiyama reagent 
(119) in acetonitrile heated at reflux.
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3. Mitsunobu Method
The procedures already mentioned, attributed to Corey, 
Masamune and Mukaiyama, have involved activated carboxyl 
intermediates. The following method, reported by Mitsunobu, 
employs the "reverse activation," wherein the hydroxyl 
group is activated (see Scheme 28). The hydroxyacid is 
converted into the reactive intermediate (14 8) upon 
treatment with diethyl azodicarboxylate (DEAD) (147) and 
triphenylphosphine (84). Then, nucleophilic attack of the 
carboxylate ion, of intermediate (148), on the carbinol 
carbon afforded the desired lactone (91). Inversion of 
configuration is observed if the carbinol carbon is chiral.
The synthesis^* of colletodiol (150) was achieved 
using this procedure (see Scheme 29). Treatment of the 
hydroxyacid (149) with reagents (147) and (84) at -10 °C 
generated an activated hydroxyl intermediate which 
spontaneously cyclised at 0 °C. Deprotection yielded the 
required macrolide (150).
0 0 
EtO—C—N = N —C—OEt
(147)
PhgP (84)
HO—(-CH2 )n— CO2H
55;
PhsP-O-
l(^H2)n 
C  1
0 (148)
E tc—Ç—NH—NH— C—OEt
b b
c— 0
PhgP^O
SCHEME 28
(91)
Me'
MeCN , H2O .
Me
Me'
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4. Other Methods
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There are a number of other types of activated 
intermediates, e.g. mixed acid anhydrides and N-acyl- 
imidazolides, which have been employed in macrolide 
syntheses. For further information and these and other 
methods of lactonisation, the recommended reviews 
should be consulted.
6 4 - 6  7
Recently Developed Lactonisation Procedures
A new lactonisation reagent was reported by Kinoshita 
et  ^^ 3-(5-Nitro-2-oxo-l,2-dihydro-l-pyridyl)-1,2-
benzisothiazole-1,1-dioxide (151) promotes lactonisation
(151 )
HO
*
(152)
' 0 ^ ( C H 2 )
lactone (91) +
SCHEME 30
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via the ester (152). Nucleophilic attack by the hydroxyl, 
yielding the macrolide (91), is catalysed by £-toluene- 
sulphonic acid (see Scheme 30).
The same group has also published^^ a procedure for the 
lactonisation of 0,0’-disilylated hydroxycarboxylic acids, as 
shown in Scheme 31. The presence of dipropylboryltriflate
(153) promotes the condensation liberating hexamethy^siloxane
(154) .
TM S O -tC H jIn -C O ^TM S
PhMe TM S-O-TM S
(154)
SCHEME 31
The Steglich procedure for estérification (DCC/DMAP/DMF) 
has been modified by Keck^^ for the synthesis of macrocyclic 
lactones (see Scheme 32). When the Steglich method was employed
HO— HCH2)i4— CO2 H
DCC
DMAP
Y
0
(155)
C—( CH2)i4~OH
SCHEME 32
DCC
DMAP
DMAP.HCL
g - o
(C H jlu
(156)
under the high dilution conditions generally required for 
lactonisation a near quantitative yield of N-acylurea (155) was 
obtained. However when 1 equivalent of DMAP.HCl was present a 
high yield of the required macrocyclic lactone (155 ) was afforded
58 .
Failure of the Steglich method, under high dilution 
conditions, was due to the low effective concentration of 
proton sources .
One of the major problems associated with the 
formation of macrolides is the requirement for relatively 
high dilutions. In their attempts to overcome this problem 
some groups have employed polymer supported reagents to 
achieve pseudodilute conditions.
8 0
Polymer supported thiol esters and polystyryldiphenyl- 
phosphine,^^ used in the Mitsunobu procedure, only produced 
low yields of macrocyclic lactones. However, a triphase 
catalytic cyclisation method, reported by Regen and 
Kimura,®^ afforded macrocyclic lactones in yields comparable
5 2
with those obtained using the Corey-Nicolaou and
H02C*—fCH2)n~0H
H2CO3 
K OMs PhMe
(P)-PR 02C4CH2)n-OMs
HO2C—("CH2)n— OMs 
(157)
KHCO 3 
H2O
H 2 C O 3 
K OMs
PhMe
lactone
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Kruizinga-Kellog (Cs^CO^, DMF, w-iodoacids) methods (see 
Scheme 33). The hydroxyacid was transformed into the 
mesylate derivative (15 7) which was added to the triphase 
system. An acid-base reaction was followed by an exchange 
of ions. Upon heating, lactonisation occurred and the 
mesylate form of the resin was regenerated.
Purification of complex reaction mixtures is also 
simplified by using polymer supported reagents.
During the planning of the synthesis of novel lactonic 
systems a number of factors have to be considered. The 
choice of lactonisation procedure is clearly of importance.
The size of ring which is to be prepared, the flexibility 
of the carbon chain, and the steric interactions which may. 
hinder the ring closure, must also be taken into account.
2.4 Synthesis of Pyrrolizidine Alkaloid Analogues
An important series of pyrrolizidine alkaloid analogues, 
prepared by Mattocks, ^ ^  ^^ are the synthanecines A - E  [(9) - 
(158) -(161)]. These monocyclic analogues of the bicyclic 
necine bases were prepared for metabolic and toxicological 
studies. Synthanecine A, analogous to retronecine (3), was 
used extensively in these studies. The synthesis of 
synthanecine A was first reported in 19 74. However, an
improved route (see Scheme 34) followed soon after.
Condensation of methylamine (162) and diethyl maleate 
(163) afforded the diester (164), which was then converted 
into the triester (166), using ethylbromoacetate(165) . Dieckmann
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cyclisation of compound (166) gave the ketone (167).
Selective reduction of the ketone followed by dehydration 
introduced the required unsaturation. Finally, reduction 
of the diester (16 8) to the diol, synthanecine A (9), was 
achieved using di-isobutylaluminium hydride.
Synthanecine B (15 8) was prepared by reduction of the 
olefinic diester (168) or the enol ether (169). This enol 
ether (16 9) was prepared by treating the ketone (167) with 
diazomethane. Selective reduction of the enol ether (169) 
gave synthanecine C (159). By exchanging diethyl maleate 
(163) for diethylglutaconate (170), in Scheme 34, 
synthanecine D (160) was prepared instead of synthanecine A. 
Synthanecine E (161) was prepared using ethyl-3-methylamino- 
butyrate (171), instead of the diester (165), in an analogous 
route.
A series of diesters and dicarbamates [(172) -(176)]
MeN
OR
(172) R= COC(Me)(Et)OMe
(173) R = P0(0EI)2
(174) R= CONHEl
(175) R= C0NM82
(176) R= CONEI2
(177) R= C02Ph
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of synthanecine A was prepared by conventional methods.
The bis-2-methoxy-2-methylbutyrate (172) and the bis- 
diethylphosphate (173) diesters were prepared via their 
corresponding acid chloride and phosphoryl chloride 
respectively. The N-ethyl dicarbamate (174) was prepared 
from synthanecine A and ethyl isocyanate; the amino 
alcohol itself, acted as a base in this reaction. Finally, 
the dicarbamates (17 5) and (176) were prepared from the bis- 
phenylcarbonate (17 7) and the appropriate amine.
The results from biological tests showed that these 
diester derivatives were metabolised to pyrrole derivatives 
which exhibited a hepatotoxicity similar to, if not 
identical to, that of pyrrolizidine alkaloids. The N-ethyl- 
carbamate diester (174) is more toxic than the common 
natural alkaloid monocrotaline (19). However, simple 
diesters are less toxic due to esterase hydrolysis (see 
Chapter 1.4).
At the start of this project no macrocyclic diesters 
of synthanecine A had been prepared. In this project, we 
have investigated methods for preparing such derivatives 
(Chapters 3-5). Some macrocyclic diesters of synthanecine 
A have been subjected to biological tests to assess their 
hepatotoxicity (Chapter 6).
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CHAPTER 3
SYNTHESIS OF TEN AND ELEVEN MEMBERED MACROCYCLIC DIESTERS 
OF SYNTHANECINE A BY THE COREY-NICOLAOU METHOD
3.1 Introduction
Macrocyclic diester pyrrolizidine alkaloids generally 
have 1 1 - or 1 2 -membered rings and are more hepatotoxic than 
simple monoester or diester alkaloids [e.g. In young male 
rats retrorsine, a 12-membered dilactone, has an LD5 Q of 34 
mg, whereas the LD50 of heliotrine (44) is 280 mg. An 
LD50 (lethal dose 50%) is the quantity of a substance 
necessary to kill 50% of exposed animals in laboratory tests 
within a specified time]. The presence and conformation of a 
macrocycle may be important factors in reducing the 
susceptibility of the ester groups to esterase hydrolysis. 
Also,oxidation of the pyrroline ring may be favoured rather 
than N-oxidation (see Chapter 1.4).
5 4
A series of semi-synthetic eleven-membered and ten 
membered*^ macrocyclic diesters of (+)-retronecine have been 
prepared by Robins and co-workers. Lactonisation of the 
hydroxycarboxylic acid intermediates was accomplished by the 
Corey-Nicolaou method (see Scheme 13). As (+)-retronecine 
(3 ) is not readily available, by synthesis or from natural 
sources, the quantities of these derivatives prepared were 
limited. Since reasonable amounts of the most toxic 
macrocyclic alkaloids are needed for further metabolic and 
toxicological studies a more accessible necine or necine 
analogue was required. Synthanecine A (9), a monocyclic
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analogue of retronecine, was selected because it is readily 
available via a short and efficient route (see Chapter 
2.4).'^’ '^
The synthesis of a series of 10- and 11-membered 
macrocyclic diesters of synthanecine A, in suitable 
quantities for toxicological testing, was achieved employing 
the widely used Corey-Nicolaou method for lactonisation.
All toxicity tests were performed at the M.R.C. Toxicology 
Unit, Carshalton (see Chapter 6).
3.2 Synthesis of Synthanecine A.
Synthanecine A was prepared by a slightly modified 
version of the route published by Mattocks (c.f. Scheme
34).i:'i3
The addition of methylamine (15 2) to diethyl maleate 
(15 3) occurred readily affording a 93% yield of the desired 
diester (154). Purification of the diester was achieved by 
an acid-base recycle (see experimental), rather than by the 
published distillation at reduced pressure. N-Alkylation 
of the diester (154) using ethyl bromoacetate (15 5) and 
potassium carbonate with ethanol as the solvent, as reported, 
gave a low yield (25%) of the triester (155). When the 
reaction mixture was heated at reflux for longer or for 
shorter periods no improvement in this yield was observed.
The use of n-butanol, a higher boiling solvent, resulted 
in a 2.5% yield. A better yield (70%) was obtained using 
acetone, containing 7% water, as the solvent. This yield
6 5 .
was improved further by employing an efficient mechanical 
stirrer. The triester (166) was cyclised by the reported 
Dieckmann procedure giving a 90% yield of the required 
pyrrolidone (167). The presence of only two AB quartets in 
the n.m.r. spectrum of compound (167) [geminal coupling 
jRa Hb ■ IB Hz and vicinal coupling J^c Hd ~  ^ Hz] suggests 
that there is only one racemate present. Application of 
the Karplus equation to the vicinal AB system resulted in 
possible dihedral angles of 25° or 135°. This did not 
allow definite assignment of stereochemistry to the 
pyrrolidone (167).
Hd
C02E1
Me
(167)
MeN /
COjEt
Unfortunately the low yield (52%) of alcohol (178) 
obtained from reduction of the ketone (16 7) could not be 
improved. Dehydration of the hydroxypyrrolidine (17 8) was 
achieved using £-toluenesulphonyl chloride in pyridine 
(88%). The last traces of pyridine were removed by 
azeotroping with water, then with benzene. Finally, 
selective reduction of the diester (168) as reported, gave 
a mixture (94%) of synthanecine A (9) and the less polar by­
product, 2 ,3-bishydroxymethyl-l-methylpyrrole (synthanecine 
A pyrrole) (179) in a ratio of 85:15 (determined by n.m.r.
6 6 .
spectroscopy). Attempted purification of synthanecine A by 
the reported acid-base recycle, which employs a citrate- 
phosphate buffer (pH 4.3), afforded a 50% recovery of amine 
which was still contaminated with the pyrrolic by-product 
(179). Synthanecine A was successfully purified by column 
chromatography on silica gel, eluting with chloroform: 
methanol:triethylamine (85:14:1). The pure necine analogue 
(9) was characterised as the picrolonate, which has a 
melting point of 175° - 176 °C (Literature value 176 °C). 
Synthanecine A was stored under dry argon at 0 °C to prevent 
oxidation to the corresponding pyrrole diol (179).
3.3 Synthesis of 11-membered Dilactones
A supply of (±)-synthanecine A was prepared using the 
synthetic procedure described above. For the diacid 
component, we first chose to use symmetrically substituted 
glutaric anhydride derivatives to avoid the problem of the 
formation of diastereomers.
Thus, treatment of synthanecine A with equimolar 
amounts of a series of 3,3-disubstituted glutaric anhydride 
derivatives (180 a-d), in dry 1,2-dimethoxyethane, gave 
quantitative yields of the corresponding 6-monoesters 
(181 a - d ) of synthanecine A (see Scheme 35). This regio- 
selective estérification was indicated by a downfield shift 
of ca. 0.4 p.p.m. for the protons at C-6 in the ^H n.m.r. 
spectrum of the monoesters compared with the signal for 
synthanecine A. The chemical shifts of the C-7 protons of 
the monoesters remained unchanged when compared with those
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in synthanecine A. No 6,7-diester formation was observed 
H n.m.r. and mass spectral data) probably because the 6- 
monoesters formed initially are zwitterionic and precipitated 
from the reaction mixture. The extent of these reactions 
was followed by the disappearance of synthanecine A (9) by 
thin layer chromatography (t.l.c.)fsee Section 3.5). These 
reactions were generally complete after ca. 10 h at room 
temperature although longer reaction times did not lead to 
degradation of the products and ensured maximum yields.
The occurrence of this regioselective estérification shows 
that the primary hydroxyl is a stronger nucleophile than the 
primary allylic hydroxyl. This difference in reactivity was 
exploited in another procedure for preparing macrocyclic 
diesters (see Chapter 4). With reference to retronecine (3), 
Robins and co-workers^** found that the primary allylic 
hydroxyl was a more reactive nucleophile than the secondary 
hydroxyl and C-9 monoesterification predominated.
The Corey-Nicolaou "double activation" method was 
selected for the lactonisation step. The pyridine-2-thiol 
esters (182 a-d) were prepared by adding 2,2*-dithio- 
pyridine (85) and triphenylphosphine (84) to suspensions of 
the 6-monoesters of synthanecine A. Vigorous stirring 
gradually effected dissolution, and the mixtures were 
stirred until formation of the pyridine-2-thiol esters was 
complete (t.l.c.). Again prolonged reaction times ensured 
maximum yields. This method for preparing thiol esters, 
reported by Mukaiyama^^, employs 2,2 -dithiopyridine as a 
Hydrogen acceptor and triphenylphosphine as an oxygen
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^acceptor (see Scheme 36).
PhaP + Py—S - S - P y  ----------- :— ) rph3P -S -P y l SPy
184) (85)
R C O 2 H
l^ h^ P—S— Py^  RCO2
(185)
H
9  „n S
[PhgP-O-C— SPy  ^ R—C—S —Py
Ph3P:0
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The pyridine-2-thiol esters underwent lactonisation 
when heated at reflux in 1,2-dimethoxyethane. Excessive 
refluxing resulted in the formation of less polar by­
products which gave a positive result (purple colouration) 
with Ehrlich's reagent (see Section 3.5). These by-products 
are presumably the corresponding pyrrolic derivatives (184 
a-d). The high dilution conditions generally required for 
macrolactonisations were achieved by diluting the reaction 
mixture (ca. 2x) before heating at reflux, or by adding the 
reaction mixture dropwise to refluxing DME. On no 
occasion was dilide formation observed.
The product mixture was initially subjected to an acid 
base recycle to remove the bulk of the pyridthione (185) and 
oxide (186) by-products. Final purification of the 
compounds was achieved by column chromatography on basic 
alumina. The 11-membered macrocyclic diester (18 3a) was
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obtained as an oil, and characterised as the salt with 
picrolonic acid (187). The other three macrocyclic
C6H4NO2-4
(187)
products (183 b - d) were crystallised (each ca. 25% overall 
yield). Correct accurate mass measurements were obtained 
for the four racemic macrocyclic products (183 a-d), and 
similar fragmentation patterns were observed in their mass 
spectra with main peaks at m/_z 123 , 107 , 9M-, 82 and 80.
This fragmentation pattern appears to be analogous to that 
observed for macrocyclic diesters of retronecine (see 
Chapter 3.5.2).
In the ^H n.m.r. spectra of the cyclised products (183 
a-d) recorded in deuteriochloroform, the protons assigned 
to C-7 had shifted downfield by ca.0.45 p.p.m. relative to 
the signal in synthanecine A, and appeared as an AB quartet 
The chemical shift difference between these protons 
(AÔ H-7) was small [0.10 - 0.19 p.p.m. for (183 b-d), and 
ca. 0 p.p.m. for (183a)]. Values of 0 - 1.24 p.p.m. for 
the chemical shift difference between the allylic protons 
at C-9 [as in (88)] have been observed for 11-membered
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macrocyclic diesters of retronecine. The two protons at 
C-6 of the macrocyclic compounds (183 a-d) are also 
diastereotopic and chemical shift differences of 0.0 7 - 
0.18 p.p.m. were observed for these protons in their 
H^ n.m.r. spectra (see Chapter 3.6.1). The distinctive mass 
spectra of compounds (183 a-d) and the non-equivalence of 
the protons at C-6 and C-7 in the n.m.r. spectra 
indicate that 11-membered macrocyclic diesters of 
synthanecine A have been produced.
Finally, the i.r. spectra of the macrocyclic dilactones 
(183 a-d) contained absorptions at ca. 1740 cm  ^
corresponding to the saturated ester carbonyls. No evidence 
was found for the presence of hydroxyl or carboxylic acid 
groups.
When synthanecine A was treated with 3-methylglutaric 
anhydride, subsequent lactonisation afforded two macrocyclic 
diastereomeric racemates (183e). The doubling of some of 
the signals in the n.m.r. spectrum of the mixture
indicated that the diastereomeric racemates (18 3e) were 
present in a 1:1 ratio. This shows that the coupling of 
the two moieties (alcohol and anhydride) proceeds in a non- 
selective manner. The diastereomers (183e) could not be 
separated by t.l.c. using a variety of solvent systems.
Full characterisation data, for the mixture, were consistent 
with the formation of the macrocyclic dilactones (183e).
A pyrrolizidine alkaloid analogue with the same diacid 
portion as dicrotaline (88) was also prepared. Reaction of
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3-hydroxy-3-methylglutaric anhydride (180f) with 
synthanecine A (9), followed by. lactonisation of the mono­
esters again produced two diastereomeric racemates (183f) 
in ca. 1:1 ratio as judged by their n.m.r. spectrum. 
Separation of the diasteromers could not be effected by 
t.l.c. Therefore,spectroscopic data were obtained for the 
mixture. The  ^H n.m.r.,  ^^ C n.m.r. and mass spectral data 
indicated that the alkaloid analogue, and a diastereomer 
had been prepared.
Finally,efforts were made to prepare macrocyclic 
dilactones with substituents on the a positions to the 
ester carbonyls, since steric hindrance around the ester 
groups is believed to enhance the toxicity of the alkaloids, 
by increasing their resistance to esterase hydrolysis.* 
Therefore synthanecine A was treated with 2,4-meso-dimethyl- 
glutaric anhydride (18 8) and the resultant monoesters were 
lactonised as described above to give two diastereomeric 
racemates (189) and (190). These racemates were purified 
by column chromatography, and were then separated by p.I.e. 
Both racemates displayed fragmentation patterns in their 
mass spectra similar to those shown by the analogues (183 
a-d).. An X-ray structure determination carried out by 
Professor G.A. Sim,®** on the more polar base confirmed its 
macrocyclic nature and established the relative 
configuration of the three chiral centres, to be as shown 
in (190) (See Section 3.7).
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Only one
enantiomer
shown
Me
MeN
(190)
The ^H n.m.r. spectra of the two racemates (189) and 
(190) showed some differences from the analogues (183 a-d). 
In particular, higher chemical shift differences were 
observed for the protons at C-6 [0.48 for (189) and 0.51 
p.p.m. for (190)] and for those at C-7 [0.20 for (189) and 
0.40 p.p.m. for (190)]. This suggests that the con­
formations of the macrocyclic rings in (189) and (190) in 
deuteriochloroform solution, may be different from those of 
the analogues (183 a-d), due to the presence of the methyl 
groups at C-10 and C-12 in (189) and (190) (see Chapter 3.7).
2,2,4,4-Tetramethylglutaric anhydride (191) was also 
treated with synthanecine A. The monoester precipitate 
afforded was subsequently transformed into the corresponding 
pyridine-2-thiol ester. All attempts to lactonise this 
thiol ester failed. The cyclisation was possibly hindered 
by the presence of the substituents a to the thiol ester 
carbonyl.
7^
As this procedure for the synthesis of macrocyclic 
diesters did not appear to produce any major by-products 
and did not require the isolation of any intermediates it 
was disappointing that only ca. 25% yields of the products 
were obtained. It was considered that these yields might 
be increased by employing the imidazole disulphide (lM-0). 
Imidazole thiol esters, such as (192), are reported^^ to be 
ca. 10 0 times more reactive than the corresponding pyridine 
analogues .
5 —
(140)
S— C— R
(192)
The C-6 monoester produced by the reaction of 
synthanecine A with 3,3-dimethylglutaric anhydride was 
treated with the disulphide (140) and triphenylphosphine 
at room temperature. Some lactonisation did occur at room 
temperature but heating at reflux in DME was necessary to 
complete the reaction. No increase in yield was observed 
using the imidazole disulphide (140).
Another modification to the Corey procedure, is the 
use of the silver ions (as the perchlorate) to activate
7 2
pyridine-2-thiol esters towards lactonisation. When a 
solution of the pyridine-2-thiol ester (182b) in DME was
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added dropwise to a solution of silver perchlorate in DME 
which was heated at reflux, no improvement in the yield was 
observed.
It may be that low yields obtained in the lactonisations 
are due to a combination of factors. One likely factor is 
the instability of the cyclised products towards the 
conditions involved in the purification procedure.
Hydrolysis of the dilactones could occur readily during the 
acid base recycle. When a pure sample of the macrocyclic 
diester (183b) was subjected to an acid-base recycle at 
room temperature, only a 40% recovery of product was 
obtained. Repeating this procedure, but keeping all 
apparatus and solutions as cool as possible, resulted in a 
51% recovery of the macrocyclic product (183b). A possible 
solution to this problem would be to devise a synthetic 
procedure that did not involve an acid-base recycle (see 
Chapter 4).
Another limitation of this procedure results from the 
persistence of triphenylphosphine oxide (186) which 
contaminates the final product. It was thought that this 
problem might be overcome by employing a polymer supported 
triphenylphosphine. Unfortunately, as time was not 
available the use of polystyryldiphenylphosphine instead 
of triphenylphosphine in the Corey-Nicolaou procedure was 
not investigated.
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3.4 Synthesis of 10-membered Dilactones,
The formation of a 10-membered macrocyclic diester of 
synthanecine A was of synthetic as well as toxicological 
interest. Since a molecular model of the 10-membered 
macrocycle (19 3) appeared to display an increase in ring 
strain, it was considered that the ring formation might be 
less favourable than for 11-membered rings. This additional 
ring strain might also have an influence on the biological 
activity of the dilactone if it could be formed.
When synthanecine A was treated with an equimolar amount 
of succinic anhydride in dry 1,2-dimethoxyethane (DME) a 
monoester precipitate was observed. This monoester was 
transformed into the corresponding pyridine-2-thiol ester,
ai
using 2 ,2 ’-dithiqjpyridine (85) and triphenylphosphine (84) 
(c.f. Scheme 35). The thiol ester was then added dropwise 
to refluxing DME to effect lactonisation. The desired
(193)
10-membered macrocyclic diester (193) was isolated as white 
crystals in ca. 30% yield. The high resolution mass spectrum
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of the free base displayed a molecular ion corresponding to 
In addition a typical fragmentation pattern for 
a synthanecine A dilactone was observed. The i.r. spectrum 
showed a saturated ester carbonyl absorption at 1736 cm”\
In the ^H n.m.r. spectrum of the macrocyclic diester (193) 
large chemical shift differences for the C-6 (0.42 p.p.m.) 
and C-7 protons (0.68 p.p.m.) were observed.
Ten-membered macrocyclic diesters with a,a-disubstitution 
[(194) and (195)] were prepared to see what effect steric 
hindrance at the a position to the ester carbonyl would have 
on the biological activity of 10-membered macrocycles. 
Synthanecine A was treated with (±)-trans-2,3-dimethyl-
jO>
Rl=H,R2=Me(194)
0 ^ 0
(195)
R’= M c ,r 2=H
Only one enantiomer shown
succinic anhydride and (±)-trans-cyclohexane-1,2-dicarboxylic 
anhydride respectively and the corresponding monoesters were 
cyclised by the Corey-Nicolaou method (c.f. Scneme 35), in 
yields of 32% and 2 3% respectively. In each case the two
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diastereomeric racemates which were obtained could not be 
separated by t.l.c. Therefore characterisation data were 
obtained for the mixtures. The high resolution mass spectra 
of both mixtures displayed characteristic fragmentation 
patterns and molecular ions corresponding to for
(194) and for (195) were observed. The i.r.
spectra of (194) and (19 5) contained carbonyl absorptions 
(ca. 1735 cm ^) consistent with the presence of saturated 
esters. The ^H and n.m.r. spectra of the diastereomeric
mixtures were complicated due to the doubling of peaks. 
However, from the H-4 signal in their n.m.r. spectra it 
was possible to estimate that in both of the dilactone 
mixtures [(194) and (195)] the diastereomeric racemates were 
present in ratios of ca. 1:1.6. Large chemical shift 
differences for the C-6 and C-7 protons were also observed 
in the ^H n.m.r. spectra (A6 H-6 = 0.6 p.p.m. and A6 H-7 =
0.9 p.p.m.).
To test the scope of this procedure it was repeated
0^ .
MeH
(196)
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with an aromatic anhydride. When phthalic anhydride was 
reacted with synthanecine A a low yield (ca. 16%) of the 
desired macrocyclic diester was obtained. The aromatic 
dilactone (196) was obtained as white prisms and characterised 
as the free base. The high resolution mass spectrum of the 
racemate (19 6) showed a correct accurate mass measurement, 
corresponding to and a fragmentation pattern
indicative of a synthanecine A dilactone was observed. A 
carbonyl absorption at 17 20 cm  ^ that is characteristic of 
the additional conjugation, was displayed in the i.r. 
spectrum of (196). In the n.m.r. spectrum of dilactone 
(196) a complex array of signals between 7.50 - 7.85 p.p.m. 
was observed, corresponding to the four aromatic protons.
Also, the signals corresponding to the C-6 and C-7 protons 
are shifted downfield by ca. 0.45 p.p.m., and split into a 
doublet of AB quartets (A6 H-6 =0.36 p.p.m.) and an AB 
quartet (A6 H-7 = 0.48 p.p.m.) when compared to the signals 
for synthanecine A.
When 3,4,5,6-tetrachlorophthalic anhydride was treated 
in a similar fashion with synthanecine A, none of the 
desired cyclised product was isolated. Also, reaction of 
maleic anhydride with synthanecine A by the above procedure, 
failed to produce any cyclised product.
3.5 Chromatographic Analysis of this Synthetic Route.
The macrocyclic diesters [(183 a - f), 139 , 190 , (193 - 
196)] were prepared by a "one-pot” reaction, wherein none 
or the intermediates were isolated. Therefore, to ensure
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maximum yields of the macrocycles it was important that all 
stages of this synthesis were carefully monitored to 
completion before the next stage was attempted. Since the 
intermediates have well defined Rf values, the reaction 
sequence was simply and efficiently monitored by thin layer 
chromatography (t.l.c.). When a sample of the reaction 
mixture was applied to a silica gel plate which was eluted 
with chloroform-methanol-conc. ammonia (85:14:1), the Rf 
values of the intermediates were as shown in figure 3.
Synthanecine'A (9 ) has an Rf value of 0.1 whereas the 
highly polar zwitterionic monoester (of. Scheme 36) does not 
move from the baseline. Transformation of the monoester 
into the pyridine-2-thiol ester was indicated by the 
disappearance of the baseline spot and formation of a u.v. 
active product with Rf value ca. 0.3. Lactonisation to the 
cyclic diester yielded a less polar product with Rf 0.5 - 0.6
R f (c a .)
# c y c lis e d  p ro d u c t 0 - 6
#
p yrid ine - 2 - th io l es ter 0 - 3
# syn th an ec in e  A 0 -1
zw itte rio n ic  m o n o e s te r 0 - 0
Figure 8
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These differences in polarity are due to the number of 
hydroxyls present in these molecules. The diol (9) has a 
small Rf value whereas the diesters have much higher Rf values
The pyrroline-containing compounds were detected on the 
thin layer chromatogram using the method reported by the 
groups of Molyneux and Roitman*^ (see Scheme 37). The
OR
MeiMeN,
CHO
H
OR
NMe
(198)
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chromatogram was sprayed with a 1% solution of o-chloranil 
in toluene, and upon heating the pyrroline intermediates 
were oxidised to their corresponding pyrroles (197). On 
subsequent spraying with Ehrlich's reagent (2% £-dimethyl- 
aminobenzaldehyde in ethanol containing 2% borontrifluoride 
etherate) these pyrroles were converted into conjugated 
adducts (19 8) which have a characteristic deep purple colour. 
Detection of any pyrrolic by-products was achieved by 
spraying the chromatogram with Ehrlich's reagent only.
The reaction with Ehrlich's reagent is the basis of the 
method for the detection of pyrrole derivatives which were 
extracted from the livers and lungs of rats during the 
toxicological tests .
3.5 Spectroscopic Analysis of these Macrocycles.
^H N.m.r. spectroscopy and mass spectrometry have 
provided essential data for the characterisation of these 
macrocyclic synthanecine A dilactones.
3.5.1 ^H N.m.r. Spectroscopy.
The important features in the ^H n.m.r. spectra of 
these synthanecine A derivatives, are the signals due to the 
protons bonded to the C-6 and C-7 carbinol carbons. The 
chemical shifts and splittings of these signals provide vital 
information on the state of estérification of this system. 
When the C-6 and C-7 hydroxyls are not esterified, as in 
synthanecine A (9), these diastereotopic protons give rise
83.
0R2 (9)r1 = r2=H
(199) r1 = r2 = COMe
(193) r 1 , r 2 =  COCH2CH2CO
(183c) r1, r2 = C0 CH2C[(CH2)4]C H 2C0
to signals with chemical shifts of 3.66 p.p.m. and 4.20 p.p.m, 
respectively. The signals corresponding to the C-6 protons 
appear as a broad doublet, due to splitting by the C-2
proton and a broad singlet is observed for the C-7 protons
as the adjoining carbon (C-3) is quaternary (see Figure 9). 
When these hydroxyls are esterified, as in the diacetate
(199), the signals for the C-6 and C-7 protons are shifted
downfield, but their appearance remains the same (see 
Figure 10). The deshielding of protons attached to the a 
carbon atom of the alcohol moiety of esters, as compared 
with the same protons in the free hydroxyls, is called the 
"acylation s h i f t " . G e n e r a l l y ,  the acylation shift for 
secondary alcohols is between 1.0 - 1.15 p.p.m. whereas for 
primary alcohols the range is from 0.40 - 0.60 p.p.m. The 
acylation shifts for the C-6 and C-7 protons of synthanecine 
A diacetate (199) [c.f. Figures 9 and 10] are ca. 0.45 p.p.m. 
which is indicative of primary alcohol acylation. This 
phenomenon was utilized when studying the monoesterification 
of synthanecine A. When synthanecine A was treated with one 
equivalent of an acylating agent (acid anhydride or N- 
acylimidazolide) the broad doublet at 3.66 p.p.m..
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corresponding to the C-6 protons, was shifted downfield by 
ca. 0.45 p.p.m. and the broad singlet at 4.20 p.p.m. 
assigned to the C-7 protons remained constant. This 
indicated that monoesterification occurred at the more 
nucleophilic primary hydroxyl rather than the primary allylic 
hydroxyl.
The conformations of macrocyclic diesters of 
synthanecine A are influenced by the presence of the fused 
pyrroline ring and the two ester groups. These constraints 
on the molecule may lead to the macrocycle adopting a 
conformation in which the diastereotopic protons at C-6 and 
C-7 are influenced to different extents by the ester 
carbonyls and, in the case of the C-7 protons, by the 1,2- 
double bond. In the simplest case where these protons are 
nearly magnetically equivalent, they give rise to broad 
signals, similar to those observed for the diacetate (199).
As the degree of non-equivalence becomes greater, the broad 
singlet due to the C-7 protons is resolved into an AB 
quartet and the broad doublet corresponding to the C-6 
protons is split into a doublet of AB quartets (see Figures 
11 and 12). The differences in the chemical shifts of the 
signals for the two protons at C-7 ( A6 H - 7) and for the 
two protons at C-6 ( A6 H - 6), are a measure of the degree 
of non-equivalence of these protons. The occurrence of 
significant A6 H - 7 and A5H - 6 values is considered to be 
convincing evidence for the presence of a macrocyclic 
diester. As a range of values have been observed for 
A5H- 6 and A6 H - 7 in macrocyclic diesters of synthanecine
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Figure 9
n.m.r. spectrum of
(± )-Synthanecine A.
C M
en
2
a:
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Figure 10
n.m.r. spectrum of
(±)-6,7-0,0-(Diacetyl)synthanecine A (199)
z
a:
a:
37
Figure 11
n.m.r. spectrum of (± )-6 , 7-0 ,0-(Succinyl)synthanecine A 
(193).
012356
Figure 12
n.m.r. spectrum of (±)-6,7-0,0-
(3,3-Tetramethyleneglutaryl)synthanecine A (183c)
o
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A it appears that these macrocycles have adopted different 
conformations (see Chapter 3.7).
3.6.2 Mass Spectrometry.
Analysis of the mass spectra of the macrocyclic 
diesters [(183 a-f), 189, 190, (193 - 196)] reveals that they 
have similar fragmentation patterns. The main ions are at 
m/z 123, 107, 94, 82 and 80. It is known that the 
characteristic fragmentation pattern of retronecine diesters 
(m/£ 136, 120, 94, 82 and 80) probably arises by cleavage of 
the allylic ester followed by loss of the diacid proton.^
The fragmentation patterns for diesters of retronecine and 
synthanecine A are similar. The ions at m/^ 136 and 120 of 
retronecine diesters contain an additional CH in the base 
fragment compared to the analogous peaks in the mass spectra 
of synthanecine A derivatives. A possible fragmentation 
pattern for the macrocyclic synthanecine A dilactones, based 
on this similarity, is shown in Scheme 38.
3.7 Conformational Aspects of Synthanecine A Dilactones.
The conformation of macrocyclic pyrrolizidine alkaloids 
in the solid state and in organic solutions can be evaluated 
from X-ray crystallographic and ^H n.m.r. spectroscopic data 
respectively, and for senecionine (20) these conformations 
appear to be similar (see Chapter 1.6).
^H N.m.r. spectroscopy can provide data on the magnetic 
non-equivalence of the C-6 (AÔ H-6) and rhe C-7 (AÔ H-7)
90
CH2)n
MeN
(CH2ln-C02H (CH2)n— CO2
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1^ '
Me
H
94
SCHEME 38
91.
diastereotopic protons of synthanecine A dilactones. The 
extent of this non-equivalence is indicative of the 
conformation adopted by the macrocycle in organic solution, 
as discussed in Chapter 1.6 (i.e. A small A6 H value 
indicates that the macrocycle adopts a conformation in which 
the diastereotopic protons are symmetrically distributed 
about the plane of the neighbouring carbonyl group and a 
large A6 H value indicates that in the adopted conformation 
one of the diastereotopic protons is located closer to the 
plane of the neighbouring ester carbonyl than the other). A 
range of A5 H -7 and A6 H - 6 values have been observed for 
this series of analogues as shown in Table 2. For macrocycles
TABLE 2 .
11-membered dilactones Aô H - 7 A6 H - 6
(p.p.m.) (p.p.m.)
(183 a) glutarate 0 0.07
(183b) 3,3-dimethylglutarate 0.16 0.17
(183 c) 3,3-tetramethyleneglutarate 0.10 0.07
(183 d) 3,3-pentamethyleneglutarate 0.13 0.13
(189) 2,4-dimethylglutarate 0.20 0.48
(190) 2,4-dimethylglutarate 0.40 0.51
10-membered dilactones
(193) succinate 0.68 0.42
(196) phthalate 0.48 0.36
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(183 a -d) the Ad H - 7 values are between 0 and 0.17 p.p.m. 
Whereas dilactones (189) and (190) exhibit AdH - 7 values 
of 0.2 and 0.4 p.p.m. respectively. A similar trend is 
observed for the AdH - 6 values of these 11-membered 
macrocyclic diesters. Therefore, it is possible that 
macrocycles (183 a-d) adopt different organic solution 
conformations from dilactones (189) and (190). This may be 
a consequence of the different patterns of substitution of 
their diacid components.
To confirm the macrocyclic nature of these products the 
structures of dilactones (183b), (183c) and (190) were 
elucidated by Professor G.A. Sim from X-ray crystallographic 
data (see Figures 13, 14 and IS respectively). It is clear 
that compounds (183b) and (183c), which exhibit small AdH - 
6 and - 7 values in the  ^H n.m.r. spectra, are macrocyclic 
and adopt solid state conformations in which their ester 
carbonyl groups are anti-parallel, with the allylic ester 
carbonyl directed below the plane of the macro-ring. On the 
other hand dilactone (190), which has large Ad H - 6 and 
AdH - 7 values, adopts a conformation in which its ester 
carbonyl groups are syn-parallel and directed above the plane 
of the macro-ring. Most 11-membered macrocyclic diesters of 
retronecine have ester carbonyl groups that are syn-parallel 
and directed below the plane of the ring.
The X-ray structure of the succinate dilactone (193) 
(Figure 16) calculated by Dr A.A. Freer, shows that this 10- 
membered macrocycle adopts a conformation in which its 
ester carbonyl are anti-parallel and directed outwards from
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-igure 13
X-ray structure of ( ± )-6 , 7-3 ,C-( 3 , 3-ci.Tiethyl' 
3-^utaryl) synthanecine A (133 b) .
94
Figure 14
X-ray structure of ( ± )-5 , 7-0 ,0-( 3 , 3-tetrame‘_ny-ene 
glutaryl)synthanecine A (133 c).
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rigure xo
X-ray structure of ( ± )-5 , 7-0 ,0-(meso 2 , 4-f iir.etny ^
glutaryl)synthanecine A (130).
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o
figure 16
■ -ray structure of (r )-5 , 7-0,0-(succinyl)- 
synthanecine A (193).
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the macro-ring. This is the same orientation as observed 
for the 10-membered macrocyclic diester (13 3) containing 
retronecine.
Some interesting differences have emerged between the 
X-ray structures of these synthanecine dilactones. Further 
X-ray studies should be carried out on other dilactones of 
synthanecine A to discover if any general trends will emerge
3.8 Conclusions.
A series of 10- and 11-membered macrocyclic diesters of 
synthanecine A [(183 a- f), 189 , 190 , (193 - 196 )] have been 
prepared using the Corey-Nicolaou procedure to effect the 
crucial lactonisation step. High resolution mass 
spectrometry and ^H n.m.r. spectroscopy have provided the 
essential data for the characterisation of these dilactones 
(see Chapter 3.6). X-ray spectral data of (183b), (190), 
(183c) and (193) show that the macrocycles adopt different 
conformations. This is also indicated by the ^H n.m.r. 
spectroscopic data.
Some of these macrocyclic diesters have been tested at 
the M.R.C. Toxicology Unit to assess their hepatotoxicity 
(see Chapter 6).
The fact that these dilactones were obtained in low 
yields, may be a consequence of the lengthy purification 
procedure. A more efficient synthetic method would not 
involve large quantities of coupling reagents and the un­
desirable acid-base recycle for purification (see Chapter 4).
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CHAPTER 4
SYNTHESIS OF A SERIES OF ALIPHATIC, QLEFINIC AND AROMATIC 
SYNTHANECINE A DILACTONES VIA THE ALLYLIC CHLORIDE (200).
i+.l Introduction.
Although the synthesis of a series of macrocyclic 
diesters of synthanecine A was accomplished using the Corey- 
Nicolaou lactonisation procedure, only low yields of these 
products were obtained (see Chapter 3). In order to produce 
sufficient material for further studies of their biological 
activity, a more efficient method for the preparation of 
macrocycles, such as (183a), was required. Use of a 
different method might also enable a wider range of 
analogues to be prepared.
MeN
(183a)
During our studies on the formation of macrocyclic 
diesters (see Scheme 35) it was observed that monoesterifi- 
cation of synthanecine A, using an anhydride, occurred 
selectively at the C-6 hydroxyl. Cyclisation was then 
effected by the intramolecular condensation of the free acid 
^nd the primary allylic hydroxyl.
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A method for the specific esterifcation of the allylic 
hydroxyl of retronecine was developed by Culvenor and co- 
workers^^ (see Scheme 7). This method relies upon the high 
reactivity of allylic chlorides towards nucleophilic dis­
placement by a carboxylate anion. A related reaction was 
reported by Vedejs and Larsen^° in which lactonisation of a 
hydroxyacid was accomplished by the carboxylate displacement 
of an allylic mesylate (see Scheme 17). We have.combined 
these methods to develop a convenient and efficient route 
to synthanecine A dilactones containing aliphatic, olefinic 
and aromatic diacids. This procedure is based upon the 
nucleophilicity of the primary hydroxyl and the electrophilic 
reactivity of the allylic chloride moieties of the key 
intermediate (200).
MeHN.
(200)
HO CL
(201)
A similar procedure has been developed, by Robins and 
Burton, employing the hydrochloride salt (201), for the 
preparation of macrocyclic diesters of retronecine.
Compound (200) could also arise by initial attack of 
the more nucleophilic hydroxy group at C-6 of synthanecine 
A (9) on thionyl chloride, followed by formation of a cyclic 
sulphite ester, and subsequent attack by chloride to give 
the product (200).
An alternative structure for this product (200) which 
is also consistent with the available n.m.r. spectroscopic 
evidence is the structural isomer (200a). Further data 
will be required to establish the correct structure of 
this reaction product.
C
MeN
a '
100 .
4.2 Synthesis of 3-Chloromethyl-2-HydroxyTiiethyl-l-MethyI-
3-Pyrrolinium Chloride (200).
8 8
Since Adams and Van Duuren prepared (7R,8R)-1- 
chloromethyl-7-hydroxy - 1 , 2-didehydropyrrolizidine as the 
hydrochloride salt (201) by treating (+)-retronecine with 
thionyl chloride at 0°C, it was anticipated that the allylic 
chloride (200) could be prepared similarly.
When synthanecine A (9) was treated with thionyl 
chloride at 0°C the desired allylic chloride (200) was 
produced. This chlorination possibly proceeded yia the 
mechanism shown in Scheme 39. The chlorosulphite (202), 
produced by the reaction of synthanecine A and thionyl
OH
50CL2
MeN,
c r
(9)
(202)
HO
Mel (203)
MeN
(200)
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chloride, dissociates into an intimate ion pair (203), the 
anion of which immediately collapses to give sulphur dioxide 
and chloride ion. Subsequent attack of the latter on the 
carbonium ion gives the desired allylic chloride (200).
When the reaction was complete (45 min) the excess 
thionyl chloride was removed under reduced pressure at 0°C 
to prevent further chlorination which would give the 6,7- 
dichloro derivative ’(204). The crude product was initially
CLC
MeN
(204)
obtained as a purple gum. Subsequently, purification and 
crystallisation afforded the hydrochloride salt (200) as 
white crystals (55%) and a brown oil (35%). The brown oil 
could be used to prepare synthanecine A dilactones, however 
lower yields (ca. 50% of the reported yields) of the 
macrocyclic products were obtained.
Correct microanalytical data were obtained for the 
crystalline hydrochloride salt (200). The accurate mass 
spectrum of the allylic chloride (200) did not display a 
molecular ion, however ions at m/^ 132 and 130 correspond to 
3 molecular ion minus CH^OH. The presence of chuorine in 
the molecule was indicated by its characteristic isotope 
pattern. The n.m.r. spectrum of the chloromethyl
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derivative (200), recorded in deuterium oxide (D%0), 
displayed a sharp singlet at 3.16 p.p.m. due to the N-Me 
group. This is a downfield shift of ca. 0.6 p.p.m. relative 
to the signal for synthanecine A and is due to the presence 
of the quaternised nitrogen. Downfield shifts for the 
signals corresponding to the N - ^  and C-2 and an upfield 
shift for the signal assigned to C-7, were observed in the 
n.m.r. spectrum of the hydrochloride salt (200), when 
compared to that of synthanecine A. The downfield shifts 
are due to the presence of the quaternary ammonium salt and 
the observed upfield shift is indicative of chlorination at 
C-7.
The allylic chloride (200) was also obtained when a 
solution of synthanecine A in dry DME at -5°C was treated 
with thionyl chloride. The free base, 3-chloromethyl-2- 
hydroxymethyl-l-methyl-3-pyrroline (205), was obtained by 
neutralising the hydrochloride salt (200) as shown in Scheme 
+^0. When the free base (205 ) was stored, even at 0 C, it 
decomposed into an intractable gum. The basic nitrogen of 
(205) may assist the primary hydroxyl towards intramolecular 
nucleophilic displacement of the allylic chloride to produce 
the cyclic ether (206), or intermolecular attack may yield 
polyether products. Quaternisation of the free amine by the 
allylic chloride to form compound (207), or a polymer is 
also possible (see Scheme 40). The allylic chloride was 
therefore stored as the hydrochloride salt (200).
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4-. 3 Synthesis of Macrocyclic Diesters of Synthanecine A.
In our initial investigations into the preparation Ox 
synthanecine A dilactones from the allylic chloride (200), 
substituted glutaric anhydride derivatives were chosen for 
the diacid moiety as this allowed a comparison to be made 
with the procedure discussed in Chapter 3 that involved 
Corey-Nicolaou lactonisation. A solution of the hydroxy
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allylic chloride (200 ) in DMF was treated with an equimolar 
amount of 3,3-dimethylglutaric anhydride (180b) in the 
presence of 2.1 equivalents of various bases. The first 
equivalent of base is employed to neutralise the hydro­
chloride salt (200) and the second is used to generate the 
carboxylate anion of the initial monoester product (209)
(see Scheme 41). VThen the hindered base, diisopropylethyl- 
amine (Hunig's base) (210) was used, no cyclised product 
was formed and the allylic chloride (200) slowly decomposed 
(t.l.c.). Possible decomposition products are the cyclic 
ether (206) and the quaternary ammonium derivatives (207) 
and (208) (see Scheme 40). With l,8-diazabicyclo[5,4,0]- 
undec-7-ene (DBU) (211) as the base a product was observed
HO
Mel
(208)
àt the expected Rf value on t.l.c. (The reactions discussed 
in this chapter were monitored by t.l.c. using the method 
reported in Chapter 4.4). The starting material (200) had 
disappeared after 5 h at room temperature, but the reaction 
fixture was left for a further ca. 20 h to ensure a 
maximum yield. After this time the solvent (DMF) was 
removed under reduced oressure and the resulting oil was 
purified by column chromatography on basic alumina. A 5 3-6
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yield of a white crystalline product was obtained. This 
product was spectroscopically and chromatographically 
identical with a known sample of the dilactcne (183 b).
MeN
(200)
b a s e
u s in g  ( 2 1 0 )  a s  base —  no re a c tio n
(211) —  53®/o y ie ld
(2 1 2 )  —  3 7 %  y ie ld
SCHEME iA
Me. .Me Me, Me 0
(180b)
MeN
(209) ♦ baseHClMe
MeN
(183b) + baseHCL
^0 improvement on this yield was obtained when another
longer base, 1 ,5 -diazabicyclo[4,3,0]non-5-ene (DBN)
(212) was employed. Other glutaric anhydride derivatives 
Were treated with the allylic chloride (200) in a similar 
fashion, using DBU (211) as base. In all cases the yields
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Me
• * N
Me
Me
(211)
c t )
(212)
(210)
of cyclised products obtained were better than those 
achieved by the Corey-Nicolaou method (Chapter 3). The 
increased yields may be partially due to the simple and 
convenient purification procedure that was used. Since this 
route does not involve large quantities of coupling reagents, 
the crude reaction mixture was subjected to column chromato­
graphy without initial purification by a potentially 
destructive acid base recycle. The reaction of glutaric 
anhydride (180a) and 1 ,1-cyclohexanediacetic anhydride 
(ISOd) with allylic chloride (200) and DBU afforded the 
corresponding macrocyclic diesters (183a) and (183d) in 37% 
and 66% yields respectively. Other macrocyclic diesters of 
interest were also prepared by the method discussed above.
A mixture of the diasteromeric racemates (183f) which are 
analogues of the pyrrolizidine alkaloid dicrotaline (88)
Were prepared in 5 2% yield. The diasteromeric racemates 
(189) and (190) were also prepared in a yield of 77%. All 
of the 11-membered macrocyclic diesters prepared by the 
procedure described above, displayed spectroscopic and 
chromatographic properties which were identical to those
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obtained for known samples.
Synthesis of a new macrocyclic dilactone (213) 
containing 2,2,4,4-tetramethylglutaric acid and synthanecine 
A was also accomplished by this method in M-M-% yield. An 
accurate mass measurement of the racemate (213) gave a 
molecular formula of and. the mass spectral
fragmentation pattern observed was typical of a macrocyclic 
diester containing synthanecine A. The i.r. spectrum of
(213) displayed an ester carbonyl absorption at 1730 cm \
In the n.m.r. spectrum of the sterically hindered 
dilactone (213), compared to that of synthanecine A, the 
signals assigned to the C-6 protons were shifted downfield 
by 0.55 p.p.m. and appeared as a doublet of AB quartets; a 
AÔ H-6 value of 0.53 p.p.m. was observed. The C-7 diastereo­
topic protons were shifted downfield by 0.46 p.p.m. and were 
magnetically equivalent. Another interesting feature in the
MeMe
Me
MeN.
(213)
H^ n.m.r. spectrum of (213), which is also consistent with 
the formation of a macrocycle, is tne distinct non
108
equivalence of the C-11 protons. Previous attempts to 
prepare the 11-membered dilactone (213) by the Corey- 
Nicolaou method had been unsuccessful. Due to the increased 
steric hindrance around its ester carbonyls, the 2,2,4,4- 
tetramethylglutarate dilactone (213) may have enhanced 
hepatotoxicity (see Chapter 1.4). The hepatotoxicity of 
this dilactone (213) will be assessed at the M.R.C.
Toxicology Unit, Carshalton.
For further comparisons with the Corey-Nicolaou method 
a series of 10-membered aliphatic macrocyclic diesters were 
prepared. Treatment of the hydrochloride salt (200) with 
succinic anhydride and DBU gave a 10% yield of the dilactone
(193). This reaction proceeded very slowly and even after a 
few days at room temperature some unreacted allylic chloride 
(200) was observed. T.l.c. also indicated the presence of a 
major by-product with Rf value of 0.0. An increase in the 
yield of the succinate cyclic diester (193) was obtained 
when the reaction mixture was heated at 70 C for 6 h. When 
( -)-2,3-dimethylsuccinic anhydride was treated with the 
allylic chloride (200) and DBU at room temperature a 17% 
yield of the 10-membered diastereomeric racemates (194) was 
obtained. This reaction also occurred slowly. The 
reactions discussed above may be unfavourable due to the 
increased strain present in 10-membered macrocycles and the 
orientation of the attacking carboxylate anion. It appears 
"that low yields of macrocyclic products are obtained wnen 
the rate of reaction is slow. One possible reason for this 
that the starting material (200) is decomposed under the
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basic rsâ-ction conditions. Preparation of the lO—memhered 
macrocycles (19 5) occurred more readily and a significant 
increase in yield was observed (51%). The presence of the 
cyclohexane ring reduces the flexibility of the attacking 
carboxylate, thus making the cyclisation more favourable.
The 10-membered macrocycles (193) - (195) displayed n.m.r, 
spectra which were identical with those obtained for known 
samples.
6 8
Deslongchamps has reported that the rate of 
cyclisation of a 10-membered carbon chain is facilitated by 
the presence of unsaturation with the appropriate stereo­
chemistry. This unsaturation reduces the degrees of freedom 
and transannular interactions of the system, therefore 
making the cyclisation more favourable on the basis of both 
the entropy and enthalpy factors (see Chapter 2.3).
When maleic anhydride, the unsaturated derivative of 
succinic anhydride, was treated with the hydrochloride salt 
(200) in the presence of DBU, the racemate (214) was 
formed after a few hours and was isolated in a 49% yield. 
Since the succinate dilactone (193) was isolated in only 
10% yield after 3 days under identical conditions it appears 
that the presence of the double bond, with cis stereo­
chemistry, has increased the rate of lactonisation and led 
to a higher yield of product. By comparing the rate of 
formation and yield of this olefinic dilactone (214) with 
those of the saturated dilactone (195) that contains a 
cyclohexane ring, it would appear that the fused ring has 
the same influence as that of the double bond. Treatment of
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2,3-dimethylmaleic anhydride in a similar manner afforded 
the corresponding racemate (215) in 33% yield. The rate
(214) R=R^= H
(215) R^ = R^ = Me
(216)
of reaction of this anhydride with the allylic chloride 
(200 ) in the presence of DBU, was noticeably slower than the 
corresponding reaction using maleic anhydride. An increased 
reaction rate was observed when 3 ,4 ,5 ,5-tetrahydrophthalic 
anhydride was treated similarly. As a consequence of this 
increased rate of reaction the racemate (216) was obtained 
in a 77% yield, which indicates that the unsaturation and 
the carbocyclic ring have had a combined beneficial 
influence on this reaction.
The three new olefinic dilactones (214), (215) and
(216) were fully characterised as free bases. When they 
Were purified by recrystallisation, the white crystalline 
solids gave correct microanalytical data. High resolution 
^^ ss spectra data on the olefinic dilactones (214), (215)
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and (216) display molecular ions corresponding to 
CigHiyNO^ and C^gH^gNO^ respectively. In all cases the 
fragmentation patterns exhibited were indicative of 
dilactones containing the synthanecine moiety (see Chapter 
3.6.2). The i.r. spectra showed a ,3-unsaturated ester 
carbonyl absorptions at ca. 17 2 5 cm , and no hydroxyl or 
carboxylic acid absorptions were observed. The key 
features in the n.m.r. spectra of the macrocyclic 
diesters (214), (215) and (216) were the AB quartets (ca.
4.85 p.p.m.) corresponding to the C-7 protons and the 
doublet of AB quartets (ca. 4.25 p.p.m.) assigned to the 
C-6 protons. The acylation shifts for these signals (ca.
0.6 p.p.m.) were consistent with the estérification of 
primary alcohols. As the extent of non-equivalence of the 
C-6 and C-7 diastereotopic protons is about the same in 
each case (see Table 3) it would appear that these macrocycles 
adopt similar conformations.
Synthanecine A
dilactone
A6 H-6 
(p.p.m.)
AÔ H-7 
(p.p.m.)
Reaction 
Yield (%)
(214) maleate 0.36 0.53 49
(215) 2,3-dimethylmaleate 0.44 0.53 33
(216) 3 ,4 , 5 ,6-tetra- 0.46 0.60 77
hydrophthalate
Table 3
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We then decided to prepare the 10-membered aromatic 
dilactone (196) to see if the aromatic ring would have an 
influence on the rate of reaction and the isolated yield. 
Previous attempts to prepare the phthalate derivative (196) 
by the Corey-Nicolaou procedure only gave low yields (ca.
16%) of the product. The hydrochloride salt (200) in DMF 
was treated with phthalic anhydride in the presence of DBU.
The starting material (200) had completely disappeared 
after 10 min. and the presence of cyclised product (Rf 0.72) 
and a highly polar by-product (Rf 0.0) were indicated by 
t.l.c. After 6 h the reaction mixture was worked up in the 
usual manner to give an 86% yield of the macrocyclic 
diester (196). In view of this encouraging result, this 
procedure was repeated with a series of symmetrically 
halogenated phthalic anhydrides. The halogenated derivatives
(217), (218) and (219) were formed at approximately the same 
rate as the phthalate dilactone (196) and in comparable 
yields (see Table 4).
The phthalate dilactone (196) was spectroscopically and 
chromatographically identical with a known sample. The 
novel halogenated phthalate derivatives (217), (218) and 
(219) were obtained as white crystalline solids and 
characterised as free bases. Appropriate molecular ions 
Were observed in their high resolution mass spectra and the 
presence of the expected isotope abundance patterns confirmed 
the presence of halogens. The mass spectral fragmentation 
Patterns of the new analogues were typical of synthanecine 
 ^^tlactones with main peaks at m/_z 123 , 107 , 94 and 82.
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MeN
(196) r’ =  r 2 = h
(217) r1 = H  , R2=Cl
(218) r 1 =  r 2 =  cL
(219) r1 =  r2 -  Br
The 'H n.m.r. spectra of the aromatic dilactones (217),
(218) and (219) displayed the characteristic AB quartets 
and doublet of AB quartets assigned to the C-7 and C-6 
diastereotopic protons respectively. Primary alcohol 
acylation shifts of ca. 0.75 p.p.m. abd 0.85 p.p.m. were 
observed for the C-6 and C-7 protons. The chemical shift 
difference of these protons (see Table 4) shows more 
variation than the olefinic series (see Table 3). This may 
be due to the presence of different conformations as a 
consequence of the steric effects of the halogens.
Synthanecine A
AÔ H-6 A6 H-7
dilactones (p.p.m.) (p.p.m.) Yields (%)
(196) phthalate 0.36 O.M-8 86
(217) M-, 5-dichlorophthalate 0.34 0.47 91
(218) 3,4,5,6-tetrachloro-
phthalate 0.23 0.23 67
(219) 3,4,5,6-tetrabromo-
phthalate 0.13 0.15
Table 4
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(220)
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Finally, treatment of the allylic chloride (200) with 
naphthalene-1,8-dicarboxylic anhydride and DBU produced an 
11-membered aromatic dilactone (220). The formation of this 
analogue (220) occurred readily and a 55% yield was obtained. 
The 11-membered macrocyclic diester (220) was characterised 
as the free base. Comparison of  ^H n.m.r. spectra of the 
dilactone (220) and synthanecine A showed that the protons on 
C-7 had shifted downfield by ca. 0.8 p.p.m. and appeared as 
an AB quartet. The signals for the protons on C-6 had also 
shifted downfield by ca. 0.8 p.p.m. and appeared as a 
doublet of AB quartets. The i.r. spectrum of the 11-membered 
dilactone (220) showed a conjugated ester carbonyl at 1725 
cm” .^ A weak absorption at 30 20 cm  ^ corresponded to the 
aryl C-H stretch. Correct accurate mass measurement and 
microanalytical data were obtained for the free base (220).
The rates of formation and yields obtained of these 
macrocyclic diesters of synthanecine A, appeared to be 
influenced by changes in the diacid moieties. Saturated 11- 
membered macrocycles were more readily formed than saturated
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lO-membered ones. Also, the presence of any structural 
feature that reduced the flexibility of the intermediate 
carboxylate anion, increased the rate of cyclisation which 
consequently led to an increase in the isolated yield.
[This is because reaction times lead to decomposition of 
some of the starting allylic chloride (200)]. For example, 
the succinate product (193) was formed slowly and in very 
low yield (10%) (see Table 5). When unsaturation was 
introduced into the 2,3-position (maleic anhydride) the 
reaction proceeded much more readily and the product (214) 
was obtained in a 49% yield. By introducing an aromatic 
ring (phthalic anhydride) the rate of reaction and yield 
were increased further.
The rate of reaction and yields of macrocyclic diesters 
obtained by this route were also dependent on the base 
employed (see Table 6).
Percentage Yields of Macrocyclic Diesters using Different Bases
macrocyclic diester base
HUNIG'S DBN DBU
(210) (212) (211)
(183b) 3,3-dimethyl-
glutarate x 37% 53%
(214) maleate x x 49%
(218) 3,4-dichloro-
phthalate 40% 24'
X no reaction
Table 5
116...
Percentage yields of 10 membcred macrocyclic diesters of 
synthanecine A obtained when DBU was used as base .
10
Me ’ Me
> -\
17 51
Me Me
33 77
86
a  Cl
/ /
91 67
CL
Table 5
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The best results were obtained when DBU was utilised. Time 
did not permit study of this reaction with other bases. 
However it is clear that good yields were obtained in the 
lactonisation by using a strong Qmti"»e Vxxsfe
4.4 Chromatographic analysis of this route.
The formation of these macrocyclic diesters was 
monitored by t.l.c. using the same procedure as described in 
Chapter 3.5. The disappearance of the allylic chloride (200) 
and the formation of macrocyclic diesters were observed, by 
t.l.c., without difficulty (see Figure 17). However, the
cyclised product
allylic chloride
possible monoester
Figure 17
likely monoester intermediate may be obscured by baseline 
by-products or it may react rapidly to produce the cyclised 
product. Therefore these reactions were not terminated 
after the disappearance of the allylic chloride (200), but 
were routinely continued for 2 4- h to ensure a maximum 
conversion. Formation of the 10-membered dilacrones (193),
(194) and (215) normally required 48 h.
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4.5 Conclusions.
A series of aliphatic, définie and aromatic 
synthanecine A dilactones were prepared in DMF, from the 
allylic chloride (200), the appropriate cyclic anhydride 
and 2 equivalents of DBU as base. This new method has 
advantages over the Corey-Nicolaou method (Chapter 3).
First, a wider variety of dilactones can be prepared under 
mild conditions. Secondly, the procedure is simple and.can 
probably be scaled up to produce larger quantities of the 
macrocyclic products, for testing purposes. Thirdly, the 
work-up procedure does not involve a potentially 
destructive acid-base recycle and better yields of all the 
macrocyclic products except (193) and (194) were obtained, 
[10-membered dilactones (193) and (194) were formed in 
better yields by the Corey-Nicolaou method, presumably 
because their intermediate carboxylates are not properly 
orientated for the efficient displacement of the allylic 
chloride].
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CHAPTER 5
SYNTHESIS OF 12-MEMBERED AND LARGER 
MACROCYCLIC DIESTERS OF SYNTHANECINE A
5.1 Introduction
A number of 10- and 11-membered synthanecine A 
dilactones have been prepared by the two routes discussed in 
Chapters 3 and 4. In one of these procedures monomeric 
diacid anhydrides were treated with synthanecine A to form 
intermediate monoesters which were then lactonised by the 
Corey-Nicolaou method (Chapter 3). In the second, initial 
estérification of the hydroxy allylic chloride (200) was also 
accomplished using monomeric diacid anhydrides, and then the 
lactonisation step was effected by carboxylate displacement 
of the allylic chloride (Chapter 4). Cyclic anhydrides are 
in most cases only formed by derivatives of succinic (221) 
and glutaric acids (222) since they form stable 5- (225) and 
6-membered (180a) rings. Therefore the methods already 
described are mainly suitable for the preparation of j.0- and
11-membered macrocyclic diesters of synthanecine A.
H02C”f” CH2 )n—CO2H
( 221) n= 2
(222 )  n =  3
(223 )  n= 4
( 2 2 4 )  n= 5
(225) (180a)
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Macrocyclic pyrrolizidine alkaloids occur most 
frequently with 11- and 12-membered rings. A few 13- 
membered pyrrolizidine dilactones have also been discovered 
Therefore, our next objective was to prepare 12- (226) and 
13-membered (227) macrocyclic diesters of synthanecine A. 
Such compounds are derivatives of adipic (223) and pimelic 
(224) acids. Since these diacids form linear polymeric
M gN
(226) n = 4
(227)  n = 5
anhydrides rather than cyclic monomeric ones a new route was 
required in which a different method for monoesterification 
was used. Novel pyrrolizidine alkaloid analogues with 
larger rings might also be prepared by this new route.
5.2 Attempted Synthesis of Macrocyclic Diesters
With 12-Membered and Larger Rings
The combination of a diacid and a diol, to produce an 
intermediate monoester must be selective otherwise a complex 
mixture of oligomers would be formed. The selective mono­
esterif ication of a diacid with synthanecine A might be 
achieved after protection of one of the carboxyl groups
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followed by activation of the other (see Scheme 42).
Treatment of synthanecine A with the activated and protected 
diacid (228) should give the C-6 monoester (229) of 
synthanecine A selectively. To complete the synthesis, the 
protected acid (229) has to be transformed into an activated 
acid (230) which can then undergo lactonisation to give
H02C4CH2)n-C02H
-)  A C 0 -{ -C H 2 )n -C 0 P
(228)
> H02C - f C H 2 ) n - C 0 P  
 ^
Synthanecine A
OH
MeN
(229)  R = P
(230) R = A
(231) R= OH
■>
MeN. /  
( 226)  n= 4
P = Protecting group 
A = Activating group
SCHEME kl
the desired macrocyclic product (226). Removal of the 
protecting group from the intermediate (229) would afford a
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hydroxy acid (231) that would probably not be readily 
manipulated due to its zwitterionic properties. Therefore, 
a non hydrolytic route from the protected acid to the 
activated acid would be preferable. This activation process 
should also be selective and not interfere with the ester 
linkage to synthanecine A.
8 9
In 1976 Masamune and co-workers reported a procedure 
for the direct conversion of phenyl and 2,2,2-trifluoroethyl 
esters into N-acylimidazolides as shown in Scheme 43. 
Imidazolyl sodium (232), produced by the reaction of 
l-(trimethylsilyl)imidazole (233) with a catalytic quantity 
of sodium phenoxide, reacted with the ester (234) to produce 
the required N-acylimidazolide (235) and the sodium alkoxide 
(236).
No * R^ — OR^  ^ —- R—6 — + Na OR^
(232) (234) (235) (236)
Me3Si— ♦ Na ----------> Na * WegSiOR?
(233) (236) (232) (237)
r 2= Ph a  CH2CF3
SCHEME 43
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The alkoxide (236) immediately reacted with more 1- 
(trimethylsilyl)imidazole (233) and the catalytic cycle 
continued until the ester (234) was completely transformed 
into the N-acylimidazolide (235). The reverse reaction, 
conversion of the N-acylimidazolide (235) back into the 
ester (234) was suppressed by the removal of the alkoxide 
(236) as the TMS ether (237). Since alkyl esters are 
inert to the silyl reagent (237) this method permits the 
selective activation of one ester in the presence of 
another.
The activation process described above appeared to be 
suitable for the penultimate step of the synthetic route 
shown in Scheme 42. Therefore, it was decided to explore 
further this route for preparing larger ring macrocyclic 
diesters (Scheme 42), using a phenyl or a 2,2,2-trifluoro­
ethyl ester as the protecting group. In our initial 
investigations adipic acid (223) was chosen as the diacid 
component since 12-membered macrocyclic pyrrolizidine 
alkaloids are commonly observed. Phenyl esters were 
employed instead of 2,2,2-trifluoroethyl ester since 
phenol was more readily available than 2,2,2,-trifluoro- 
ethanol. The monophenyl ester (238) of adipic acid was 
prepared when molar equivalents of phenol and adipic acid 
were coupled using l-chloro-2-methylpyridinium iodide (119) 
(see Scheme 44) (Also see Chapter 2.4, Mukaiyama method). 
However, complete separation of the half ester (238) from 
the pyridone by-product (144) proveà to be difficult.
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(119)
HO2C -(-CH2I4—CO2H
CH2CL2
EyN
H O 2C — (-CH2 4 — 8 — 0 —
5 - 2  1
(233)
SCHEME U
An alternative method for the activation of carboxylic 
acids for estérification is by their conversion into N-acyl­
imidazolides by treatment with N,N' carbonyldiimidazole (GDI) (50)
R'COiH
(240)
(50)
r2q H
0
«il 9
r’- C - 0 R 2
SCHEME 45
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(see Scheme M-5). A comprehensive review on the preparation 
and properties of N-acylimidazolides has been published by
9 0
Staab.
Treatment of adipic acid (223) with a molar equivalent 
of GDI produced a white precipitate of an N-acylimidazolide 
(see Scheme 46). A ^H n.m.r. spectrum of the product
 co r  ( I c q )
(239)
dry DME
(240)
PhOH
SCHEME 46
C O 2R 2
(238) rU h , r2= Ph 
(241) Rl = R2=Ph
obtained from this reaction displayed 3 singlets of equal 
intensity with chemical shifts of 7.10, 7.47 and 8.19 p.p.m. 
These signals correspond to the three protons on the 
imidazole ring of the activated acid (239). Also, the 
signals assigned to the methylene protons a to the imidazole 
carbonyl were shifted downfield by 0.5 p.p.m. relative to 
the signals for adipic acid. The occurrence of this down­
field shift and the presence of the 3 singlets discussed 
above indicate the formation of an N-acylimidazolide.
This ^H n.m.r. spectrum also showed two singlets at 7.08
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p.p.m. and 7.77 p.p.m. of relative intensity 2:1 which 
correspond to the three protons of imidazole (240) which is 
a by-product of this reaction. Imidazole (240) can normally 
be removed by washing a solution of the reaction mixture in 
CHgCl^, with water. Similarly, to remove the imidazole 
peaks from an n.m.r. spectrum the organic solution in the 
n.m.r. tube is shaken with DgO. When D 2O was added to the 
CDCI3 solution of this product mixture the spectrum of the 
N-acylimidazolide (239) was not observed. Therefore, the 
N-acylimidazolide (239) is probably present as a zwitterion 
or an imidazolium salt.
When the precipitate of the N-acylimidazolide (239) was 
treated directly with phenol a mixture of the required 
monophenyl adipate (238), unreacted adipic acid (223) and 
diphenyl adipate (241) was obtained (see Scheme 46); how­
ever the monophenyl ester (238) was easily purified by an 
acid base recycle. Extraction of monophenyl adipate (238) 
was carried out at ca. pH 5 to ensure that adipic acid (223) 
remained dissolved in the acidic solution.
Finally, a mixture of monophenyl adipate (238) diphenyl 
adipate and adipic acid was also prepared by reacting 
equimolar amounts of adipic acid (223) and phenol under 
Dean Stark conditions, with concentrated sulphuric acid as 
the catalyst. Purification of this reaction mixture was 
accomplished by an acid base recycle as discussed above.
This latter method was most convenient as it did not require 
a complex coupling reagent.
The monophenyl ester (238) of adipic acid was
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characterised as the free acid. An accurate mass measurement 
of the half ester (238) gave a molecular formula of C 1 2H 1 4O 4 
and the mass spectral fragmentation pattern displayed a 
peak at m/_z 129 that corresponds to the loss of OPh. The
i.r. spectrum showed a phenyl ester carbonyl absorption at
— 1 — 1
175 5 cm and a free acid carbonyl absorption at 16 9 5 cm
In the n.m.r. spectrum of the phenyl ester (238) of adipic
acid, recorded in deuteriochloroform, the signals assigned 
to the methylene protons a to the ester carbonyl were 
shifted downfield by ca. 0.18 p.p.m. compared with the 
signals for adipic acid. A complex array of signals between 
7.0 and 7.5 p.p.m. were assigned to the phenyl protons.
For the activation of the free acid, preparation of an 
N-acylimidazolide was chosen. N-Acylimidazolides are
9 0
accessible in good yields by the method described by Staab 
(see Scheme 4 5).
Reaction of monophenyl adipate (238) with GDI at room 
temperature afforded the desired phenyl imidazolyl adipate 
(242) (see Scheme 47). The N-acylimidazolide (243) was 
isolated in 85% yield. Formation of this activated acid
H02C“(-CH2 U— C02Ph
(233)
CDI
dry DME
0  
N — C H ”CH2 L — C02Ph
(242) ♦ imidazole (240)
SCHEME 47
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(242) was indicated by the presence of the three singlets of 
equal intensity at 7.11, 7.46 and 8.15 p.p.m. in its 
n.m.r. spectrum. These signals were assigned to the
three protons of the imidazole ring. A downfield shift of
0.5 p.p.m. for the methylene protons a to the imidazolide 
carbonyl relative to the signals for adipic acid was also 
observed. The accurate mass spectrum of the product (242) 
did not display a molecular ion. However, a peak at m/^
205 corresponds to the molecular ion minus CjHjNi. The i.r. 
spectrum showed a phenyl ester carbonyl absorption at
1780 cm ", and an imidazolide carbonyl absorption at 1730
•  1 ^  1
cm . No sign of an absorption at 1695 cm corresponding
to a free acid carbonyl stretch could be found. A  ^^ C
n.m.r. spectrum on the product was also consistent with the 
formation of phenyl imidazolyl adipate (242).
Treatment of a solution of synthanecine A in dry DME 
with the imidazolide (242) at room temperature afforded the 
C-6 monoester (243 ) of synthanecine A selectively (see Scheme 48 )
Im-C0-{-CH2U-C02Ph
MeN dry DME MeN
( 243)  = C0fCH2)^-C02Ph, R2 = H
(244) R^ = R^ = C04CH2)^-C02Ph
SCHEME 48
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The presence of some unreacted synthanecine A and diester 
(244) of synthanecine A was indicated by t.l.c. The t.l.c. 
procedure used and method of detection was the same as that 
discussed in Chapter 3.4. Imidazole (240) and the unreacted 
synthanecine A were removed when a solution of the reaction 
mixture in CH^Cl^ was washed with water. The protected 
intermediate (243) was obtained in 49% yield after purifi­
cation by column chromatography on basic alumina. The ^H 
n.m.r. spectrum of the synthanecine A derivative (243) _ 
displayed a downfield shift of 0.4 p.p.m. for the C-6 
protons and no change in the chemical shifts of the protons 
on C-7 when compared to the ^H n.m.r. spectrum of 
synthanecine A. This indicated that the C-6 hydroxyl of 
synthanecine A had been selectively esterified. The signals 
corresponding to the methylene protons a to the carboxyl 
esterified with synthanecine A were shifted upfield by 0.5 3 
p.p.m. relative to the imidazolide (242). An accurate mass 
measurement on the monoester (243) of synthanecine A gave a 
molecular ion of C^gH^gNO^ and the mass spectral 
fragmentation pattern was typical for a molecule containing 
a synthanecine A moiety. An ion at m/_z 2 54 which 
corresponds to the molecular ion minus OPh showed that the 
product (243) also contained a phenyl ester. An i.r. 
spectrum of the compound (243) in chloroform showed two 
carbonyl absorptions. In addition to the phenyl ester carbonyl 
stretch at 1760 cm”  ^ there was another carbonyl stretch at 
1740 cm”  ^ corresponding to the saturated ester attached to 
synthanecine A.
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To complete this synthetic route the phenyl ester
(243) had to be converted into the N-acylimidazolide (245), 
by the route illustrated in Scheme 43, followed by the 
intramolecular condensation of the allylic hydroxyl with 
this activated acid to give the cyclised product (226) (see 
Scheme 49).
OH
MeN MeN,
( 243) R = OPh (226)
(245)  R = - N
SCHEME 49
A solution of the synthanecine A derivative (243) in 
dry THF was treated with 1 equivalent of 1-(trimethyl- 
silyl)imida.zole ( 233 ) in the presence of a catalytic amount 
of sodium phenoxide. When a ^H n.m.r. spectrum of the 
product from this reaction was initially analysed it 
appeared as if no reaction had occurred. However t.l.c. of 
the reaction mixture showed the presence of a number of 
pyrroline-containing compounds. After a closer examination 
of the ^H n.m.r. spectrum a singlet at ca. 0.00 p.p.m.
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suggested that the allylic hydroxyl might have reacted with 
the trimethylsilylimidazole to afford the trimethylsilyl- 
ether (246) (Scheme 50 shows possible products for the 
reaction discussed above, and the following series of 
reactions ).
Treatment of the phenyl ester (243) with 2.2 
equivalents of 1-(TMS ) imidazole ( 233 ) and a catalytic 
amount of sodium phenoxide also yielded a complex product 
mixture (t.l.d.). A n.m.r. spectrum of the product 
from this reaction did not display any signals corresponding 
to methylene protons a to a phenyl ester carbonyl. A small 
signal at 8.1 p.p.m. indicated the presence of a very small 
quantity of an N-acylimidazolide, which may be compound 
(247). Although the phenyl ester (243) may have been 
transformed into an N-acylimidazolide, the lactonisation 
could not occur if the allylic hydroxyl was protected as 
the TMS ether. To permit the cyclisation, the TMS ether 
would have to be removed after the formation of the N- 
acylimidazolide ( 247) .
A convenient procedure for the cleavage of silyl 
ethers under anhydrous conditions was reported by Corey and
9 I
Snider. Fluoride ion, in the form of tetra n-butylammonium 
fluoride was used in this procedure making use of the 
strength of the Si-F bond. Potassium fluoride in the 
presence of 1,4,7,10,13,1 6 -hexaoxocyclooctadecane (18- 
Crown-6) (248) has also been used as a source of ’naked 
fluoride ion.*^ The crown ether (248) has the ability to 
complex metal salts and dissolve them in polar, non po±ar 
n^d aprotic solvents.
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0
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MeNMeN
(226)  n = A(245)  n = A
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(227)  n= 5
N
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( 2 4 8 )
Cleavage of the TMS ether (2M-7) by fluoride ion under 
anhydrous conditions may yield the alkoxide of the allylic 
hydroxyl (245). Spontaneous lactonisation of this alkoxide 
would afford the required macrocyclic diester (226) (see 
Scheme 50).
The phenyl ester (243) was reacted with 2.2 equivalents 
of TMS imidazole (233) and a catalytic quantity of sodium 
phenoxide at room temperature. After 2 h ca. 2 equivalents 
of anhydrous potassium fluoride and a catalytic amount of 
18-Crown-6 (248) were added to the reaction mixture. The 
reaction mixture was stirred at room temperature for a 
further 5 h. A solution of the reaction mixture in the 
CHjCl^  was washed with aqueous KCl to remove the unreacted 
KF, the 18-Crown-6 and imidazole. The only other by-product, 
phenol, was removed by washing the CE^Cl^ solution of the 
reaction mixture with 1M NaOH. A n.m.r. spectrum of the 
purified product displayed a downfield shift of 0.4 p.p.m. 
for the C-7 protons when compared to the H n.m.r. spectrum 
of the starting material (243). The signal assigned to the
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protons on C-7 appeared as a broad singlet and no chemical 
shift difference (A6H-5) was observed for the C-6 protons.
It may be that this larger macrocycle adopts a conformation 
in which the C-6 and C-7 diastereotopic protons are 
magnetically equivalent. Also, the signals at 2.5 8 p.p.m. 
in the n.m.r. spectrum of the starting material (243) 
which correspond to the methylene protons a to the phenyl 
ester carbonyl have shifted upfield to 2.30 p.p.m., as would 
be expected for the 12-membered cyclic diester (226). How­
ever, an accurate mass measurement of the isolated product 
gave molecular ions plus 1 and minus 1 from the expected 
value of m/_z 253. T.l.c. of the reaction product showed a 
complex mixture of pyrroline-containing compounds and no 
crystalline derivatives could be prepared. One possible 
explanation for this result is that a mixture of oligomers 
has been formed.
This previous sequence of reactions was repeated except 
that pimelic acid (224) was used instead of adipic acid
(223) (see Scheme 51). Monophenyl pimelate (249), phenyl-
imidazolyl pimelate (250) and the synthanecine A derivative 
(251) were prepared and characterised as for the adipate 
homologues [(238), p. 126], [(242), Scheme 47] and [(243 ), 
Scheme 49] respectively. Lactonisation of the phenyl 
pimelate derivative (251) was attempted using 1-(trimethyl- 
silyl)imidazole ( 233 ) and a catalytic amount of sodium 
phenoxide as described previously for the adipate homologue.
phenyl ester (251) was treated with 2.2 equivalents of
i-(TMS)imidazole ( 233 ) and sodium phenoxide for 30 min. at
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room temperature. A  ^H n.m.r. spectrum of the purified 
product of this reaction displayed 3 singlets with chemical 
shifts of 7.11, 7.48 and 8.15 p.p.m. which is characteristic 
of an N-acylimidazolide [Probably compound (252) in Scheme 
0^]. These three singlets of equal intensity were also of 
equal intensity to the signal corresponding to -the C 4 
olefinic proton. A broad triplet at 2.85 p.p.m. was 
assigned to the methylene protons a to the imidazolide 
oarbonyl and a broad triplet of equal inuensity wao obser
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at 2.30 p.p.m. that corresponds to the methylene protons ct 
to the carboxyl esterified with synthanecine A. The signals 
for the protons of the synthanecine A moiety remained 
unchanged relative to the starting phenyl ester (251). The 
product obtained above was dissolved in dry THF and treated 
with KF and 18-Crown-6 (248). The product mixture obtained 
was purified as described earlier (p.133 ). A n.m.r. 
spectrum of the mixture after purification, was analogous to 
that of the mixture of compounds obtained previously (p.134 ) 
for the adipate homologue. Again the signals corresponding 
to the C-7 protons were shifted downfield by 0.5 p.p.m. 
relative to the phenyl ester (251), and appeared as a broad 
singlet. The C-6 protons were also magnetically equivalent. 
The high resolution mass spectrum of the mixture displayed 
the correct accurate mass measurement but a crystalline 
derivative could not be prepared. T.l.c. of the product 
indicated the presence of a complex mixture of compounds.
It may be that during the lactonisation step the reaction 
solution was too concentrated and intermolecular reactions 
occurred to yield a mixture of oligomers.
Accordingly, the synthanecine A derivative (231) was 
treated with TMS imidazole (233) and sodium phenoxide and 
then this product mixture was added dropwise to a solution 
of KF and 18-Crown-6 in THF at reflux. A complex mixture 
of products was still obtained. T.l.c. and spectroscopic 
data obtained were similar to those obtained above.
At this point it was decided that a fresh approach to 
the synthesis of dilactones (226) and (227) was necessary.
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5.3 Synthesis of Macrocyclic Diesters With 
12-Membered and Larger Rings
The Corey-Nicolaou lactonisation method has been 
successfully employed for the synthesis of 1 0 - (193) and
11-membered (183 a) macrocyclic diesters of synthanecine A 
(see Chapter 3). Therefore, a possible route to the 12- 
membered dilactone (226) is by Corey-Nicolaou lactonisation 
of the 6 - (253 ) or 7- (2.5M-) monoester hydroxy acids.
MeN
0R2
(253) r1= C0(CH2)4-C02H , r 2=H
(254) r1 = H ,  r 2= C0(CH2)4-C02H
5-Monoesters, such as (253), are formed selectively 
when synthanecine A is esterified with an activated acid, 
since the C-6 hydroxyl is a stronger nucleophile than the 
primary allylic hydroxyl. Therefore, the 6 -monoester (253) 
might be prepared by the selective monoesterification of 
synthanecine A using an N-acylimidazolide such as (239)
(see p .12 5 ) .
(239)
13
The N-acylimidazolide (239), produced by the reaction 
of adipic acid and 1 equivalent of CDI (50), was treated 
directly with a molar equivalent of synthanecine A at 
room temperature. A highly polar product was formed 
(t.l.c.). When lactonisation of this presumed monoester 
intermediate was attempted by the Corey-Nicolaou method 
none of the desired product (226) was isolated.
The work presented in Chapter 4 showed that the C-7 
hydroxyl of synthanecine A can be readily esterified via 
the allylic chloride (200). It was considered that the 
chloromethyl derivative (2 0 0 ) might be used to prepare the 
desired 7-monoester. (254) which could then be cyclised to 
give the required dilactone (226) by the Corey-Nicolaou 
procedure.
The allylic chloride (200) in dry DMF was treated with 
adipic acid and 2 equivalents of DBU (211) at room 
temperature. After 48 h a highly polar product was 
observed (t.l.c.). (This reaction was monitored by t.l.c. 
using the same solvent system and method of detection as 
reported in Chapter 3.4). This product was considered to 
be the required 7-monoester (254). The solvent (DMF) was 
removed under reduced pressure and dry DME was added to the 
reaction mixture since our successful lactonisations, by 
the Corey-Nicolaou method, were effected in this solvent. 
When 2.2 equivalents of 2 ,2 ’-dithiodipyridine (85) and 
triphenylphosphine (84) were added to the vigorously 
stirred reaction mixture the zwitterionic monoester (254) 
gradually dissolved, leaving a white solid. Formation of
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(223) n = 4
(224) n = 5
(256) n = 6
(257) n= 7
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(259) n = 6 R= H
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A
0
0
MeN
(226)  n = 4
(227) n = 5
(262) n = 6
(263) n= 7
(264) n = 8
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the thiol ester (255) was indicated by the presence of a 
distinctive u.v. active product of Rf ca. 0.3 (t.l.c.). The 
white solid, probably the hydrochloride salt of DBU, was 
allowed to settle out before the yellow solution of the thiol 
ester (255) was removed, by syringe, and added dropwise to 
DME heated at reflux. The formation of lactonised material 
was indicated by the appearance of a product of Rf 0.6 (t.l.c.) 
A pure product was obtained (12%^yield) after the reaction 
mixture had been subjected to an acid base recycle followed 
by column chromatography on basic alumina. Again, the 
initial acid base recycle was required to remove the bulk of 
the oxide (186) and 2-pyridthione (185) by-products.
Correct microanalytical data was obtained for the 
picrolonate salt of the 1 2 -membered macrocyclic diester
(226). An accurate mass spectrum of the free base (226) 
showed a molecular ion at m/z 253 corresponding to C^jH^gNO^. 
The mass spectral fragmentation pattern displayed main peaks 
at m/_z 123, 111, 107, 94, 82 and 80 which is also consistent 
with the formation of the 12-membered dilactone (226). A 
characteristic carbonyl absorption at 17 3 5 cm  ^ was observed 
from the i.r. spectrum of the pure product (226). In the 
^H n.m.r. spectrum of the dilactone (226 ) the C-6 and C-7 
diastereotopic protons appeared distinctly non-equivalent 
(AÔH-6 = 0.76 p.p.m. and AÔH-7 =0.72 p.p.m.). The other 
signals in this ^H n.m.r. spectrum were approximately 
identical to those observed in the ^H n.m.r. spectrum of the 
adipate product prepared via an N-acylimidazolide (see 
previous section). The n.m.r. spectra of these products
were also nearly identical.
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The 13-inembered macrocyclic diester (227 ) was prepared 
in a 16% yield from the allylic chloride (2 0 0 ) and pimelic 
acid (224) using the procedure described above. This 
dilactone (227) was characterised as the picrolonate salt 
and consistent chromatographic and spectroscopic data were 
obtained on the free base (227). The n.m.r. spectrum of 
the pimelate cyclic diester (227) showed that the C-6 
(A6H=0.47 p.p.m.) and C-7 (A6H-7 =0.16 p.p.m.) diastereo­
topic protons are magnetically non equivalent. High 
resolution mass spectral data displayed a molecular ion 
corresponding to C 1 4H 2 1NO4 and a fragmentation pattern 
indicative of a synthanecine A dilactone. The i.r. spectrum 
of compound (227) showed a saturated ester carbonyl at 
17 3 5 cm ^.
It is now apparent that the two mixtures of products , 
obtained from adipic (223) and pimelic acids (224),discussed 
in the previous section were not the required dilactones 
[(226) and (227)] of synthanecine A. The spectroscopic and 
chromatographic data obtained for these mixtures suggest 
that they are oligomeric.
Novel pyrrolizidine alkaloid analogues with 14- (262),
15- (263) and 16-membered (264) macrocycles were prepared 
by treating the allylic chloride (200) with suberic (256), 
azelaic (257) and sebacic acids (258) respectively. The 
intermediate monoesters (259), (260) and (261) were 
lactonised by the Corey-Nicolaou procedure as described 
previously for the adipate derivative (226) (see Scheme 52). 
The dilactone (262) was characterised as its picrolonate
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salt; however crystalline derivatives could not be 
prepared from the 15- (253) and 16-membered (264) dilactones. 
Correct accurate mass measurements were obtained for the 
picrolonate of compound (262) and for the free bases (263) 
and (264). The mass spectral fragmentation patterns 
exhibited by these macrocycles were indicative of 
macrocyclic diesters of synthanecine A (see Chapter 3.4). 
Saturated ester carbonyl absorptions at 17 35 cm  ^ were 
observed in the i.r. spectra of the 14- ( 262 ) 15- (263 ) and
16-membered ( 264) dilactones. The ^H n.m.r.' spectra of the 
12- (226 ), 13- ( 227 ), 14- (262 ), 15- (263 ) and 16-membered 
(264) macrocyclic diesters of synthanecine A showed varying 
degrees of non equivalence for the C-6 and C-7 diastereotopic 
protons (see Table 7).
Synthanecine A dilactones
A6 H-6 
(p.p.m.)
AÔ H-7 
(p.p.m.) Yields (%)
adipate (226 ) 0.76 0 . 72 12
pimelate (227) 0.47 0 .16 16
suberate (262 ) 0.73 0 . 2 1 10
azelate (263 ) 0.54 0.14 15
sebacate (264) 0.30 0.08 15
TABLE 7.
The isolated yields of the macrocyclic diesters (226),
(227), (262 -264) are poor, but it should be noted that 
uncrystallised allylic chloride (2 0 0 ) was used in these
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syntheses. Crystalline material was prepared later in this 
project. Also, due to time restrictions the optimum 
conditions for this route were not established.
Some areas for further research are:
1 . The use of other solvents for both the estérification 
and lactonisation steps, e.g. Yamada and co-workers*^ used 
benzene for the estérification of carboxylic acids using 
DBU and alkyl halides. DMF was never used for the 
lactonisation step.
2. Use of other bases could be investigated.
3. Lactonisation of the monoester hydroxy acids by another
7 9
method, e.g. the Keck procedure, could be attempted.
5.4 Conclusions.
Using the Masamune procedure [l-(TMS) imidazole/NaOPhJ 
to convert the phenyl ester (243 ) of 6-0-(adipyl) synthenecine 
A into its imidazolyl derivative (245), for subsequent 
lactonisation afforded a complex mixture of products. These 
products are probably oligomers, formed by the non specific 
attack of the nucleophilic reagents.
Synthanecine A dilactones with 12-16 membered 
macrocycles have been prepared. The initial estérification 
step was achieved by the carboxylate displacement of the 
C-7 allylic chloride of compound (200), and the lactonisation 
was effected by the Corey-Nicolaou procedure. Although only 
low yields of the macrocyclic diesters were obtained, it should 
be noted that the reaction conditions for this sequence have 
not been optimised.
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CHAPTER 6 ■
biological a c t i v i t y of m a c r o c y c l i c d ie st e rs OF SYNTHANECINE A.
6.1 Introduction.
Pyrrolizidine alkaloids which are esters of unsaturated
4.
amino alcohols, such as retronecine (3), are hepatotoxic.
These alkaloids are transformed, in the liver, into reactive 
pyrrolic metabolites which are potent alkylating agents.
Other organs, such as the lungs and kidneys, can be damaged 
if these pyrrolic derivatives are sufficiently stable to be 
transported in the bloodstream. Detoxification of 
hepatotoxic ester alkaloids occurs mainly by esterase 
hydrolysis or N-oxidation. Both processes form water soluble 
products which are readily excreted. For further details on 
the metabolism of pyrrolizidine alkaloids see Chapter 1.4.
Previous investigations, by Mattocks, have shown that 
diesters of synthanecine A, such as (265), are metabolised 
in a similar fashion and can exhibit an analogous toxic 
action.*'* However, they have relatively low toxicity as their 
structures are open to hydrolysis by esterase enzymes.
Me
Me
Me
MeN
(265)
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The aim of this work was to investigate the biological 
activity of a series of macrocyclic diesters of synthanecine 
A, shown in Figure 18, as they are analogues of the most 
toxic pyrrolizidine alkaloids. The experimental work for 
this Chapter was carried out at the M.R.C. Toxicology Unit, 
Carshalton by Dr A.R. Mattocks, Miss J. Brown, and myself, 
during my 3 month visit to this establishment. From the 
results obtained an attempt was made to relate the 
metabolism and likely toxicity of the pyrrolizidine 
alkaloid analogues to their structure.
6 .2 Experimental Discussion.
Similar doses of a series of synthanecine A dilactones 
(see Figure 18) were given, as single intraperitoneal 
injections, to rats, some of which had been pretreated with 
triorthocresyl phosphate (TOCP). TOCP is an esterase* 
inhibitor. Two hours after dosing, the levels of pyrrolic 
metabolites in the livers and lungs of the rats were
measured by the procedure reported by Mattocks and White 
(Previous work** had shown that the levels of pyrrolic 
metabolites in the livers of rats, 2 h after being dosed 
with synthanecine A diesters, had passed a transient peak 
and reached a comparatively steady level). The pyrrole 
measurements are shown in Table 8 . Each result shown is 
an average value, obtained from a series of experiments 
differing only in the size of dose, in the range 20 - 15 0 
mg./Kg (error limits are also shown). For comparison, 
pyrrole levels from monocrotaline (19) and ditiglyl 
synthanecine A (265) are also shown.
9 5
Figure 18
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MeN
(193) R = R  =H
MeN
(183a) r1=r2=r3=rA=h
(189) r ’ = r 2=H , R^=R^=Me
(190) R ^R ^ rM e  , r2=R^=H
MeN
(196)
(183d)Rl, r 2 =  (CH2)5
E tH N -C -0 0 -C -N H E t
MeN,
(174)
only one enantiom er shc3wn in each case
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TABLE 8 PYRROLIC METABOLITE LEVELS IN LIVERS AND LUNGS
Compound TOCP
predose
Pyrr. per 100 
Liver
(193) succinate 0
d
(1 2 ) 0.07 ± 0.004
+ (1 2 ) 0.55 ± 0.04
(194) (±)-2,3-dimethyl- 0 (1 2 ) 1.05 ± 0.05
succinate + (1 2 ) 2.47 ± 0.11
(196) phthalate 0 (1 2 ) 0.34 ± 0.03
+ (1 2 ) 2.57 ± 0.25
(183a) glutarate 0 (9) 0.16 ± 0.008
+ (9) 2.68 ± 0.07
[(189)+(190)]meso-2,4-dimethy1- 0 (18) 0.145± 0.014
glutarate + (1 2 ) 2.54 ± 0.11
(183b) 3 ,3-dimethyl- 0 (2 1 ) 2.07 ± 0.15
glutarate + (2 1 ) 1.77 ± 0.14
(183d) 3,3-pentamethylene- 0 (9) 1.22 ± 0.19
glutarate + (9) 1.48 ± 0.18
(19) monocrotaline 0.64®
(265) bistiglylsynthanecine A 0 .0024^
a Expressed as absorbance of Ehrlich colour from 0.5g tissue
b (Liver pyrrole level after TOCP predosing)/(liver pyrrole
c The dose calculated to give the same 2h liver pyrrole level 
bis-N-ethylcarbamate (174).
d Number of results in parentheses.
e For reference.
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OF RATS GIVEN SYNTHANECINE A DILACTONES
mg/kg ± SE 
Lung
TOCP
Enhancement
Potential 
toxic dose 
(mg/kg)
770
100
(4) 0.425±0.07
(4) 0.53 ± 0.15
50
22
(3) 0.04 ± 0.009
(4) 0.18 ± 0.055
160
21
(3 ) 0.07 ± 0.015
16 . 20
370
17.5 22
31
36
samples. 
without TOCP).
(0.54) as an LD^g dose (44 mg/kg) of synthanecine A
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6.3 Results and Discussion.
The metabolic fates and potential hepatotoxicities 
of the synthanecine A dilactones shown in Figure 18, were 
revealed upon examination of the pyrrole measurements shown 
in Table 8 . Furthermore, the susceptibilities of these 
dilactones to esterase hydrolysis were also assessed.
The levels of pyrrolic metabolites found in the 
livers of rats, which had not received TOCP, represent the 
metabolic fates of the compounds administered. Thus, the
3,3-dimethylglutarate (183 b) and 3,3-pentamethylene 
glutarate dilactones (183 d) , which have large liver 
pyrrole measurements, are readily metabolised by hepatic 
microsomal oxidases to pyrrolic metabolites. Conversely, 
the succinate (193), glutarate (183 a) and 2,4-dimethyl- 
glutarate [(189) + (190)](mixture of diastereomers used) 
dilactones, which gave low levels of pyrrolic metabolites, 
appear to be metabolised primarily by the other available 
routes (i.e. hydrolysis or N-oxidation).
These measurements also give an indication of the
9 7
potential hepatotoxicities of the compounds. Therefore, 
the succinate (193) and glutarate dilactones (18 3 a) and 
[(189) + (190)] should have low toxicity whereas the 3,3- 
dimethylglutarate dilactone (18 3 b) should have 
exceptionally high toxicity; in fact on a par with the 
most toxic natural pyrrolizidine alkaloids, c.f. monc- 
crotaline (19). Finally, from the results shown, 
macrocyclic diester analogues should be more hepatotoxic 
than simple diesters, c.f. compound (265).
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Hydrolysis of the synthanecine A dilactones (Figure 
18), by esterase enzymes, was also examined. The extent 
of esterase hydrolysis was determined from the increase 
in the level of pyrrolic metabolites produced by rats which 
had received TOCP (TOCP enhancement), the esterase 
inhibitor. [Enzymic hydrolysis limits pyrrole production 
because the hydrolysis products are less lipophilic and 
microsomal oxidation occurs more readily with lipophilic 
molecules. The hydrolysis products are also readily 
excreted.] From Table 8 it can be seen that large TOCP 
enhancements are observed for dilactones which gave low 
levels of pyrrolic metabolites when untreated rats were 
used, and vice versa. Therefore, esterase hydrolysis is 
an important detoxification route as it has a significant 
effect on the amounts of pyrrolic metabolites formed from 
many of these compounds.
TOCP enhancement values are a measure of the 
susceptibilities of these dilactones to esterase hydrolysis, 
Thus, dilactones (183a) and [(189) + (190)] which display 
the largest TOCP enhancements are the most susceptible to 
hydrolysis in vivo. Dilactones (193), (196), (194) and 
(183 d) are progressively less vulnerable to enzymic 
hydrolysis and dilactone (183 b) appears to be resistant 
to the esterase action.
The succinate (193) and glutarate (183 a) dilactones 
are extremely susceptible to hydrolysis, as expected, 
since their ester groups are relatively unhindered. The
2,3-dimethyl succinate analogue (194) is less susceptible
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to hydrolysis due to the presence of the methyl substituents 
a to the carbonyl groups of its necic acid. These 
substituents protect the dilactone either due to steric 
hindrance or because steric interactions restrict the 
dilactone from attaining a conformation that allows the 
esterase enzyme access to either of its ester groups. 
Surprisingly, the 2,4-dimethyl glutarate dilactone mixture 
[(189) + (190)] showed a significantly large TOCP 
enhancement. In fact this compound was no more protected 
from hydrolysis than the unsubstituted glutarate dilactone 
(183 a). In contrast to this, the 3,3-dimethyl glutarate 
dilactone (18 3 b) has a TOCP enhancement of 0.9. This 
shows that disubstitution B to the ester carbonyls renders 
this 1 1 -membered dilactone resistant to esterase hydrolysis. 
Similarly, the 3,3-disubstituted glutarate dilactone (183 d) 
is virtually unaffected by the esterase action. This 
suggests that the geminal disubstitution of dilactones 
(183 b) and (183 d) limits the extent to which their esters 
are capable of being forced into contact with an esterase.
In support of this, molecular models can be used to 
illustrate the considerable limitations that the gem- 
dimethyl substituents impose on the flexibility of the 
glutarate moiety. Finally, the fused aromatic ring of 
dilactone (196) does not appear to have much influence on 
the esterase activity.
As TOCP pretreatment eliminates the effects of esterase 
hydrolysis, the residual differences in the levels of 
pyrrolic metabolites must be due to the influence of other
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metabolic processes, such as N-oxidation, To observe these 
differences more readily a potential toxic dose, relative to 
synthanecine A bis-N-ethylcarbamate (174), was calculated 
for each dilactone (see Table 8 ). [This is the dose required 
to give the same 2 h pyrrole level (1.23) as an LD50 dose 
(44 mg/Kg) of the dicarbamate (174)]. From these results it 
can be seen that dilactones (194), (196),(183 a) and [(189) + 
(190)] afford slightly higher levels of pyrrolic metabolites 
than dilactones (183 b) and (183 d) , when esterase 
hydrolysis influences are eliminated. Therefore,the 
functional requirements for esterase resistance are not 
necessarily the same as those for pyrroline ring oxidation.
Pyrrolizidine alkaloids are not significantly converted 
into pyrrolic metabolites in lung tissue. As this is 
probably also true of synthanecine A dilactones, the 
metabolites found in the lungs of most rats were presumably 
formed in the liver. These metabolites must be sufficiently 
stable to be transported.
6 . 4 Toxicity Tests.
Investigations into the toxicity of the synthanecine A 
dilactones (Fig. A) have also been carried out at the MRC 
Toxicology Unit, Cashalton, by H.E. Driver. The results 
obtained, which will be presented elsewhere, confirm that, 
for this series of dilactones, hepatotoxicity is directly 
related to the liver levels of pyrrolic metabolites. Thus, 
the 3,3-dimethylglutarate dilactone (183b) is highly 
hepatotoxic whereas the 2,4-dimethyl analogue mixture
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[(189 ) + (190)] has low toxicity.
6.5 Hydrolysis of 11-membered Synthanecine A Dilactones 
under aqueous alkaline conditions.
6.5.1 Introduction.
Hydrolysis, by esterase enzymes, is an important 
detoxification route for synthanecine A dilactones, ^  vivo. 
Steric interactions, caused by acid branching, can have a 
significant bearing on the extent of the esterase activity 
i.e. 3,3-Disubstituted glutarate dilactones are virtually 
resistant to esterase hydrolysis whereas the 2,4-dimethyl 
[(189) + (190)] and glutarate (183 a) dilactones are readily 
hydrolysed (see Chapter 6.4). As this observation was 
unexpected we decided to study the effects of acid branching 
on the rates of hydrolysis of synthanecine A dilactones 
under aqueous methanolic alkaline conditions.
The rates of alkaline hydrolysis of esters can be
g g
determined using the procedure reported by Mattocks. This 
method involves measuring the decrease in pH against time 
as the ester is hydrolysed. i.e. When an ester is hydrolysed 
by an equivalent of OH", the latter is expended and the pH 
falls. If excess ester is present, the disappearance of OH 
will approximate to first order kinetics, and
t = time
Kt log e - p p = change in pH
Therefore, a plot of pH change against time should be 
linear through the origin, and The reaction half time with
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Rates of alkaline hydrolysis of synthanecine A 
dilactones (183a), (183b) and [(189 ) + (190 )] .
2 , 4 - dimethyl glutarate
0-3 - 3 ,3  “dimethylglutarate
0*6 -
0 4 -
02-:
3020 time (hr)10
Figure 19
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respect to OH is log 2/slope. When 1 equivalent of OH was 
used per diester the fall in pH was almost linear with time 
over at least 1 pH unit, and reaction half times could be 
calculated from curves representing a pseudo first-order 
disappearance of OH .
6.5.2 Results and Discussion.
The reaction half-times (see Table 9) for the alkaline 
hydrolysis of the synthanecine A dilactones (183 a), (183 b) 
and [(189) + (190)] (a mixture of diastereomers was used) 
were determined as described above. A plot of pH change 
against time is shown on Figure 19. As one equivalent of 
OH was used per dilactone, these plots represent the pseudo 
first-order disappearance of OH .
Table 9
Dilactone tj (h)
(183 a) glutarate 0.8
[(189) + (190)] 2,4-dimethylglurate 4.9
(183 b) 3,3-dimethylglutarate 10.3
From the result, it can be seen that the dilactones 
(183 a), (183 B) and [(198 ) + (190 )] are hydrolysed at different 
rates under the reported conditions. Again, the 3,3-di­
substituted glutarate dilactone (183 b) appears to be less 
vulnerable to hydrolysis than its structural isomers [(189) + 
(190)]. This gives further support to our previous findings, 
that substitution 0 to the ester carbonyls of 11-membered
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dilactones provides more protection against hydrolysis than 
a substitution. As expected, the glutarate dilactone (18 3 a) 
was the most susceptible to alkaline hydrolysis as its ester 
groups are relatively unhindered.
Attempts to repeat this analysis for the pentamethylene 
glutarate (183 d) and phthalate (196) dilactones were 
unsuccessful, as these dilactones were not soluble in the 
specified conditions.
6 .6 Conclusions.
The metabolic fates of a series of 10- and 11-membered 
macrocyclic diesters of synthanecine A were determined. As 
expected, these alkaloid analogues were metabolised 
similarly to pyrrolizidine alkaloids. The levels of 
pyrrolic metabolites formed in the livers of rars varied . 
considerably, and gave a good indication of the potential 
hepatotoxicity of the compound dosed. Detoxification of 
the synthanecine A dilactones occurred mainly by esterase 
hydrolysis, and vivo and vitro studies showed that 
acid branching had a significant influence on the esterase 
activity. 3,3-Disubstituted glutarate dilactones (183 b) 
and (183 d) were virtually resistant to esterase hydrolysis 
and therefore are good analogues of the most toxic 
pyrrolizidine alkaloids. Surprisingly, the 2,4-dimethyl 
glutarate mixture [(189) + (190)] was readily hydrolysed. 
This result is inconsistent with previous findings,^ that 
dilactones of a substituted necic acids are less susceptible 
to esterase hydrolysis.
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CHAPTER 7
EMILINE
7.1 Introduction.
Esters of otonecine (266) constitute a group of 
unusual pyrrolizidine alkaloids because they do not contain 
the 1-azabicyclo[3,3,0]octane (pyrrolizidine) nucleus (1). 
About 2 3 have been discovered, all of which are macrocyclic 
diesters. The majority of these [20] are 12-membered [such 
as (267)] and are mainly found in plants belonging to the 
family Compositae. The rest [3] are 11-membered otonecine 
dilactones. Two of these were isolated from plants 
belonging to the family Leguminosae, whereas the third, 
emiline was isolated from Emilia flammea Cass., a plant also 
belonging to the family Compositae.
9 9 . 1 0  0
Emiline was first discovered in 1969, and in 1970
OHHO
Me
( 2 6 6 )
HO ,Me
Me'
Ob-v._ H Me
Me
(2 6 7 )
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its structure (268) was assigned. This structure was 
formulated from spectroscopic (n.m.r., i.r., m.s.) and 
analytical data. When the ^H n.m.r. spectrum used in this 
analysis was examined, it did not appear to be consistent 
with the reported structure. e.g. The singlets at 51.54 and 
2.08 p.p.m. appeared to be of equal intensity rather than 
2:1, as reported. Consequently, we decided to reinvestigate 
the structure of emiline, using high resolution n.m.r. 
spectroscopy and modern n.m.r. spectroscopic techniques, 
such as distortionless enhancement by polarisation transfer 
(DEPT) and two-dimensional ^H n.m.r. correlation spectroscopy 
(COSY), which are readily available today.
7.2 Results and Discussion.
Emilia flammea, grown ar the Botanical Gardens in 
Glasgow, was extracted by a standard method (see Experimental) 
The crude alkaloidal mixture was composed of five compounds 
(t.l.c.). However, 90 and 200 MHz ^H n.m.r. spectra of the 
mixture showed that it was primarily emiline. Upon 
trituration and crystallisation of the crude mixture, using 
hexane, a pure white solid was obtained. This product was 
spectroscopically identical to emiline. An accurate mass 
spectrum of the white solid displayed a molecular ion at 
m/z 365.1825, which is consistent with the proposed 
molecular formula of emiline, C^gH^^NO^. The  ^H n.m.r. 
spectrum of this product (Figure 20) is identical to the 
published spectrum^°° and the white solid has a m.pt. of 
103 - 105 °C (Lit. 105 - 107 °C).
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Further analysis of this product confirmed our belief, 
that emiline had been assigned the wrong structure. ^
N.m.r. spectroscopy, involving a DEPT pulse sequence, was 
employed to determine the number of each type of carbon atom 
(CH3 , CH^, etc.) in this alkaloid. The results obtained are 
shown in Table 10 . This Table also includes the expected 
values for structure (2 6 8).
Table 10
Carbon Type Found Expected
C
CH
CH;
CH.
As expected emiline has one less methyl group than 
initially reported.
A revised structure (269) is proposed for emiline.
ÇH2  HO 17 18
HO Me
(268) ( 2 6 9 )
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This structure, which is consistent with the published data,^°° 
is based on the results obtained from an in depth spectro­
scopic analysis, involving  ^^ C DEPT n.m.r. spectroscopy, 
high resolution (200 MHz) ^H n.m.r. spectroscopy and ^H 
n.m.r. two-dimensional correlation spectroscopy (COSY), of 
our sample of emiline.
The  ^^ C (C = 0 at 191.5 p.p.m.) and ^H (N-Me at 2.0 6 
p.p.m.) n.m.r. spectroscopic data obtained are consistent 
with the presence of the otonecine moiety, therefore it was 
the necic acid moiety, of (268), that required the 
structural alteration. As mentioned previously, this 
structural reassignment should involve the loss of a methyl 
group and the introduction of a methylene group (see Table 
1 0), which would increase the size of the macrocycle to 1 2 .
A simultaneous change in the number of quaternary and 
tertiary carbons, by -1 and +1 respectively, should follow.
Of the four methyl groups, in structure (268) only two, 
C-17 and C-19 were candidates for exclusion. Loss of the 
C-17 methyl would introduce a CHOH proton. As this type of 
proton is not observed in ^H n.m.r. spectrum (see Figure 20), 
removal of the C-19 methyl was favoured.
The position for insertion of the methylene was chosen 
to accommodate the coupling pattern observed in the two- 
dimensional ^H n.m.r. COSY spectrum (see Figures 21 and 22).
In a 2-D ^H n.m.r. COSY spectrum the diagonal represents 
the one dimensional ^H n.m.r. spectrum and the off-diagonal 
shaded areas, which are symmetrically distributed about the
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diagonal, are indicative of coupling between protons. For 
example, the boxed area at c_a. 3.3 p.p.m. is a result of 
coupling between the C-2 proton and both of the C-3 protons.
Those couplings (connectivities) associated with the 
necic acid are outlined in Figures 21 and 2 2 and are listed 
in Table 11. The following carbon numbers are from our 
proposed structure ( 269 ). Examination of the 2-D ^H n.m.r. 
spectrum (Figure 21) showed that the olefinic (C-19) protons 
(C^CHg) are coupled to the C-18 methyl protons (A) (homo- 
allylic coupling) and two other proton sources (B and C), 
now known to be the 14-H^ and 1^-H^ protons. Furthermore, 
it can be seen that the C-21 methyl protons are coupled to 
the neighbouring methylene protons (D) which in turn are 
coupled to another proton source (E), the chemical shift of 
which was determined by decoupling at 1.5 p.p.m. This 
proton source is the C-15 proton. Finally, upon examination 
of the expanded spectrum, (Figure 22), coupling•between 
the C-15 proton and both of the C-l<4 protons is observed 
(F and G ) .
Table 11
A I9-H2 I8-H3 E 2O-H2 15-H
B I9-H2 14-Ha F 15-H l^-H^
C I 9- H 2 14-H% G 15-H 14-Hb
D 2 I - H 3 2O - H 2
As well as being consistent with the spectroscopic data 
presented, structure (269) is also more suited to the plant
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origin of the alkaloid (i.e. otonecine alkaloids isolated 
from plants belonging to the family Compositae are generally
12-membered). Also, the substitution pattern of the necic 
acid of structure (269) is similar to that of known 
otonecine alkaloids, such as (267).
Confirmation of this structure and determination of the 
stereochemistry could be achieved from X-ray crystallographic 
data, but unfortunately a suitable crystal could not be grown,
7.3 Conclusions.
Detailed n.m.r. spectroscopic analysis of emiline, an 
alkaloid from Emilia flammea, showed that the published 
structure (268) is incorrect. On the basis of our 
spectroscopic data a revised structure (269) is proposed.
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CHAPTER 8 
EXPERIMENTAL.
8.1 General Notes.
All melting points were measured with a Kofler hot-stage 
apparatus and are uncorrected. The optical rotation was 
measured with an Optical Activity Ltd. AA-10 polarimeter. 
Infra red spectra were obtained on a Perkin Elmer 580 
spectrophotometer and ultra violet spectra with a Pye-Unicam 
SP-lOO spectrophotometer. Nuclear magnetic resonance spectra 
were recorded with a Perkin Elmer R3 2 spectrometer operating 
at 90 MHz (6p), a Varian XL-100 spectrometer operating at 
25 MHz or with a Bruker WP-200 SY spectrometer operating
at 200 MHz (6^0 or 50 MHz (6^). Spectra were recorded for 
solutions in deuteriochloroform unless otherwise stated, 
with tetramethylsilane as internal standard. Mass spectra 
were determined with A.E.I. MS 12 or 902 spectrometers.
T.l.c. of the bases was carried out on Kieselgel G 
plates of 0.25 mm thickness and developed with chloroform - 
methanol - cone. ammonia (85:14:1) unless otherwise stated.
The bases were located by oxidation with o-chloranil, 
followed by treatment with Ehrlich's reagent.
1,2-Dimethoxyethane (DME) and tetrahydrofuran (THE) were
dried by distillation from potassium hydroxide and then from
sodium-benzophenone under argon prior to use. N ,N-Dimethyl-
formamide (DME) was dried utilising 3A molecular sieves as
detailed by Burfield and Smithers.^°^ Organic solutions were
dried with anhydrous magnesium sulphate and solvents were
0
evaporated off under reduced pressure below 50 C.
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8.2 EXPERIMENTAL TO CHAPTER 3
8.2.1 Preparation of Synthanecine A (£)
Diethyl 2-methyIaminosuccinate (164 ) ^ ° ^ - Methylamine in 
ethanol (33%, 120 ml, 1.15 mol) was added, in portions at 
0 - 5  °C, to diethyl maleate (172 g, 1.0 mol) with occasional 
stirring and ice-bath cooling (in order to maintain the 
exothermic reaction below 10 °C). After addition was 
complete, the flask was stoppered and kept in the ice-bath 
for a further 3 0 min, then allowed to stand at room temperature 
for 48 h. The ethanol was removed under reduced pressure 
and the colourless residue was dissolved in sufficient 4M 
hydrochloric acid to give an acidic solution. The acidic 
solution was washed with methylene chloride (3 x 500 ml), 
basified with conc. ammonia, and extracted with methylene 
chloride (3 x 500 ml). The combined extracts were dried 
(MgSO^), filtered and concentrated under reduced pressure 
to give diethyl 2-methylaminosuccinate (164) as a colourless 
oil (184.8 g , 90%); '^ jnax 3 350 (N-H), 2 980 (C-H),
.2 810 (N-Me), 1 730 (C=0), and 1 180 cm”  ^ (C-0); 6^ 1.25 
(3 H, t, J 8 Hz, COgCHgCHj), 1.27 (3 H, t, J 8 Hz,
CO^CH^CH^), 1.78 (1 H, s, NH) , 2.40 (3 H, s, NMe), 2.60 (1 H,
dd, J g e m  16, J y i c  7 3-%)' <1 ^d, 16» ^ ^ i c
5 Hz, 3-H), 3.57 (1 H, dd, 5, 7 Hz, 2-H), 4.04-
4.33 p.p.m. (4 H, complex, 2 x CO 2CH2 ) • cvfeobs
D i e t h y l ( N - e t h o x y c a r b o n y l m e t h y l ) - 2 - m e t h y l a m i n o s u c c i n a t e  
(166) - Ethyl b r o m o a c e t a t e  (34 ml, 0.31 mol) was added to a 
mixture of diethyl 2 - m e t h y l a m i n o s u c c i n a t e  (60 g, 0.30 mol)
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and anhydrous potassium carbonate (62 g, 0.45 mol) in 
aqueous acetone (7% H^O) (2 20 ml). The mixture was heated 
at reflux for 24 h, cooled to room temperature, filtered 
and the filtrate concentrated vacuo. The oily residue 
was dissolved in sufficient 2M hydrochloric acid to give an 
acidic solution. This acidic solution was washed with 
ether (3 x 50 ml), basified with conc. ammonia solution and 
extracted with ether (3 x 70 ml). The combined extracts 
were dried (MgSO^), filtered and concentrated under reduced 
pressure to give the title compound (166) (61 g, 70%);
\ a x  (CHCl,) 2 980 (C-H), 2 800 (NMe), 1 730 (C=0) and 
1 180 cm  ^ (C-0); 6^ 1.12 - 1.40 (9 H, complex 3 x
CO,CH,CH,), 2.44 (3 H, s, NMe), 2.67 (1 H, dd, J 16, J .2 2 7 J 3 7 3 — gem — VIC
8 Hz, 3-H), 2.84 (1 H, dd, J 16, J . 7 Hz, 3-H), 3.43
5 5 ’ ’ — g e m  — V I C
(2 H, s, NCH;), 3.88 (1 H, dd, 7, 8 Hz, 2-H),
4.04 - 4.34 p.p.m. (6 H, complex, 3 x CO^CH^).
Diethyl l-methyl-4-oxopyrrolidine-2,3-dicarboxylate (16 7) - 
The triester (166) (20 g , 70 mmol) in dry benzene (130 ml) 
was stirred with sodium hydride (oil free) (1.74 g , 73 mmol) 
at room temperature, under dry argon. After 5 h the 
reaction mixture was extracted with water (3 x 80 ml). The 
aqueous extracts were combined, washed with diethyl ether 
(2 X 200 ml) and acidified with concentrated hydrochloric 
acid, with ice cooling, to pH 1. The acidic solution was 
washed with ether (3 x 2 50 ml), and then the pH was 
adjusted to 6 with conc. ammonia solution. The aqueous 
solution was extracted with chloroform (3 x 3 00 ml) and the 
combined chloroform extracts were dried (MgSO^), filtered.
166 .
and concentrated dm vacuo to give the pyrrolidone (16 7 ) as
an oil (15.8 g, 94%); (^^HCl^) 2 980 (C-H), 2 800
(N-Me), 1 770 (C=0, ketone), 1 730 (C=0, ester), and 1 180
cm  ^ (C-0); 6^ 1.23 (6 H, t, J 7.5 Hz, 2 x COgCHzCH;),
2.50 (3 H, s, NMe), 2.95 (1 H, d, J 18 Hz, 5-H), 3.56—gem ’
(1 H, d, 18 Hz, 5-H), 3.58 (1 H, d, 8 Hz, 2-H),
3.83 (1 H, d, 8 Hz, 3-H) and 4.21 p.p.m. (4 H, m,
2 X CO^CH,).
Diethyl 4-hydroxy-l-methylpyrrolidine-2,3-dicarboxylate (178) 
A solution of sodium borohydride (1.77 g , 20.5 mmol) in 
water (10 ml) was added to an ice-cold solution of the crude 
pyrrolidone (16 7) (10 g , 41 mmol) in aqueous sodium hydroxide 
(2%) (75 ml). The mixture was stirred at 0 °C for 1.5 h, and 
then carefully acidified with 2M hydrochloric acid. The 
acidic solution was washed with ether (2 x lO0 ml), basified 
with conc. ammonia solution, and extracted with ether (3 x 
120 ml). The combined extracts were dried (MgSO^), filtered, 
and concentrated vacuo to give the title compound (17 8 ) 
as an oil (5.2 g, 52%); v ^ (CHCl,) 3 500 (0-H), 2 980 
(C-H), 2 800 (NMe), 1 730 (C=0), 1 180 cm”  ^ (C-0); 1.16
- 1.40 (6 H, complex, 2 XCO 2CH2CH3 ), 2.45 (3 H, s, NMe),
2.5 - 3.7 (6 H, complex, 2-H, 3-H, 4-H, 5-H 2 and OH), and
4.08 - 4.50 p.p.m. (4 H, complex, 2 x COz^Hg).
Diethyl 1 -methyl-3-pyrroline-2 ,3-dicarboxylate (168) - 
A solution of toluene-£-sulphonyl chloride (45 g , 2.4 mol) in 
pyridine (70 ml) was added to a solution of the hydroxy- 
pyrrolidine (178) (15 g , 0.6 mol) in pyridine (30 ml). The
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niix'tur'e was heated on a steam—bath in a stoppered flask for 
2 h, after which most of the solvent was removed under 
reduced pressure. The residue was dissolved in sufficient 
ice-cold dilute hydrochloric acid to give an acidic 
suspension. The acidic suspension was washed with ether 
(4 X 1 5 0 ml), basified with conc. ammonia solution, and 
extracted with ether (3 x 200 ml). The combined ether 
extracts were dried, filtered, and concentrated by rotary 
evaporation to give a dark red oil. To remove the pyridine 
residues, the oil was azeotroped with water (3 x lo ml), 
and then benzene (3 x 15 ml). The product was redissolved 
in ether, dried (MgSO^), filtered, and concentrated im vacuo 
to give the title compound (16 8 ) as a dark red oil (1 2 . 2 g,
88%); V (CHCIJ 2 980 (C-H), 2 800 (NMe), 1 725 (C=0),max. ^
1 645 (C=C) and 1 180 cm"^ (C-0); 1.23 (6 H, t, J 8 Hz,
2 X CO2CH2CH3 ), 2.50 (3 H, s, NMe), 3.52 (1 H, br d,
17 Hz, 5-H), 4.00 (1 H, br d, J 17 Hz, 5-H), 4.20 (1 H, 
s, 2-H), 4.05-4.35 (4 H, complex, 2 x CO^CH^) and 6.85 p.p.m 
(1 H, br s, 4-H).
2,3-Bishydroxymethyl-l-methyl-3-pyrroline (Synthanecine A) 
(9) A IM solution of di-isobutylaluminium hydride (DIBAL) 
in toluene (137 ml, 0.13 mol) was added,with stirring and 
cooling to 20 - 25 °C over 30 min.,to a solution of the 
diester (168) (5.1 g , 0.02 mol) in dry toluene (37 ml), 
under argon. The reaction mixture was kept at room 
temperature for 1 h. Ethyl acetate (9 ml) was added to 
consume the excess DIBAL, followed after 5 min by acetone 
(80 ml) and celite (16 g). Then methanol (16 ml) was added
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very slowly with cooling to 30 - 35 °C. The mixture was 
shaken vigorously until gelling occurred (5 min), then 
water (200 ml) was added. The mixture was shaken again, to 
break up the gel, then stirred at room temperature for 1.5 h. 
The resulting suspension was filtered (water pump) and the 
solid residue was washed with hot water (2 x 50 ml) and hot 
methanol (2 x 50 ml). The combined filtrates were 
concentrated under reduced pressure, and then azeotroped 
with benzene (4 x 20 ml). Finally, a solution of the 
product in DME was dried (MgSO^), filtered, and concentrated 
to give a brown oil (3.02 g , 94%) which contained the title 
compound (9) and the pyrrole derivative (179) in a ratio of 
85:15.
Purification of the product mixture was attempted 
using a citrate-phosphate buffer as r e p o r t e d . A  
solution of the product mixture (231 mg) in chloroform (5 ml) 
was extracted with the pH 4.5 buffer (3 x 5 ml) (The buffer 
solution was prepared from 61.5 ml of 0.IM citric acid and 
3 8.5 ml of 0.2M sodium hydrogen phosphate). The combined 
buffer extracts were washed with chloroform (5 x 15 ml), 
basified with IM potassium hydroxide, and saturated with 
potassium carbonate. This alkaline solution was extracted 
with chloroform (5 x 2 0 .ml) and the combined extracts were 
dried (MgSO^). Filtration and concentration of the organic 
solution gave a brown oil (125 mg, 54%) which contained 
synthanecine A (9), but was still contaminated with the 
pyrrolic byproduct (179).
Synthanecine A (9) was successfully purified, by
1 59 .
column chromatography, as follows. The mixture (500 mg, 3.5
mmol) was chromatographed on silica gel (x40). Elution with
chloroform -methanol -TEA (85:14:1) gave first the pyrrole 
diol (179); 6^ (90 MHz) 3.55 (2 H, br s , 2 x OH), 3.62 (3 K,
s, NMe), 4.49 (2 H, s, 7-Hz), 4.56 (2 H, s, 6 - H^ ) , 6.05 
(1 H, d, J 3 Hz, 4-H) and 6.53 p.p.m. (1 H, d, J 3 Hz, 5-H). 
Further elution afforded pure synthanecine A (9) (2 80 mg, 
56%); (C H C I3 ) 3 400 ( 0 - H ) ,  2 980 ( C - H ) ,  2 800 (NMe) ,
and 1 650 cm”  ^ (C=C); 6^ (90 MHz) 2.50 (3 H, s, NMe), 3.25
(1 K, m, 5-H), 3.53 (1 H, m, 2-H), 3.67 (2 H, br d , J 3 Hz,
G-H^) ,  3.88 (1 H, m, 5-H), 4.16 (2 H, br'S, 7-Hz), 4.79 
(2 H , br s , 2 X OH) and 5.73 p.p.m. (1 H, br s, 4-H); 6^
(25 MHz) 40.9 (NMe), 59.2 (C-6), 61.0 (C-5 and -7), 73.8 
(C-2), 124.2 (C-4) and 141.7 p.p.m. (C-3); m/z 143 (M+),
112, 94, 82, 67, 53 and 42. The picrolonate of synthanecine 
A had m.p. 175 - 176 °C. (Lit.^^ 176 °C).
8.2.2 Synthesis of 11-Membered Macrocyclic Diesters of 
Synthanecine A.
1. General Procedure - Glutaric anhydride or a derivative 
(1 mmol) was added to a solution of (±)-synthanecine A (9)
(1 mmol) in dry DME (20 ml) under argon. The reaction 
mixture was stirred at room temperature until all the' 
synthanecine A had reacted to form a zwitterionic monoester 
(t.l.c., Rp 0.0, 12 - 18 h). 2 ,2'-Dithiodipyridine (85)
(1.2 mmol) and triphenylphosphine (84) (1.2 mmol) were 
added and the mixture was stirred vigorously until rhiol 
ester formation was complete (t.l.c., Rp ca. 0.3, 12 - 18 h).
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The reaction mixture, a clear yellow solution, was diluted 
with DME (20 ml) and then heated at reflux under argon until 
lactonisation was complete (t.l.c., Rp 0 . 5 - 0 .5 , ca. 6 h). 
The solution was cooled and then concentrated under reduced 
pressure to afford a yellow oil; this oil was extracted 
with IM citric acid (3 x i+ ml). The combined acid extracts 
were washed with chloroform (5 x 12 ml), then basified with 
conc. ammonia (pH >10), and extracted with chloroform (4 x 15 
ml). The chloroform extracts were dried, filtered, and 
concentrated to give crude cyclised products as yellow oils. 
Purification was achieved by column chromatography on basic 
alumina eluting with increasing proportions of chloroform in 
dichloromethane (starting with 1 0 % chloroform).
(±)-6 ,7-0,0 -(Glutaryl)synthanecine A (183 a) - By using 
glutaric anhydride (180 a) the glutarate dilactone (183 a) was 
obtained as an oil (21%), Rp 0.55; (CC1%) 2 950,
2 850, 2 790, 1 745, 1 455, 1 275, 1 245 and 1 02 5 cm”A  
(200 MHz) 1.98 (2 H, m, 11-H%), 2.33 (4 H, m, 10- and 
I2-H2 ), 2.42 (3 H, s , NMe), 3.16 (1 H, m, 5-H), 3.45 (1 H, m,
2-H), 3.77 (1 H, m, 5-H), 4.05 (1 H, dd, ’ -vie  ^ %=)
6-K), 4.12 (1 H, dd, J^^m -vie  ^ ’ 6 -H), 4.63 (2 H,
br s, 7-H2 ) and 5.86 p.p.m. (1 H, br s, 4-H); 5^ (25 MHz)
20.7 (C-11), 33.7 and 34.1 (C-10 and -12), 40.8 (NMe), 59.8 
and 60.7'(C-5 and -6 ), 63.6 (C-7), 71.0 (C-2), 130.0 (C-4),
137.0 (C-3), and 172.3 p.p.m. (C-9 and -13); m/z 239 (M*), 
123 , 107 , 94 , 82 , 67 , 53 and 42 (Found: M'*’, 239.1154.
C1 2H 1 7NO4 requires M, 239.1158). The picrolonate had m.p.
192 - 194 °C (decomp.), (from ethanol), (Found: C, 52.45;
171.
H, 4.9; N, 13.6. CagH^gNgOg requires C, 52.48; H, 5.01;
N, 13.91%) .
( ± ) - 6 ,7-0,0-(3,3-Dimethylglutaryl)synthanecine A (183 b) -
The general procedure was repeated using 3,3-dimethyl-
glutaric anhydride to give the title compound (18 3 b) (2 5 %
yield) as white prisms, m.p. 93 - 94 [from benzene-light
petroleum (b.p. 60 - 80 °C)1, R_ 0.6; v (CCI,) 2 960,r max. ’
2 950, 2 880, 2 790, 1 740, 1 330, 1 180, and 1 150 cm"A
(90 MHz) 1.20 (6 H, s, 15- and I6 -H3 ), 2.21 and 2.25
(both 2 H, s, together 10- and I2-H2 ), 2.48 (3 H, s, NMe),
3.22 (1 H, m, 5-H), 3.59 (1 H, m, 2-H), 3.84 (1 H, m, 5-H),
3.96 (1 H, dd, J 11, J . 7 Hz, 6 -H), 4.13 (1 H, dd,—gem — V I C  ’
^^em 11' ^:vic 3 6 -H), 4 . 5 8  (1 H, d, J^^m 1? 7-%)'
4.74 (1 H, d, J 12 Hz, 7-H) and 5.87 p.p.m. (1 H, br s, —gem ’  ^  ^ ’
4-H); (25 MHz) 30.1 (C-15 and -16), 34.0 (C-11), 41.4
(NMe), 44.2 and 44.3 (C-10 and -12), 60.9 and 61.1 (C-5 and 
-6 ), 65.4 (C-7), 71.3 (C-2), 129.9 (C-4), 137.0 (C-3), and
171.3 and 171.8 p.p.m. (C-9 and -13); m/^ 267 (M^), 153,
123 , 107 , 94 , 80 , 55 , and 41 (Found: M*^, 267.1474 ; C, 62.9; 
H , 7.78; N, 5.2. C^^H^iNO^ requires M, 267.1471; C,
62.90; H, 7.92; N, 5.24%). The picrolonate had m.p. 20 7 - 
20 8 °C (decomp.) (from ethanol). (Found: C, 54.2; H, 5.4;
N, 13.1. C^^H^gNgOg requires C, 54.23; H, 5.50; N, 13.18%)
(±)-6 ,7-0,0-(3,3-Tetramethyleneglutaryl)synthanecine A 
(183 c ) - The title compound (183 c) was afforded (26% yield) 
as white prisms when 3 ,3-tetramethyleneglutaric anhydride 
(180 c) and synthanecine A (9) were treated as described in
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the general procedure; m.p. 93 - 96 [from benzene-light
petroleum (b.p. 60 - 80 °C)]; 0.6; (CHCI3) 2 950,
2 880, 2 790, 1 733, 1 460, 1 328, and 1 160 cm”A  (360
MHz) 1.66 (8 H, m, 15-, 16-, 17- and I8 -H2 ), 2.31 (4 H, m,
10- and I2-H2 ), 2.49 (3 H, s, NMe), 3.22 (1 H, m, 5-H), 3.55
(1 H, m, 2-H), 3.86 (1 H, m, 5-H), 4.03 (1 H, dd, 11,
J^i^ 7 Hz, 6 -H), 4.10 (1 H, dd, 11, 3 Hz, 6 -H),
4.62 (1 H, br d, J 12 Hz, 7-H), 4.72 (1 H, br d, J 12—gem ’ —gem
Hz, 7-H), and 5.87 p.p.m. (1 K, br s, 4-H); (25 MHz)
23.4 (C-16 and -17), 39.3 and 39.5 (C-15 and -18), 41.4 
(NMe), 42.7 (C-10 and -12), 44.7 (C-11), 60.9 and 61.1 (C-5 
and -6 ), 65.4 (C-7), 71.4 (C-2), 129.8 (C-4), 137.2 (C-3), 
and 171.8 and 172.2 p.p.m. (C-9 and -13); m/_z 29 3 (M^),
123 , 107 , 94 , 82 , 67 , 53 and 42 (Found: M"^  , 293.1633 ; C, 
65.55; H, 8.0; N, 4.65. CigHzsNO^ requires M, 293.1627;
C, 65.51; H, 7.90; N, 4.75%). The picrolonate had m.p.
217 - 220 ^C (decomp.) (from ethanol) (Found: C, 56.1; H,
5.7; N, 12.6. C^gHgiNgOg requires C, 56.01; H, 5,60; N, 
12.56%).
(±)-6 ,7-0,0-(3,3-Pentamethyleneglutaryl)synthanecine A 
(183 d ) - Treatment of 3,3-pentamethyleneglutaric anhydride 
as described in the general procedure afforded the title 
compound (183 d) (26%) as prisms; m.p. 101 - 102 °C [from 
benzene - light petroleum (b.p. 60 - 80 °C)]; Rp 0.6;
\ a x  (CHCI3 ) 2 930, 2 860, 2 790, 1 730, 1 455, 1 330, and 
1 165 cm ; 6 .^ (90 MHz) 1.55 (10 H, m, 15-, 16-, 17-, 18- 
and lO-H,), 2.28 (2 H, s, 10- or 12-H,), 2.30 (2 H, s, 12- 
or lO-Hg), 2.46 (3 H, s, NMe), 3.20 (1 H, m, 5-H), 3.58
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(1 H, m, 2 - H ) ,  3 .8 5  (1 H, m, 5 - H ) ,  3 .98  (1 H, dd, J 13,
—gem
ivic ’ 6-H), 4 .1 1  (1 H, d d ,  13 ,  4 Hz,  6 - H ) ,
4 .58  (1 K,  d ,  J 13 Hz,  7 - H ) ,  4 . 7 1  (1 H, d ,  J 13 Hz,  gem —gem
7-H), and 5 . 8 6  p.p.m. (1 H, br s, 4-H); 6 . ( 2 5  MHz) 21.6
(C-16 and -18), 25.8 ( C - 1 7 ) ,  36.7 (C-11), 37.4 and 37.6 
(C-15 and -19), 41.4 (NMe), 41.8 (C-10 and -12), 60.9 and
61.1 (C-5 and -6 ), 65.5 (C-7), 71.2 (C-2), 129.8 (C-4 ),
137.0 (C-3), and 171.5 and 171.9 p.p.m. (C-9 and -13); 
m/z 307 (M*), 167, 123, 108, 107, 94, 81, 67, 53 and 42 
(Found: M"^, 307.1795 ; C ,. 6 6 .6 ; H, 8.3; N, 4.6. CifH^gNO^ 
requires M, 307.1784; C, 66.42; H, 8.20; N, 4.57%). The 
picrolonate had m.p. 210 - 214 °C (decomp.) (from ethanol) 
(Found: C, 56.8; H, 5.75; N, 12.0. Cz^Hg^NgOg requires
C, 5 6 . 7 3 ;  H, 5 . 8 2 ;  N, 1 2 . 25 %) .
6 ,7-0,0-(3-MethyIglutaryl)synthanecine A (18 3 e )- The title 
compound (18 3 e) was obtained (25%) as a mixture of two 
diastereomeric racemates, when 3-methylglutaric 
anhydride was treated with synthanecine A as described in 
the general procedure, Rp 0.6; j^^ ax (^HClg) 2 970, 2 950,
2 880, 2 785, 1 740, 1 460, 1 379, 1 300, 1 257, and 
1 135 cm"A (90 MHz) 0.98 and 1 .0 5  (3 H, d, I5 -H3 ),
2.25 (5 H, m, lO-H^, 11-H and 1 2 - H z ) ,  2.50 (3 H, s, NMe), 
3.14 (1 H, m, 5-H), 3.45 (1 H, m, 2-H), 3.80 (1 H, m, 5-H), 
4.07 (2 H, m, 6 -H2 ), 4.62 (2 H, m, 7-Hz) and 5.85 p.p.m.
(1 H, br s, 4-H); 6 _ (25 MHz) 22.6 (C-15), 28.6 and 29.0
(C-1 1 ), 40.8, 41.0, 41.2, 41.8 and 4 2 . 5  (C-10, C-12 and 
I]^ e ) , 59.6 , 60 . 0 and 60.8 (C-5 and -6 ), 63.4 and 63.8 (C-7),
71.3 and 71.5 (C-2), 129.6 and 130.5 (C-4), 137.0 and 137.4
174.
(C-3), and 171.7, 172.0 and 172.5 p.p.m. (C-9 and -13); 
m/_z 253 (M ), 123 , 107 , 94 , 82 , 69 , 53 and 41 (Found: 
253.1304. requires M, 253.1314). The picrolonate
of the mixture (183 e) had m.p. 172 - 174 °C (from ethanol) 
(Found: C, 53.4; H, 5.3; N, 13.4. C 2 3H 2 7N 5O 9 requires
C, 53.38; H, 5.26; N, 13.54%).
6 .7-0,0-(3-Hydroxy-3-methyIglutaryl)synthanecine A (183 f) -
3-Hydroxy-3-methylglutaric anhydride (180 f) was treated as
described above to give .the title compound (183 f ) (as a
1 : 1 mixture of two diastereomeric racemates) as an oil (2 2 %
yield), 0.5; v (CCI.) 3 530, 2 980, 2 950, 2 850,’ F ’ max ^
2 790, 1 740, 1 725, 1 455, 1 375, 1 325, 1 260 and 1 165 
cm” A  (5^  (90 MHz) 1.39 (3 H, s, 15-Hg), 2.47 (3 H, s,
NMe), 2.50 (2 H, s, 10- or IT-Hg), 2.56 (2 H, s, 12- or 
lO-H,), 3.23 (1 H, m, 5-H), 3.58 (1 H, m, 2-H), 3.85 (1 H, 
m, 5-H), 3.92 (1 H, br s, OH), 4.37 (2 H, m, 6 -H2 ), 4.55 
(1 H, d, J 12 Hz, 7-H), 4.72 (1 H, d, 12 Hz, 7-H)
and 4.91 p.p.m. (1 H, br s, 4-H); 6^ (25 MHz) 29.5 (C-15),
41.2 (NMe), 45.5, 45.6 and 45.3 (C-10, -11, and -12), 60.7,
6 0.9 and 61.6 (C-5 and -6 ), 6 5.4 and 65.5 (C-7), 70.9 and
71.1 (C-2), 130.6 and 131.2 (C-4), 136.2 and 136.4 (C-3), 
and 171.1, 171.4 and 171.8 p.p.m. (C-9 and -13); m/z 269 
(M^), 107 , 94 , 82 , 60 , 51 and 43 (Found: M'*’, 269.1261 . 
CigHigNOg requires M, 269.1263).
6 .7-0,0-(Meso-2,4 -Dimethylglutaryl)synthanecine A [(189) + 
(190)] - A mixture of two diastereomeric racemates [(189) +
(190)] (Rp 0 . 6 and 0 . 5 5 respectively) was obtained when
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synthanecine A (9) was treated with meso-2,4-dimethylglutaric 
anhydride as described in the general procedure (30% yield).
The picrolonate salt of this mixture had m.p. 192 - 196 °C 
(decomp.) (Found: C, 54.35; H, 5.3; N, 13.2. C 21+H2 9N 5O 9 
requires C, 54.23; H, 5.50; N, 13.14%).
Pure samples of each diastereomeric racemate were 
obtained by preparative layer chromatography when 2 mm 
silica plates were eluted with chloroform -methanol -conc. 
ammonia (85:14:1).
( 2 R , 1 0 S , 1 2 R ) -  and (2S,10R,12S)-6 ,7-0,0-(Meso-2,4-dimethyl- 
glutaryl)synthanecine A (189) was obtained as an oil;
Rp 0.6; V (CCl^) 2 975,  2 940,  2 880,  2 790,  1 745,
1 463,  1 380 and 1 255 cm"A 6^ (90 MHz) 1.12 (6H,  d,
7 Hz, 15- and I6 -H3 ), 1.16 - 2.50 (4 H, m, 10-H, II-H2 , and 
12-H), 2.48 (3 H, s, NMe), 3.24 (1 H, m, 5-H) , 3.50 (1 H, 
m, 2-H), 3.82 (1 H, m, 5-H), 4.00 (1 H, dd, J^^m -vie 
4 Hz, 6 -H), 4.4 8 (1 H, dd, -vie  ^ 6- H ) , 4 . 5 6  (1 H, d ,
J 12 Hz, 7-H), 4.76 (1 H, d, 12 Hz, 7-H), and 5.94—gem —gem
p.p.m. (1 H, br s, 4-H); <5^  (50 MHz) 18.7 (C-15 and -16),
38.8 (C-10 or -12), 40.0 (C-11), 40.6 (NMe and C-12 or -10),
58.8 and 60.8 (C-5 and -6 ), 62.4 (C-7), 71.1 (C-2), 130.7 
(C-4), 137.2 (C-3), and 175.3 and 176.8 p.p.m. (C-9 and 
-13); m/z 267 (M^), 123, 107, 94, 82, 67, 55, and 42.
(Found: M*^, 267.1471 . Ci^HziNO^ requires M, 267.1470 ).
(2R,10R,12S)- and (2 S ,1 0 S ,1 2R )-6 ,7-0,0 -(Meso-2,4-dimethy1- 
glutaryl)synthanecine A (19 0) was obtained as prisms [from
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benzene - light petroleum (b.p. 60 - 80 °C)1, m.p. 53 
Rp 0.55; (CCI4 ) 2 980 , 2 940 , 2 880 , 2 785 , 1 750 ,
1 462 , 1 258 , 1 180 , and 1 155 cm’A  5^ (90 MHz) 1.13 (3 H, 
d, Jyic -6 - or I6 -H3 ), 1.14 (3 H, d, 7 Hz, 16- or
I5-H3 ), 1.17 - 2.50 (4 H, m, 10-H, ll-H^, and 12-H), 3.24 
(1 H, m, 5-H), 3.52 (1 H, m, 2-H), 3.77 (1 H, m, 5-H), 3.90 
(1 H, dd, 12, 6 Hz, 6 -H), 4.41 (1 H, dd, 12,
-vie  ^ 6 -H), 4.53 (1 H, d, Hz, 7-H), 4.93 (1 H, d,
-gem Hz, 7-H), and 5.82 p.p.m. (1 H, br s, 4-H); 6 ^ (25 
MHz), 18.9 (C-15 and -16), 39.2 (C-10 or -12), 39.7 (C-11),
40.5 (C-12 or -10), 40.9 (NMe), 60.3 and 60.7 (C-5 and -6 ),
63.3 (C-7), 71.8 (C-2), 127.4 (C-4), 138.0 (C-3), and 175.5 
and 176.1 p.p.m. (C-9 and -13); m/z 267 (M^), 181, 123, 107, 
94 , 82 , 56 , and 42 (Found: M'*’, 267.1470 . C^^HaiNO^ requires 
M, 267.1470).
Attempted Synthesis of (t)-6 ,7-0,0 -(2,2,4,4-Tetramethyl- 
glutaryl)synthanecine A (191) - When synthanecine A (9) was 
treated with 2 ,2 ,4,4-tetramethylglutaric anhydride as 
described in the general procedure (p. 169) none of the 
desired cyclised product (191) was isolated.
2. Modifications of the General Procedure
71
A) Use of 2 ,2 ^-Dithiobis(4-tert-butyl-l-isopropylimidazole) 
Synthanecine A ( 2 0 0 mg, 1.40 mmol) was treated with 3,3- 
dimethyIglutaric anhydride (199 mg, 1.40 mmol) as described 
in the general procedure (p. 169), except that 2,2 -dithiobis- 
(4-t-butyl-l-isopropylimidazole) (140 ) was added instead of 
2,2'-dithiodipyridine (85). The solution of the
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intermediate thiol ester in DME was heated at reflux for 3 h 
only. The cyclised product obtained after the work-up (65 
mg, 17%), was identical in all respect to (±)-6 ,7-0 ,0-(3 ,3- 
dimethylglutaryl)synthanecine A (183 b) obtained previously 
(p. 171).
7 2
B) Use of Silver Perchlorate - Treatment of synthanecine 
A (19 0 mg, 1.3 3 mmol) with 3,3-dimethyIglutaric anhydride 
(189 mg, 1.33 mmol) was carried out as described in the 
general procedure, except that the solution of the inter­
mediate thiol ester (182b) in DME was added dropwise, over 
1 h, to a suspension of silver perchlorate (566 mg, 2.74 
mmol) in DME heated at reflux under argon. During this 
addition the refluxing DME gradually discoloured until a 
brown gum was deposited. The resulting clear yellow solution 
was heated at reflux for a further 6 h, and it was then 
cooled and decanted from the brown deposit. Purification of 
the supernatant layer afforded a cyclised product (26 mg,
7%) that was spectroscopically and chromatographically 
identical to (±)-6,7-0,0-(3,3-dimethylglutaryl)synthanecine 
A (183 b).
3. Acid-Base Recycling of (±)-6,7-0,0-(3,3-dimethyl­
glutaryl ) synthanecine A (18 3 b ) - A solution of the
title compound (183 b) (55 mg) in dichloromethane (4 ml) was 
extracted with IM citric acid (3 x 3 ml). The combined 
acidic extracts were basified with conc. ammonia, added to 
the initial solution of dichloromethane, and extracted 
further (4 x 12 ml) with the same solvent. The combined
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organic extracts were dried (MgSO^), filtered and concentrated 
to give the title compound (183b) (22 mg, 40%).
When this procedure was repeated, keeping all apparatus 
and solutions as cool as possible, (±)-6,7-0,0-(3,3-dimethyl­
glutaryl ) synthanecine A was recovered in 51% yield.
8.2.3 Synthesis of 10-Membered Macrocyclic Diesters of 
Synthanecine A.
General Procedure. - The general procedure for the preparation 
of 11-membered macrocyclic diesters of synthanecine A, 
described on p. 169, was repeated using succinic anhydride 
and derivatives.
(±)-6,7-0,0-(Succinyl)synthanecine A (193 ) - By use of 
succinic anhydride, the succinate dilactone (193) was obtained 
as white needles (30%), m.p. 106 - 108 °C [from benzene - 
light petroleum (b.p. 60 - 80 °C)] ; Rp 0.67; (CHOI,)
2 950, 2 7 9.5 , 1 735, 1 600, 1 575, 1 560, 1 419, 1 165, and
1 040 cm"A ( 200 MHz) 2.50 (3 H, s, NMe), 2.41 - 2.72n ‘
(4 H, m, lO-Hz and ll-Hg), 3.22 (1 H, m, 5-H), 3.59 (1 H, m, 
2-H), 3.85 (1 H, m, 5-H), 3.98 (1 H, dd, ^vic ^
6-H), 4.40 (1 H, dd, -vie  ^ ’ 5-H), 4.40 (1 H, d,
-gem Hz, 7-H), 5.08 (1 H, d, Hz, 7-H) and 5.94 p.p.m.
(1 H, br s, 4-H); 5^ (25 MHz) 33.2 (C-10 and C-11), 41.4 (me),
60.9 and 61.6 (C-5 and -6), 65.7 (C-7), 71.1 (C-2), 131.0 
(C-4), 136.1 (C-3), 171.9 and 172.8 p.p.m. (C-9 and -12); 
m/z 225 (M^), 123, 111, 108 , 107 , 94 , 82 and 80. (Found: M"^ 
225.1005; C, 58.8; H, 6.9; N, 5.9. CiiN^gNC^ requires M, 
225.1001; C, 58.65; H, 6.71; N, 6.22%).
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6 .7-0,Q-(Trans-2,3-dimethyIsuccinyl)synthanecine A (194) - 
Treatment of (±)-trans-2,3-dimethvlsuccinic anhydride as 
described in the general procedure gave the title compound 
(194) (32%) as a mixture of the two diastereomeric racemates, 
Rp 0.67; (CHCl;) 2 980, 2 945, 2 790, 1 735, 1 452,
1 335, 1 185, and 1 096 cm"^; 5 (360 MHz) 1.15 - 1.22 (6 H,
m, 14- and 15-Hg), 2 . 34 - 2 . 53 ( 2 H, m, 10- and 11-H), 2.48
and 2.50 (3 H, s, ‘NMe), 3.22 (1 H, m, 5-H), 3.62 (1 H, m,
2-H), 3.88 (1 H, m, 5-H), 3.89 - 3.99 (1 H, m, 6 -H), 4.16 -
4.30 (1 H, m, 7-H), 4.52 - 4.57 (1 H, m, 6 -H), 5.11 and 5.21
(1 H, d, J ca. 13 Hz, 7-H), 5.86 and 5.93 p.p.m. (1 H, br s,
4-H); m/z 253 (M^), 111, 108, 107, 94, 82, 69, and 55.
(Found: M'*’, 253 . 1313 . C^gH^gNO^ requires M, 253.1313 ).
6 .7-0,0-(Trans-cyclohexane-1,2-dicarboxyl)synthanecine A (195) 
- The title compound (195) was prepared, as a mixture of two 
diastereomeric racemates, when synthunec'me.. A was treated 
with (±)-trans-cyclohexane-1 ,2-dicarboxylie anhydride in a 
similar fashion (23%), R^ 0.75; v (CHCI3 ) 2 945, 2 865,
2 790, 1 733, 1 578, 1 450, 1 420, 1 328, 1 255, 1 183 and
1 120 cm"A (200 MHz) 1.07 - 1.86 (8 H, m, 14-, 15-, 16-
and 17-Hz), 2.23 - 2.50 (2 H, m, 10- and 11-H), 2.47 and 
2.49 (3 H, s, NMe), 3.21 (1 H, m, 5-H), 3.58 (1 H, m, 2-H), 
3.60 - 3.91 (1 H, m, 6-H), 3.87 (1 H, m, 5-H), 4.08 - 4.78
(2 H, m, 6 - and 7-H), 5.20 - 5.52 (1 H, m, 7-H) and 5.85 and
5.92 p.p.m. (1 H, br s, 4-H); m/z 279 (M^) 123,111, 108,
107 , 94 , 82 and 67 (Found: M"^ , 279 . 1465. C 1 5H 2 1NO4 requires
M, 279.1471).
,80 .
Phthaly1)synthanecine A (196) - When synthanecine
A (9) was treated with phthalic anhydride by the standard
method, the title compound (136) was afforded (16%) as white
prisms, m.p. 153 - 155 C [benzene - light petroleum (b.p.
60 - 80 °C)]; Rp 0.72; (CHCI3) 2 950, 2 785, 1720,
1 602, 1.450, 1 283, 1 130, and 1 035 cm"'; 6^ (200 MHz) 2.55
(3 H, s, NMe), 3.26 (1 H, m, 5-H), 3.80 (1 H, m, 2-H), 3.92
(1 H, m, 5-H), 4.30 (1 H, dd, J 12, J . 7 Hz, 6 -H), 4.66—gem ’ — V I C  ’ ’
(1 H, dd, Jggm 12, Jy-c Hz, 6 -H), It. 80 (1 H, d,
Hz, 7-H), 5.28 (1 H, d, J 12 Hz, 7-H), 6.00 (1 H, br s,—gem
4-H) and 7.50 - 7.85 (4 H, m, 14-, 15-, 16- and 17-H);
5^ 41.6 (NMe), 60.5 and 61.9 (C-5 and -6 ), 65.4 (C-7), 71.3 
(C-2), 129.3, 129.5, 131.7, and 131.8 (C-14, -15, -16, and 
-17), 130.6 (C-4), 132.1 and 132.4 (C-10 and -11), 136.8 
(C-3), 168.1 and 168.6 p.p.m. (C-9 and -13); m/z 273 (M*),
197 , 124 , 110 , 94 , 82 , and 42 (Found: M*^ , 273.1004 ; C, 66.1; 
H, 5.7; N, 5.1. C 1 5H 1 5NO4 requires M, 273.1001; C, 65.92;
H, 5.52; N, 5.13%).
Attempted Synthesis of (±)-6 ,7-0,0-(Maleyl)synthanecine A 
(214) - Maleic anhydride (1 mmol) was added to a stirred 
solution of synthanecine A (9) (1 mmol) in dry DME (20 ml) 
under argon; after a few seconds a white gum was deposited. 
When 2 ,2 '-dithiodipyridine (1 .2 mmol) and triphenylphosphine 
(1 .2 mmol) were added to the reaction mixture the solution 
gradually turned dark red and no thiol ester formation was 
observed.
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Attempted synthesis of (± )-6 , 7-0 ,0-(4,5-dichlorophthalyl) 
synthanecine A (218) - Wnen synthanecine A (9) was treated 
with 4,5-dichlorophthalic anhydride as described in the 
general procedure, thiol ester formation appeared to occur 
(t.l.c.). However, none of the chlorinated phthalate 
derivative (218) was isolated after the reaction mixture was 
heated at reflux for 8 h and then worked-up by the usual 
procedure.
1 8 2 .
8.3 EXPERIMENTAL TO CHAPTER 4
8.3.1 Synthesis of (-)-3-Chloromethy1-2-hydroxymethyl-3- 
pyrrolinium chloride (200) Method (a) - Thionyl 
chloride (2 ml, 2.8 mmol), cooled to 0 °C, was added to 
synthanecine A (9) (0.5 g, 3.5 mmol) at -5 °C. The mixture 
was stirred, to facilitate dissolution of the synthanecine 
A, for 45 min at 0 ^C after which the excess thionyl 
chloride was removed under reduced pressure (0 °C, ca. 2 
mm Hg). The resulting purple residue was dissolved in 
ethanol and treated with activated charcoal until the purple 
colouration was removed (ca. %2). The solution was then 
filtered through celite, to remove the charcoal, and 
concentrated ^  vacuo to give a pale brown oil (0.59 g, 85%). 
Crystallisation using ethanol/acetone afforded the title 
compound (200) (0.38 g, 55%) as white prisms, m. pt. 135 °C;
R„ 0.28: V (KBr) 3 340 (0-H), 2 920 (C-H), 2 640 (R3N -H),F max.
1 090 (C-0), 835 (RzC=C(R)-H) and 695 cm"' (C-Cl); 6%(D%0)
(90 MHz) 3.12 (3 H, s, NMe), 3.85 - 4.65 (3 H, complex 5 -H2 
and 2-H), 4.09 (2 H, br s., 6-H%), 4.35 (2 H, br s, 7-H2 ), 
and 6.07 p.p.m. (1 K, br s, 4-H); 6^(D20) (25 MHz) 41.0 
(C-7), 44.7 (NMe), 59.9 and 64.0 (C-5 and -6), 78.4 (C-2),
127.5 (C-4) and 136.8 p.p.m. (C-3), m/z 132 and 130 (M^- 
CH3OH), 112, 9 4 , 81, 67 and 53. (Found: C, 42.3; H, 6 .6 ;
N, 7.0. C 7H 1 3NOCI2 requires C, 42.44,; H, 6.62; N, 7.07%).
Method (b) - Thionyl chloride (20 ml, 28 mmol) was added 
to a solution of synthanecine A (1.0 g , 7.0 mmol) in dry 
DME (10 ml), under argon, at -5 °C and the mixture was 
treated as described in Method (a ). The product (0.8 g.
183.
58%), obtained as white prisms, was identical in all 
respects to the foregoing hydrochloride salt (200).
8.3.2 Synthesis of Synthanecine A Dilactones 
General Procedure - The anhydride (1 mmol) and base (2.1 
mmol) were added to a solution of (±)-3-chloromethyl-2- 
hydroxymethyl-l-methyl-3-pyrrolinium chloride (200) (1 mmol) 
in dry DMF (18 ml) under argon, and the mixture was stirred 
at room temperature, generally for 2 4 h. The solvent (DMF) 
was removed vacuo (ca. 40 , 3 mm Hg) to give the crude
product as an oily or crystalline residue, which was 
purified by column chromatography on basic alumina (5% v/v 
chloroform in dichloromethane as eluent). The polarity of 
the eluant was steadily increased by increasing the 
proportion of chloroform.
Attempted synthesis of (± )-6 , 7-0,0-(3,3-Dimethylglutaryl)- 
synthanecine A (183 b) - When 3 ,3-dimethylglutaric anhydride 
(180 b) was treated with synthanecine A (9), as described 
in the above general procedure, using Hunig’s base as base, 
none of the desired cyclised product was observed (t.l.c.).
(±)-6,7-0,Q-(3,3-Dimethylglutaryl)synthanecine A - When the 
reaction above was repeated using DBU (211) instead of 
Hunig's base (210) the white crystalline product afforded 
(53%) was identical in all respects to the title compound 
(18 3 b ) , prepared previously (p. 171).
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(±)-6,7-0,0-(3,3-Dimethylglutaryl)synthanecine A (183 b ) - 
The above reaction was repeated, using DBN (212) instead of 
DBU (211). The pure product (37%) was chromatographically 
and spectroscopically identical to the foregoing dilactone 
(183 b).
(±)-6,7-0,0-(Glutaryl)synthanecine A (183 a ) - When glutaric 
anhydride (180 a) was used in the presence of DBU (211) the 
glutarate dilactone (183 a) was afforded in 37% yield. This 
product was spectroscopically and chromatographically 
identical with the product obtained by the Corey-Nicolaou 
method (p. 170).
(±)-6,7-0,0-(3,3-Pentamethyleneglutaryl)synthanecine A 
(183 d) - Using 3,3-pentamethyleneglutaric anhydride (180 d) 
in the presence of DBU, the title compound (18 3 d) was 
obtained in 86% yield. This product was identical in all 
respects to the product prepared by the Corey-Nicolaou 
method (p. 172).
6,7-0,0-(3-Hydroxy-3-methyIglutary1)synthanecine A (183 f) - 
When 3-hydroxy-3-methylglutaric anhydride (183 f) was 
treated as described in the general procedure, using DBU
(211) as base, the title compound (183 f) was obtained (52%) 
as a mixture of two diastereomeric racemates. This product 
was spectroscopically and chromatographically identical to 
the dilactone (183 f) obtained previously (p. 174).
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6,7-0,0-(Meso-2,4-dimethyIglutaryl>synthanecine A [(189) + 
(190 )] - Treatment of meso-2,4-dimethylglutaric anhydride 
(188) as described in the general procedure, using DBU (211) 
as base, afforded the title compounds (77% yield) as a 
mixture of two diastereomeric racemates. This product was 
identical in all respects to the mixture obtained previously 
(p. 174).
(±)-6,7-0,0-(2,2,4,4-Tetramethylglutaryl)synthanecine A
(191) - Treatment of 2,2,4,4-tetramethylglutaric anhydride 
(213) with synthanecine A as described in the general 
procedure, using DBU as base, gave the title compound (191) 
(44%) as a colourless oil which crystallised upon standing; 
m.p. 83 - 84 °C; Rp 0.68; v^^^.^CCl^) 2 975, 2 780, 1 740,
1 280 and 1 160 cm"'; (200 MHz) 2 x 1.19, 1.20 and 1.21
(3 H each, s, 15-, 16-, 17- and I8-H3), 1.73 (1 H, d,
14.5 Hz, 11-H), 2.05 (1 H, d, 14.5 Hz, 11-H), 2.48
(3 H, s, NMe), 3.23 (1 H, m, 5-H), 3.53 (1 H, m, 2-H),
3.76 (1 H, m, 5-H), 3.81 (1 H, dd, J^^m Hz, 2.5 Hz,
6-H), 3.86 (1 H, dd, 12 Hz, 7.5 Hz, 6-H), 4.63
(2 H, br s, 7-H2 ) and 5.77 p.p.m. (1 H, br s, 4-H); 6^ (25 
MHz) 26.0, 27.4, 28.3 and 28.9 (C-15, -16, -17 and -18),
41.0 (NMe), 41.7 and 42.0 (C-10 and -12), 51.7 (C-11), 60.3 
and 60.9 (C-5 and -6), 63.7 (C-7), 71.3 (C-2), 127.3 (C-4),
137.9 (C-3) and 176.2 and 176.4 p.p.m. (C-9 and -13); m/z 
295 (M^), 123 , 108 , 107 , 94, 83 and 70 (Found: M*^,
295.1767. C^gH^gNO^ requires M, 295.1783). The picrolonate 
salt had m.p. 191 - 192 C (from ethanol). (Found: C, 55.8,
H, 6.0; N, 12.5. C 2 gH3 3N 5 0 g requires C, 55.80; H, 5.94;
N, 12.52%).
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(±)-6,7-0,0-(Succinyl)synthanecine A (193 ) - Use of 
succinic anhydride with DBU (211) as base gave a product 
(10% yield) after 72 h, which was identical in all respects 
to the title compound (193), prepared previously (p. 178). 
When the above procedure was repeated with heating at 7 0 °C 
for 6 h, the title compound (193) was obtained in 18% yield
6.7-0,0-(Trans-2,3-dimethylsuccinyl)synthanecine A (194) - 
Treatment of (±)-trans-2,3-dimethylsuccinic anhydride with 
synthanecine A, using DBU as base, for 72 h at room 
temperature gave the title compound (194) (17% yield), as a 
mixture of two diastereomeric racemates. This product was 
spectrally and chromatographically identical to the mixture 
prepared by the Corey-Nicolaou procedure (p. 179).
6.7-0,0-(Trans-cyclohexane-1,2-dicarboxyl)synthanecine A 
(19 5) - Use of (±)-trans-cyclohexane-1,2-dicarboxylic 
anhydride in the presence of DBU (211), as described in the 
general procedure (p. 183), gave the title compound (195) 
as a mixture of two diastereomeric racemates (51% yield). 
Characterisation data on this mixture was identical to that 
obtained for the product prepared previously (p. 179).
(±)-6, 7-0 ,>0- (Maleyl )synthanecine A (214 ) - When maleic 
anhydride was treated with synthanecine A (9), as described 
in the general procedure, with Hunig's base (210) or DBN
(212) as base none of the desired cyclised product (214) 
was observed (t.l.c.). Using DBU (211) as base, the title 
compound (214) was obtained (49% yield) as prisms, m.p. 82
187
-83 °C (ethyl acetate - hexane); R„ 0.59; v (CCl^)
F. max.
2 955 , 2 790 , 1 735 , 1 290 and 1 151 cm”^  A (EtOH) 2 48
max.
nm (e 924); 6^ (200 MHz) 2.47 (3 H, s, NMe), 3.18 (1 H, m,
5-H), 3.62 (1 H, m, 2-H), 3.83 (1 H, m, 5-H), 4.10 (1 H, dd,
4 e m  Hz, 6 Hz, 6-H), 4.46 (1 H, dd, 12 Hz,
3.5 Hz, 6-H), 4.60 (1 H, d, Hz, 7-H), 5.13 (1 H, d,
—gem Hz ; 7-H), 5.95 (1 H, br s, 4-H), 6.27 and 6.35 p.p.m.,
(2 H, ABq, J 12 Hz, 10- and 11-H); (25 MHz) 41.4 (NMe),
60.5 and 61.8 (C-5 and -6), 65.5 (C-7), 71.4 (C-2), 130.6
131.1 and 131.6 (C-4, -10, and -11) 136.2 (C-3), 166.2 and
165.4 p.p.m. (C-9 and -12); m/z 223 (M^) 110, 94, 82 and 67
(Found; M'*’, 223 . 0842 ; C, 59.5; H, 5.9; N, 6.0.
requires M, 223.0844; C, 59.18; H, 5.87; N, 6.27%).
(±)-6,7-0,0-(2,3-DimethylmaIeyl)synthanecine A (215) - 
Treatment of synthanecine A with 2,3-dimethylmaleic anhydride, 
using DBU (211) as base, gave the title compound (215) (33% 
yield) as thread-like needles, m.p. 96 - 97 (hexane);
Rp 0.72; V (CCIJ 2 940, 2 850, 2 785, 1 720, 1 650,
1 267 and 1 105 cm"^; X ^ (EtOH) 238 nm (e 2 854); 6
IH3.X •
(200 MHz), 1.89 (6 H, m, 14- and 15-H,), 2.41 (3 H, s, NMe),
3.11 (1 H, m, 5-H), 3.55 (1 H, m, 2-H), 3.77 (1 H, m, 5-H),
4.00 (1 H, dd, J 12 Hz, 6 Hz, 6-H), 4.44 (1 H, dd,—gem —VIC
J 12 Hz, J . 3.5 Hz, 6-H), 4.53 (1 H, d, J 13 Hz, 7-H),—gem ’ — V I C  —gem
5.06 (1 H, d, J 13 Hz, 7-H) and 5.88 p.p.m. (1 H, br s,—gem
4-H); 5 (50 MHz) 15.3 and 15.7 (C-14 and -15), 41.3 (NMe),
6 0.3 and 61.2 (C-5 and -6), 64.7 (C-7), 71.4 (C-2), 131.2 
(C-4), 133.7 and 135.0 (C-10 and -11), 136.36 (C-3), 158.6 
and 169.8 p.p.m. (C-9 and -12); m/^ 251 (M ), 148, 124, 107,94
188
82 and 70 (Found: , 251 . 1159 ; C, 62.0; H, 6.9; N, 5.3.
requires M, 251.1158; C, 62.13; H, 6.82; N,
5.57%).
(±)-6 ,7-0,0-(3)4,5 ,6 -Tetrahydrophthalyl)synthanecine A (216)
By use of 3,4,5,6 -tetrahydrophthalic anhydride and DBU (211)
as base the title compound (216) (71%) was afforded as
thread-like needles, m.p. 112 - 113 °C (Hexane); Rp 0.74;
V (CCI4 ) 2 950, 2 870, 2 785, 1 725, 1 450, 1 270, 1 140, max. J 5 J 3 3 5 5
1 095 and 1 035 cm”S   ^ (EtOH) 254 nm (e 2 013); (200’ max. ’ h
MHz) 1.65 (4 H, m, 15- and 16-H%), 2.40 (4 H, m, 14- and 17-
Hg), 2.47 (3 H, s, NMe), 3.17 (1 H, m, 5-H), 3.60 (1 H, m,
2-H), 3.83 (1 H, m, 5-H), 4.06 (1 H, dd, 12 Hz, 6
Hz, 6 -H), 4.52 (1 H, dd, Hz, 3.5 Hz, 6 -H), 4.55
(1 H, d, J 13 Hz, 7-H), 5.15 (1 H, d, J" 13 Hz, 7-H)’ ’ —gem —gem
and 5.94 p.p.m. (1 H, br s, 4-H); 6  ^ (25 MHz) 21.1 and 21.2
(C-15 and -16) 25.7 and 26.1 (C-14 and -17) 41.3 (NMe), 60.4 
and 61.2 (C-5 and -6 ), 64.7 (C-7), 71.6 (C-2), 131.5 (C-4),
135.8 and 136.4 (C-9 and -10), 137.6 (C-3), 168.3 and 169.7 
p.p.m. (C-9 and -12); m/z 277 (M^), 123, 110, 107, 94, 82,
5 3 and 42 (Found: M"**, 277.1315; C, 64.8; H, 7.0; N, 5 .0 .
CisHjgNO^ requires M , 277.1315; C, 64.96; H, 6.91; N, 
5.05%).
(±)-6 ,7-0,0 -(Phthalyl)synthanecine A (196 ) - Using phthalic 
anhydride in the presence of DBU (211), the title compound 
(196) was afforded in 8 6 % yield. This product was identical 
in all respects to the phthalate dilactone (196) prepared 
previously (p. 180).
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(±)-6,7-0,0-(4,5-DichIorophthalyl)synthanecine A (2 1 8 ) -
Treatment of synthanecine A (9) with 4,5-dichlorophthalic
anhydride, using Hunig's base (210) as base, gave the title
compound (218) in 40% yield, m.p. 177 - 178 °C (ethanol);
Rp 0.78; (KBr) 2 960, 2 855, 2 790, 1 730, 1 590,
1 550, 1 375, 1 300, 1 127, 833 and 775 cm” ;^ X (EtOH)
252 (£ 5 550), 286 (e 843), and 269 nm (e 630); 6^ (200
MHz), 2.49 (3 H, s, NMe), 3.20 (1 H, m, 5-H), 3.71 (1 H, m,
2-H), 3.85 (1 H, m, 5-H), 4.23 (1 H, dd, J 12 Hz, J • 6’ ’ —gem —VIC
Hz, 6-H), 4.57 ( 1 H, dd, J 12 Hz, J . 4 Hz, 6-H), 4.77' ' ’ —gem ' —VIC
(1 H, d, Jgem Hz, 7-H), 5.24 (1 H, d, 13 Hz, 7-H),
6.02 (1 H, m, 4-H), 7.61 (1 H, s, 14- or 17-H) and 7.64 p.p.m. 
(1 H, s, 17- or 14-H); 6^ (50 MHz) 41.6 (NMe), 60.5 and 62.6
(C-5 and -6), 66.3 (C-7), 71.3 (C-2), 131.3, 131.5, 131.9 and
132.0 (C-4, -10, -11, -14 and -17), 136.2, 136.3 and 136.5
(C-3, -15 and -16), 166.0 and 166.8 p.p.m. (C-9 and -12);
m/z 343 and 341 (]%+), 265 , 144 , 124 , 110 , 94 , 82 and 74 
(Found: M"*" , 341.0199 ; C, 52.5; H, 3.7; N, 4.0.
CjgHj3 ^^Cl^NO^ requires M, 341.0222; C, 52.76; H, 3.84; N, 
4.10%) .
When DBN (212) or DBU (211) was used as base the title 
compound (218) was obtained in yields of 24 and 91% 
respectively.
(±)-6,7-0,0-(3 ,4,5,6-Tetrachlorophthalyl)synthanecine A 
(217) - Treatment of 3,4,5,6-tetrachlorophthalic anhydride 
with synthanecine A (9), as described in the general 
procedure (p. 183), using DBU as base give the title compound 
(217) (67%) as needles, m.p. 139 - 141 °C (ethyl acetate);
190.
Rp 0.77; (KBr) 2 955, 2 890, 2 845, 2 770, 1 735,
1 525, 1 452, 1 232, 1 169, 1 095, 1 082, 689 and 5 78 cm ^ ;
^max.^CHClg) 2 945, 2 850, 2 785, 1 740, 1 450, 1 355, 1 270,
1 175, and 1 100 cm"^; (EtOH) 225 (e 39 810), 298
(e 1 053) and 308 nm (e 1 100); 5 (200 MHz) 2.49 (3 H, s,
NMe), 3.19 (1 H, m, 5-H), 3.77 (1 H, m, 2-H), 3.87 (1 H, m,
5-H), 4.31 (1 H, dd, J^^m Hz, 7 Hz, 6 -H), 4.54
(1 H, dd, 11.5 Hz, J„. 4 Hz, 6 -H), 4.95 (1 H, d, J—gem — V I C  ’ ’ ’ ’ —gem
13 Hz, 7-H), 5.18 (1 H, d, J 13 Hz, 7-H), and 6.06 (1 H,—gem
br s , 4-H); 6^ (50 MHz) 42.2 (NMe), 60.3 and 62.6 (C-5 and
-6 ), 65.9 (C-7), 71.0 (C-2), 131.2, 131.4, 131.5, 131.8,
136.9 and 137.0 (C-10, -11, -14, -15, -16, -17), 132.5 (C-4),
136.1 (C-3), 162.8 and 163.2 p.p.m. (C-9 and -12); m/.z 
414, 412, 410 and 408 (M^), 241, 213, 142, 110, 94 and 82 
(Found: M ^ , 410.9404; C, 52.5; H, 3.7; N, 4.0.
Cl5H 1 1 ^^Clj^^ClNO^ requires M, 410.9413; C , 52.76; H,
3.84; N, 4.10%).
(±)-6 ,7-0,0-(3,4,5,6 -Tetrabromophthalyl)synthanecine A (219) 
Treatment of synthanecine A (9) with 3,4,5,6 -tetrabromo- 
phthalic anhydride as described in the general procedure, 
using DBU (211) as base, gave the title compound (219) in 
an 81% yield, m.p. 160 - 161 (ethanol); Rp 0.77;
(KBr) 2 955, 2 850, 2 785, 1 738, 1 385, 1 245, 1 220, 1 150,
1 0 70, and 9 89 cm”^; X (EtOH) 230 (e 4 326) and 310 nm
(£ 127); 5» (200 MHz) 2.48 (3 H, s, NMe), 3.19 (1 H, m,
5-H), 3.78 (1 H, m, 2-H), 3.87 (1 H, m, 5-H), 4.35 (1 K, dd,
igem Jvic ® Hz, 6 -K), ^.48 (1 H, dd, H  ^z,
4 Hz, 6 -H), 4.98 (1 H, d, Hz, 7-H), 5.13 (1 K, d.
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-gem Hz, 7-H), and 6.05 p.p.m. (1 H, br s, 4-H); 6  ^(50 
MHz) 42.3 (NMe), 60.2 and 62.7 (C-5 and -6 ), 65.8 (C-7), 70.9 
(C-2), 123.7, 123.8, 2 x 133.7, 134.4, and 134.7 (C-10, -11, 
-14, -15, -16 and -17), 132.2 (C-4), 136.4 (C-3), 163.9 and
164.1 p.p.m. (C-9 and -12); m/^ 588 (M^), with a cluster of 
isotope peaks, 419, 231, 124, 110, 107, 94 and 82 (Found:
588. 7364; C, 30.8; H, 2.0; N, 2.4. C i jKj /  ’ Brj® ‘ Br^NO^ 
requires M, 583.7380; C, 30.59; H, 1.88; N, 2.38%).
(±)-6,7-0,0-(Naphthalene-1,8-dicarboxyl)synthanecine A (220) 
The title compound (220) was afforded in 65% yield when 
synthanecine A (9) was treated with naphthalene-1 ,8 - 
dicarboxylic anhydride, in the presence of DBU (211) as base; 
m.p. 178 - 179 °C (ethanol); Rp 0.70; (KBr) 3 300 ,
2 950, 2 790, 1 715, 1 578, 1 505, 1465, 1 390, 1 285, 1 200,
1 150 and 770 cm  ^ (EtOH) 226 (s 4 307) and 296 nm
(£ 875); 6^(200 MHz) 2.50 (3 H, s, NMe), 3.22 (1 H, m, 5-H), 
3.73 (1 H, m, 2-H), 3.81 (1 H, m, 5-H), 4.23 (1 H, dd, J 
12 Hz, 2vic  ^ Hz, 6 -H), 4.79 (1 H, dd, J^^m Hz, 3 Hz,
6 -H), 4.85 (1 H, d, Jgem Hz, 7-H), 5.19 (1 H, d, J^^m 
Hz, 7-H), 5.92 (1 H, br s, 4-H), 7.52 (2 H, t, J 8 Hz, 15-
and 21-H), 7.89 - 8.01 p.p.m. (4 H, m, 16-, 17-, 19- and
2 0-H); 6^(50 MHz) 41.2 (NMe), 60.4 and 60.7 (C-5 and -6 ),
64.1 (C-7), 71.7 (C-2), 125.2, 125.3, 127.2, 129.4, 2 xl29.6, 
2 X 129.9, 132.2, 132.3, 134.1 and 137.5 (C-3, -4, -10, -11, 
-12, -16, -17, -18, -19, -20 and -21) and 2 x 169.0 p.p.m.
(C-9 and -13); m/z 323 (M+) 220, 198, 154, 126, 107, 94 and
8 2 (Found: M"*", 323.1169 ; C, 70.5; H, 5.3; M, 4.3.
C\gHi,NO^ requires M, 323.1157; C , 70.58; H, 5.26; N, 
9.33%).
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8.3 EXPERIMENTAL TO CHAPTER 5
8.3.1 Attempted synthesis of 12-membered and larger 
macrocyclic diesters via N-acylimidazolides.
Monophenyl adipate (238) - [Method (a)] 2-Chloro-l-methyl- 
pyridinium iodide (9.6 g, 38 mmol) was added to a stirred 
solution of adipic acid (5 g, 34 mmol) and TEA (9.8 ml, 71 
mmol) in dry dichloromethane (50 ml) under argon. After 15 
min phenol (3.2 g , 34 mmol) was added and the reaction 
mixture was stirred at room temperature for a further 10 h. 
Most of the dichloromethane was removed ^  vacuo and the 
resulting solution was extracted with IM sodium hydroxide 
(3 X 15 ml). The combined basic extracts were washed with 
dichloromethane (3 x i+O ml), acidified with 2M hydrochloric 
acid, and extracted with dichloromethane (4 x 7 0 ml). The 
combined organic extracts were dried (MgSO^), filtered and 
evaporated at reduced pressure to give the crude phenyl ester 
(238) (2.2 g , 2 9%). The only impurity was a small amount of 
the pyridone byproduct (144). Multiple recrystallisations 
were required to obtain a pure sample of monophenyl adipate 
(238); m.p. 96 - 97 °C [from benzene -light petroleum (b.p. 
60 - 80 °C)]; Rp 0.5 [silica, ethyl acerate - light
petroleum (b.p. 60 - 80 C) (1:1)]; (KBr) 3 040 (OH)
- 1
1 758 (C=0, phenyl ester), 1 695 (C=0, acid) and 1 130 cm 
(C-0); 6^ (90 MHz) 1.80 (4 H, m, 3- and 4 -H2 ), 2.44 (2 H, 
t, J 6 Hz, 5-H2 ) and 2.59 (2 H, t, J 6 Hz, 2-H%), and 7.00 - 
7.50 p.p.m. (5 H, m, Ph); 6  ^ (25 MHz) 24.0 and 24.2 (C-3
and -4), 33.6 and 33.9 (C-2 and -5), 121.5 (C-3 and -5 ), 
125.8 (C-4'), 129.4 (C-2' and -6'), 150.7 (C-l'), 171.8
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(C-l) and 179.7 p.p.m. (C-6 ); m/z 22 2 (M^) 129, 1 1 1 , 1 0 1 , 
94, 83 and 77. (Found: . 222.0899; C, 64.75; H, 6.33.
C 1 2H 1 4O 4 requires M, 222.0893; C, 54.85; H, 6.35%).
Monophenyl adipate (238 ) - [Method (b)] CDI (50) (2.2 g,
13.7 mmol) was added to a solution of adipic acid (2.0 g,
13.7 mmol) in dry DME (35 ml) under argon. The reaction 
mixture was stirred until effervescence had subsided (ca.
20 min); a white suspension was observed. The solvent was 
removed vacuo to give the N-acylimidazolide (239) as a 
white crystalline solid. 6^ (90 MHz) 1.87 (4 H, m, 2 % 
CH^CH^CO,), 2.41 (2 H, t, J 6 Hz, CH2CO2H), 2.90 (2 H, t,
J 6 Hz, CH^CO^Im), 7.10 (1 H, s, Im), 7.47 (1 H, s, Im) and 
8.19 p.p.m. (1 H, s ; Im). Singlets at 7.10 and 7.68 p.p.m. 
correspond to imidazole (240). (KBr) 3 300 (OH),
1 730 (C=0, imidazolide) 1 700 (C=0, acid). A suspension 
of the N-acylimidazolide (239), prepared as described above, 
in dry DME (35 ml) under argon, was treated with phenol 
(1.3 g, 13.7 mmol) at room temperature. After 16 h the 
solvent was removed by rotary evaporation and the white 
solid afforded was treated with saturated aqueous sodium 
hydrogen carbonate (50 ml) until effervescence ceased. The 
aqueous solution was washed with ether (3 x 50 ml), 
acidified with 2M hydrochloric acid to pH 5 and extracted 
with dichloromethane (3 x 6 0 ml). The combined organic 
extractions were dried (MgSO^), filtered and concentrated in 
vacuo to give monophenyl adipate (238) (1.1 g , 36%) which 
was identical in all respects to the sample obtained as 
described in method (a).
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Monophenyl adipate (238 ) - [Method (c)] Adipic acid (50 g, 
0.34 mol), phenol (32 g, 0.34 mol) and conc. sulphuric acid 
(1 ml) were added to toluene (3 50 ml). The solution was 
heated at reflux until the correct amount of water (ca. 6 ml) 
was collected in a Dean-Stark apparatus (ca. 30 h). Some of 
the toluene (150 ml) was removed by distillation and the 
resulting solution was allowed to cool before it was added, 
slowly with stirring, to a flask containing saturated aqueous 
sodium hydrogen carbonate ( 350 ml). l^ /hen effervescence had 
subsided the aqueous solution was washed with diethyl ether 
(3 X 350 ml) and acidified with 2M hydrochloric acid to pH 5. 
The acidic solution was extracted with chloroform (3 x 40 0 
ml) and the combined organic extracts dried (MgSO^). Removal 
of the solvent gave a white crystalline solid (33 g , 44%) 
which was identical in all respects to the phenyl ester (238).
(N-imidazolyl)phenyl adipate (242) - CDI (50) (1.75 g , 11 
mmol) was added to a solution of monophenyl adipate (238)
(2 g, 9 mmol) in dry DME (45 ml) under argon. When
effervescence had subsided (ca. 20 min) the solvent was 
removed iji vacuo and the resulting white solid was dissolved 
in dichloromethane (40 ml). The organic solution was washed 
with water (3 x 40 ml), to remove imidazole (240), dried 
(MgSO^), and concentrated at reduced pressure to give the 
title compound (242) (2.45 g, 85%) as a white solid;
(KBr) 3 122 (C=C-H), 1 750 (0=0, phenyl ester), 1 730 (0=0
imidazolide) and 1 13 0 cm  ^ (0-0); 5^ (90 MHz) 1.90 (4 H,
m, 3- and 4 -H2 ), 2.63 (2 H, t, J 5 Hz, 2-H2 ), 2.65 (2 H, t,
J 5 Hz, 5-H2 ), 7.00 - 7.50 (5 H, m, Ph), 7.19 (1 H, s, Im),
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7.48 (1 H, s, Im) and 8.15 p.p.m. (1 H, s, Im); 6^ (25 MHz)
23.3 and 24.1 (C-3 and -4), 33.9 and 34.8 (C-2 and -5),
115.0 (Im), 121.5 (C-3' and -5'), 125.9 (C-4'), 129.4 (C-2' 
and -6 '), 131.1 (Im), 136.1 (Im), 150.7 (C-l'), 169.0 (C=0, 
imidazolide) and 171.6 p.p.m. (C = 0, phenyl ester); m/_z 205 
(M^-Im), 177, 159, 135, 111, 94, 87 and 77.
Phenyl ester (243) of 6-0-(adipyl)synthanecine A - 
Synthanecine A (9) (300 mg, 2.1 mmol) was dissolved in dry 
DME (20 ml) under argon and the N-acylimidazolide (242) (510 
mg, 2.1 mmol) was added. The reaction mixture was stirred 
at room temperature. After 48 h the solvent was removed in 
vacuo and the resulting brown oil was dissolved in dichloro­
methane (20 ml). The organic solution was washed with water 
(3 X 20 ml) to remove imidazole (240), dried (MgSO^) and 
filtered. After removal of the solvent under reduced 
pressure the residual oil was purified by column chromato­
graphy [basic alumina, chloroform - dichloromethane (1:5)]. 
This afforded pure phenyl ester ( 243 ) of 6 -0_-(adipyl )- 
synthanecine A (360 mg, 49%); Rp 0.47; (CC1%) 3 450
(OH), 2 780 (N-Me), 1 760 (C=0, phenyl ester), 1 740 (C=0, 
saturated ester) and 1 130 cm  ^ (C-0); (90 MHz) 1.75
(4 H, m, 2 X CH^CH^CO^), 2.39 (2 H, m, CH^CO,), 2.48 (3 H, 
s, N-Me), 2.56 (2 H, m, CH^CO^Ph), 2.83 (1 H, br s, OH),
3.25 (1 H, m, 5-H), 3.59 (1 H, m, 2-H), 3.81 (1 H, m, 5-H), 
4.16 (1 H, s, 7-Hz), 4.18 (1 H, d, J 5 Hz, 6 -H2 ), 5.71 (1 H, 
br s, 4-H) and 7.00 - 7.50 p.p.m. (5 H, m, Ph); (25 MHz)
24.2 (2 X CH2CH2CO2 ), 33.8 (2 x CHgCOz) 41.8 (N-Me), 59.5
196 .
and 61.4 (C-5 and -7), 65 . 2  (C-8 ), 70.7 (C-2), 2 x 121.5 (Ph),
124.0 (C-4), 125.7 (Ph), 2 x 129.4 (Ph) , 141.2 (C-3), 150.7 
(Ph), 171.8 (C=0 phenyl ester), 173.2 (C=0, saturated ester); 
m/z 347 (M*) 254 , 222 , 124 , 1 1 1 , 108 , 94 and 82.  (Found: 
347.1732. CigHzgNOg requires M, 347.1732.
Attempted lactonisation of the phenyl ester (243) of 6-0- 
(adipyl)synthanecine A - First attempt - 1-(Trimethylsilyl)-
imidazole (42 pi, 0.29 mmol) and sodium phenoxide (catalytic) 
were added to a stirred solution of the phenyl ester (243)
(10 0 mg, 0.2 9 mmol) in dry THF (1.4 ml) under argon. After 
1 h the solvent was removed in vacuo to leave an oil; 6^
(90 MHz) 0.02 (9 H, s, TMS), 1.76 (4 H, m, 2 x CH2CH2CO2 ),
2.39 (2 H, m, CH2CO2 ), 2.50 (3 H, s, N-Me), 2.56 (2 H, m, 
CH^COzPh), 3.25 (1 H, m, 5-H), 3.60 (1 H, m, 2-H), 3. 80  (1 H, 
m, 5-H), 4.20 (2 H, s, 7-H2 ), 4.21 (2 H, d, J 5 Hz, 6 -H2 ),
5.71 (1 H, br s, 4-H) and 7.00 - 7.50 p.p.m. (5 H, m, Ph). 
Singlets at 7.10 and 7.68 p.p.m. correspond to imidazole 
(240); Rp 0.7, 0.6 and 0.2 (imidazole).
Second attempt - A solution of the phenyl ester (243) ( 1 0 0 
mg, 0.29 mmol) in dry THF (1.4 ml) under argon was treated 
with 1 -(trimethylsilyl)imidazole (93 pi, 0.64 mmol) and 
sodium phenoxide (catalytic) as described above. A clear oil 
was formed; (90 MHz) 1.75 (4 H, m, 2 x CH^CHgCOg), 2.35
(4 H, m, CH2CO2 ), 2.52 (3 K, s, N-Me), 3.27 (1 H, m, 5-H),
3.65 (1 H, m, 2-H), 3.83 (1 K, m, 5-H), 4.23 (2 H, s , 7-H,), 
4.23 (2 H, d, J 5 Hz, 6 -H2 ) and 5.7 8 (1 H, br s, 4-H). Small 
signals at 2.8 8 (CH^COIm) and 5.17 p.p.m. (Im) are probably
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due to an N-acylimidazolide. Signals at 7 . 1 0 and 7 . 6 7 p.p.m. 
correspond to imidazole (240); Rp 0.6, 0.5, 0.4 and 0.3.
Third attempt - To a stirred solution of the phenyl ester
(243) (100 mg, 0.2 9 mmol) in dry THF (1.4 ml) under argon
was added 1-(trimethylsilyl)imidazole (233) (93 pi, 0.64
mmol). After 5 min at room temperature sodium phenoxide
(catalytic) was added. The mixture was stirred for 2 h and
was then treated with anhydrous potassium fluoride (37 mg,
0.64 mmol) and 18 - Crown - 6 ( 248 ) (catalytic). After a
further 5 h at room temperature the solvent was removed by
rotary evaporation. The oily residue was dissolved in
dichloromethane (10 ml) and the organic solution was washed
successively with aqueous potassium chloride (IM) (3 x 8 ml)
to remove imidazole (240) and 18 -Crown - 6  (248), and then
with dilute sodium hydroxide C8 ml) and water (2 x s ml) to
remove phenol. The organic solution was dried (MgSO^),
filtered and concentrated to give an oil (69 mg); Rp 0.4,
0.5 and 0.6; v (CHCl,) 2 950 (C-H), 2 870 (N-Me) and max.
1 730 cm”  ^ (C=0, saturated ester); 6^ (90 MHz) 1.65 (4 H, 
m, 2 X CH2CH2CO2 ), 2.34 (4 H, m, 2 x CH2CO2 ), 2.50 (3 H, s , 
N-Me), 3.27 (1 H, m, 5-H), 3.60 (1 H, m, 2-H), 3.84 (1 H, m,
5-H), 4.16 (2 H, d, J 5 Hz, 6 -H2 ), 4.65 (2 H, s, 7 -H2 ) and 
5.81 p.p.m. (1 H, br s, 4-H); 6^ (50 MHz) 24.3 (2 x 
CHzCHgCOg), 33.7 (2 x CH2CO2 ), 41.8 (N-Me), 60.5 and 61.4 
(C-5 and -6 ), 65.0 (C-7), 70.6 (C-2), 127.2 (C-4), 136.0 (C- 
3), 172.8 and 173.0 (2 x C=0); m/z 254, 252, 199, 123, 107 
and 94 [expected M'*’ for (± )-6 , 7-0 ,0-(adipyl )synthanecine A 
(226) is m/z 253].
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Monophenyl pimelate (249) - A mixture of pimelic acid (50.0 
g, 0.31 mol), phenol (29.4 g , 0.31 mol) and conc. sulphuric 
acid (1 ml) in toluene (40 0 ml) was heated at reflux for ca. 
35 h with azeotropic removal of water (5.6 ml) using a Dean- 
Stark apparatus. Some of the toluene (20 0 ml) was removed 
by distillation and the resulting solution was allowed to 
cool before it was added slowly to a stirred solution of 
saturated aqueous sodium hydrogen carbonate (350 ml). When 
effervescence had subsided the aqueous solution was washed 
with diethyl ether (3 x 300 ml), and then carefully 
neutralised with 2M hydrochloric acid until a white 
suspension was observed (pH 7). The suspended white solid 
was extracted with diethyl ether (3 x 400 ml). The combined 
organic extracts were dried (MgSO^), filtered, and 
concentrated vacuo to give the title compound (249)
(30.3 g , 4.1%); m.p. 51 - 53 [from benzene -light 
petroleum (b.p. 60 - 80 *^0]; Rp 0.5 [silica, ethyl acetate 
- light petroleum (b.p. 60 - 80 °C) (1:1)]; (KBr)
3 050 (OH), 2 970 (C-H), 1 755 (C=0, phenyl ester), 1 700 
(C=0, acid), 1 205 (C-0), 690 and 762 cm  ^ (monosubstituted 
phenyl); 6^  ^ (90 MHz) 1.20 - 2.00 (6 H, m, O-Hg, 4 -H2 and
5 -H2 ), 2.36 (2 H, t, J 6 Hz, 6 -H2 ) and 2.54 (2 H, t, J 6 Hz,
2-H2 ), and 7.00 - 7.50 p.p.m. (5 H, m, Ph); 6^ (25 MHz)
24.2 and 24.5 (C-3 and -5), 28.4 (C-4), 33.8 and 34.0 (C-2 
and -6), 121.6 (C-3* and -5*), 125.7 (C-4*), 129.4 (C-2 and 
-6'), 150.8 (C-l'), 172.0 (C=0, phenyl ester) and 179 p.p.m. 
(C = 0, acid); m/^ 236 (M*) 143 , 125 , 94 and 69. (Found: M'*', 
236.1049; C, 66.12; H, 6.81. requires M,
236.1049; C, 66.08; H, 6.83%).
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(N-imidazolyDphenyl adipate (250 ) - Treatment of mono­
phenyl pimelate (249) (2.0 g, 8.47 mmol) with CDI (50) (1.55 
g, 1 0 . 2 mmol) as described for compound (242), gave the 
title compound (250) (2.30 g , 95%); (KBr) 3 0 60
(C=C-H), 2 970 (C-H), 1 760 (C=0, phenyl ester) and 1 730 
cm  ^ (C=0, imidazolide); 6^ (90 MHz) 1.20 - 2.00 (6 H, m, 
3-Ha, 4-Hz and 5-Hz), 2.55 (2 H, t, J 6 Hz, 2-Hz), 2.83 (2 H, 
t, J 6 Hz, 6 -H2 ), 7.00 - 7.50 (5 H, m, Ph), 7.08 (1 H, s,
Im) , 7.45 (1 H, s, Im) and 8.12 p.p.m. (1 H, s, Im); m/z 
219 (M^-Im), 173, 143, 125, 114, 94 and 83.
Phenyl ester (251) of 6-0-(pimelyl)synthanecine A - 
Synthanecine A (310 mg, 2.2 mmol), dissolved in dry DME (20 
ml) under argon, was treated with the N-acylimidazolide (250) 
(6 20 mg, 2 . 2 mmol) as described for the preparation of 
compound (243). The title compound (251) was afforded as an 
oil (329 mg, 41%). v (CHCI3) 3 610 (OH), 2 970 (C-H),
2 790 (N-Me), 1 7 55 (C=0, phenyl ester) and, 1 730 cm ^
(C = 0, saturated ester); <5^  (90 MHz) 1 . 20 - 2 . 00 (6 H, m, 
CH2CH2CH2CO2 and 2 x CH2CH2CO2 ), 2. 37  (2 H, t, J 6 Hz,
CH2CO2 ), 2.51 (3 H, s, N-Me), 2.57 (2 H, t, J 5 Hz, CH^C0 2 Ph),
2.71 (1 H, s, OH), 3.26 (1 H, m, 5-H), 3.63 (1 H, m, 2-H),
3.75 (1 H, s, 5-H), 4.18 (2 H, s, 7-H2 ), 4 . 2 0  (2 H, d, J 5 
Hz, 6-H2 ), 5. 75  (1 H, br s, 4-H), 7.00 - 7.50 (5H, m, Ph).
8 (25 MHz) 24 . 5  (2 x ÇH2CH2CO2 ) ,  28 . 5  (CH2CH2CH2CO2 ) ,  34 . 1
(2 X CH2CO2)5 41.8 (N-Me), 5 9.6 and 61.5 (C-5 and -6 ), 6 5.3 
( C - 7 ) ,  70 . 6  ( C - 2 ) ,  2 X 1 2 1 .6  (Ph), 1 2 4 . 1  ( C - 4 ) ,  125.8 (Ph),
2 X 129.4 (Ph), 141.3 (C-3), 150.8 (Ph), 172.1 (C=0, phenyl 
ester) and 173.5 p.p.m. (C=0, saturated ester); m/z 361
200 .
(M*) 143, 1 1 2 , 124, 108, 94 and 82. (Found: M'^  , 361 .1861.
C 2 0H 2 7NO 5 requires M, 361.1889).
Attempted lactonisation of the phenyl ester (251) of
6-0-(pimelyl)synthanecine A . - When a stirred solution of 
the phenyl ester (251) (85 mg, 0.24 mmol) in dry THF (2.3 
ml) under argon, was treated with 1 -(trimethylsilyl)- 
imidazole (75 yl, 0.5 2 mmol) and sodium phenoxide (catalytic) 
in a manner similar to that described for the attempted 
lactonisation of the adipic homologue (243) (first attempt)
a colourless oil was afforded; 6^ (90 MHz) 1.20 - 2.00
(6 H, m, CH2CH2CH2CO2 and 2 x CHzCHgCOz), 2.30 (2 H, t,
J 6 Hz, CH2CO2 ), 2.51 (3 H, s , N-Me), 2.85 (2 H, t, J 6 Hz, 
CH2C0 Im), 3.25 (1 H, m, 5-H), 3.62 (1 H, m, 2-H), 3.74 (1 H,
m, 5-H), 4.20 (2 H, s, 7-H2 ), 4.21 (2 H, d, J 5 Hz, 6 -H2 ),
5.72 (1 H, br s , 4-H), 7.11 (1 H, s, Im), 7.48 (1 H, s, Im) 
and 8.17 p.p.m. (1 H, s, Im). This ^H n.m.r. spectrum is 
consistent for the N-acylimidazolide (252). Singlets at
7.10 and 7.69 p.p.m. correspond to imidazole (240) and 
signals between 6.78 and 7.30 p.p.m. were assigned to the 
trimethylsilyl ether of phenol.
The colourless oil, prepared above, was dissolved in 
dry THF (2.5 ml) under argon and anhydrous potassium fluoride 
(30 mg, 0.52 mmol) and 18 - Crown - 6 (catalytic) were added. 
The reaction mixture was stirred at room temperature for 5 h 
then purified by a series of washings, as described 
previously (p. 197, third attempt), to yield a mixture of 
pyrroline containing compounds (t.l.c.); Rp 0.35, 0.45,
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0 . 50 , 0.60 ; 2 970 (C-H) and 1 735 cm  ^ (C = 0) ;
(90 MHz) 1.55 (5 H, m, CHgCHzCHaCOg and 2 x CH^CHgCOg),
2.31 (4 H, m, 2 X CH^CO^), 2.51 (3 H, s, N-Me), 3.29 (1 H, 
m, 5-H), 3.65 (1 H, m, 2-H), 3.85 (1 H, m, 5-H), 4.18 (2 H, 
d, J 5 Hz, 6-H^), 4.67 (2 H, s, 7-H^) and 5.83 p.p.m. (1 H, 
br s, 4-H); 5^ (25 MHz) 24.5 (2 x CHgCHzCOz), 28.6
(CH2CH2CH2CO2)5 41.7 (N-Me), 60.7 and 61.4 (C-5 and -6 ),
65.4 (C-7), 70.7 (C-2), 127.7 (C-4), 136.7 (C-3), 173.1 and 
173.3 p.p.m. (2 X C=0); m/z 267 (M^) 167, 149, 107, 94, 83 
and 71. (Found: M, 267.1485. Ci^H^iNO^ requires M,
267.1470.
Second attempt. - The phenyl ester (251) ( 10 0 mg, 0.28 mmol) 
was treated with 1-(trimethylsilyl)imidazole (89 yl, 0.61 
mmol) and sodium phenoxide (catalytic) as described above. 
The resulting solution was added (via syringe) dropwise over 
a period of 6 h to a stirred suspension of anhydrous 
potassium fluoride (35 mg, 0.61 mmol) and 18 - Crown - 5 (248 ) 
(catalytic) in dry THF (10 ml) heated at reflux under argon. 
Heating at reflux was continued for a further 1 h, and the 
reaction mixture was worked up, as reported previously 
(p. 197), to yield a colourless oil that was identical in 
all respects to the foregoing mixture.
8.3.2 Synthesis of 12-membered and larger macrocyclic 
diesters of synthanecine A .
General procedure - The diacid (0.5 mmol) and DBU (211)
(1.05 mmol) were added to a solution of the allylic chloride 
(200) (0.5 mmol) in dry DMF (3 ml) under argon. The mixture
202  .
was stirred at room temperature until the starting material
(200) had reacted (t.l.c.) (ca. 43 h). The DMF was removed
under reduced pressure (3 mmHg) and dry DME (35 ml) was
added to the resulting oily residue. 2,2'-Dithiodipyridine
(1 . 0 6 mmol) and triphenylphosphine (1.06 mmol) were added
and the reaction mixture was stirred vigorously at room
temperature, under argon, until thiol ester formation was
complete (t.l.c., Rp ca. 0.3) (ca. 48 h); a yellow solution
containing a suspended white solid was observed. The white
solid was allowed to settle out before the yellow solution
was taken up in a syringe. This solution was added dropwise
over 2 h to dry DME (70 ml) heated at reflux, under argon.
Refluxing was continued until lactonisation was complete
(t.l.c., R_ 0.6 - 0.7)(ca. 10 h). The reaction mixture was r —
worked up as described in the general procedure on page 169.
(±)-6 ,7-0,0-(Adipyl)synthanecine A (226) - The reaction of
adipic acid (73 mg, 0.5 mmol) with the allylic chloride (200)
(10 0 mg, 0 . 5 mmol), was carried out as described in the
general procedure to yield the title compound (226) (15 mg,
12%) as an oil, Rp 0.68; ^^ax 9 940 (C-H), 2 780
(N-Me), 1 735 (0=0), 1 260 and 1 170 (C-0), 994 and 908 cm ^;
ôrj (200 MHz) 1.70 (4 H, ra, 11- and 12-Hz), 2.30 (4 H, m, 10- 
rl
and 13-H%), 2.50 (3 H, s, N-Me), 3.25 (1 H, m, 5-H), 3.61 
(1 H, m, 2-H), 3.76 (1 H, dd, Jg^m -vie  ^ Hz, 6 -H), 3.81 
(1 H, m, 5-H), 4.52 (1 H, dd, J^^m ’ i^ vic Hz, 6 -H),
4.31 (1 H, d, Jg2m Hz, 7-H), 5.03 (1 H, d, u^^m Hz,
7-H), 5.86 (1 H, br s, 4-H); 8^ (50 MHz) 23.7 and 23.8
(C-11 and -12), 33.7 and 33.3 (C-10 and -13), 41.25 (N-Me),
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61.0 and 61.2 (C-5 and -6 ), 65.2 (C-7), 70.3 (C-2), 129.6 
(C-4), 136.5 (C-3), 173.0 and 173.4 p.p.m. (C-9 and -14); 
m/z 253 (M^), 251 , 123 , 107 , 94 and 55 (Found: , 253.1316 .
C^gH^gNO^ requires M , 253.1314). The picrolonate had m.p.
207 - 209 °C (from ethanol); m/_z 264 (picrolonic acid), 253 
(M^), 111, 108 , 107 , 94 and 80 (Found: M"^ , 253 . 1320 . 
CigHigNO^ requires M, 253.1314). (Found: C, 53.6; H, 5.4;
N, 13.4. CzgH^yNgOg requires C, 53.38; H, 5.26; N, 13.53%),
(±)-6,7-0,Q-(Pimelyl)synthanecine A (227) - Treatment of
the allylic chloride (200) (166 mg, 0.84 mmol) with pimelic
acid (134 mg, 0.84 mmol) was performed as described in the
general procedure to afford the title compound (227) (35 mg,
16%) as an oil; Rp 0.69; (CCIJ 2 940 (C-H), 2 780
(N-Me), 1 735 (C = 0), 1 260 , 1 160 (C-0) and 1060 cm" \
8^ (200 MHz), 1.20 - 1.90 (6 H, m, 11-, 12- and lO-H^), 2.35
(4 H, m, 10- and 14-H%), 2,50 (3 H, s, N-Me), 3.25 (1 H, m,
5-H), 3.50 (1 H, m, 2-H), 3.81 (1 H, m, 5-H), 3.88 (1 H, dd,
J 11.5 Hz, J . 7.5 Hz, 6 -H), 4.35 (1 H, dd, 11.5
— g e m  — VIC — gem
Hz, 2 Hz, 6-H), 4.54 (1 H, d, J^^m Hz, 7-H), 4.70
(1 H, d, J 12 Hz, 7-H), and 5.88 (1 H, br s, 4-H); 8p —gem ^
(50 MHz) 23.8 and 24.1 (C-11 and -13), 27.1 (C-12), 34.2 and
36.0 (C-10 and -14), 40.9 (N-Me), 60.6 and 60.8 (C-5 and 
-6 ), 64.9 (C-7), 70.6 (C-2), 130.3 (C-4), 136.9 (C-3), 173.7 
and 173.8 (C-9 and -15). The picrolonate salt had m.p.
186 - 187 ^C (from ethanol); m/_z 26 7 (M^) 264 (picrolonic 
acid) 234., 156 , 124 , 123 , 111, 108 , 107 and 94. (Found: M+, 
267.1468. C 1 4H 2 1NO4 requires M, 267.1470). (Found: C, 54.1;
H, 5.4; N, 13.1. Ca^HzgNgOg requires C, 54.23; H, 5.50;
N, 13.8%).
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(±)-6,7-0,0-(Suberyl)synthanecine A (262) - In a similar
fashion, suberic acid (87 mg, 0.5 mmol) was reacted with the
allylic chloride (200) (100 mg, 0.5 mmol) to afford the
title compound (262) (14 mg, 10%) as an oil; Rp 0.73;
v^ax (CCI*) 2 940 (C-H), 2 785 (N-Me), 1 735 (C=0), 1 250
and 1 168 (C-0) and 910 c m " S  8^ (200 MHz) 1.30 (4 H, m,
12- and lO-H,), 1.70 (4 H, m, 11- and 14-Hz), 2.33 (4 H, m,
10- and 15-Hz), 2.54 (3 H, s, N-Me), 3.29 (1 H, m, 5-H),
3.60 (1 H, m, 2-H), 3.74 (1 H, dd, J 11 Hz, J . 3.6 Hz,’ —gem ’ —VIC
6 -H), 3.80 (1 H, m, 5-H), 4.47 (1 H, dd, J 11 Hz, J .
’ ’ ’ ’ ’ — g em — VIC
2 Hz, 6-H), 4.54 (1 H, d, 12 Hz, 7-H), 4.75 (1 H, d,
J 12 Hz, 7-H), and 5.88 p.p.m. (1 H, br s, 4-H); 8p (50—gem ^ ^ ’ C
MHz) 24.4 and 24.5 (C-12 and -13), 25.7 and 25.8 (C-11 and 
-14), 32.6 and 32.9 (C-10 and -15), 41.2 (N-Me), 60.8 and
61.1 (C-5 and -6 ), 66.3 (C-7), 70.2 (C-2), 130.6 (C-4),
137.2 (C-3), 173.8 and 174.0 p.p.m. (C-9 and -16). The 
picrolonate salt had m.p. 191 - 193 °C (from ethanol); m/_z 
281 (M^) 264 (picrolonic acid), 248, 111, 108, 107 and 94. 
(Found: M'^  , 281 . 1632 . C 1 5H 2 3NO4 requires M, 281.1627 ).
(Found: C, 55.1; H, 5.5; N, 12.6. C^gHg^NgOg requires
C, 55.04; H, 5.73; N, 12.84%).
(±)-6 ,7-0,0-(Azelayl)synthanecine A (263) - Treatment of
the allylic chloride (200) (250 mg, 1.26 mmol) with azelaic
acid (237 mg, 1.26 mmol) as described above afforded the
title compound (263) (56 mg, 15%) as a colourless oil; Rp
0.68; V (CCI.) 2 940 (C-H), 2 785 (N-Me), 1 735 (C=0),
’ max. “
1 242 and 1 162 (C-0); 8 ^ (200 MHz) 1.30 (6 H, m, 12-, 13- 
and 14-H%), 1.60 (4 H, m, 11- and I5 -H2 ), 2.35 (4 H, m, 10-
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and 16-Hz), 2.51 (3 H, s, N-Me), 3.28 (1 H, m, 5-H), 3.52
(1 H, m, 2-H), 3.80 (1 H, m, 5-H), 3.88 (1 H, dd, J 11 Hz,—gem
J . 7.5 Hz, 6-H), 4.42 (1 H, dd, J 11 Hz, J . 3 Hz,
— V I C  ■ —gem ’ — V I C
6-H), 4.59 (1 H, d, 12 Hz, 7-H), 4.73 (1 H, d, J 12—gem ' —gem
Hz, 7-H), and 5.88 p.p.m. (1 H, br s, 4-H); 6^ (50 MHz)
23.5 and 23.6 (C-12 and -14), 26,0 (C-13), 26.9 and 27.1 (C- 
11 and -15), 33.9 and 34.1 (C-10 and -16), 41.1 (N-Me), 60.6 
and 61.1 (C-5 and -6), 65.5 (C-7), 70.6 (C-2), 130.0 (C-4),
137.1 (C-3), 173.6 and 173.7 p.p.m. (C-9 and -17); m/z 295 
(M^), 217 , 123 , 107 , 94 , 82 and 67. (Found: M"^ , 295 .1785.
CigHasNO^ requires M, 295.1784). The picrate and picrolonate 
salts could not be prepared.
(±)-6,7-0,0-(Sebacyl)synthanecine A (264) - The allylic 
chloride (200) (200 mg, 1 mmol) and sebacic acid (204 mg,
I mmol) were reacted as described in the general procedure,
to yield the title compound (264) (47 mg, 15%) as a colourless
oil; Rp 0.68; (CCI,) 2 940 (C-H), 2 780 (N-Me), 1 735
(C=0), 1 260 and 1 168 cm”  ^ (C-0); (200 MHz) 1.31 (8H, m,
12-, 13-, 14- and I5-H2 ), 1.65 (4 H, m, 11- and lO-Hg), 2.33 
(4 H, m, 10- and 1 7 -H2 ), 2.53 (N-Me), 3.32 (1 H, m, 5-H),
3.60 (1 H, m, 2-H), 3.83 (1 H, m, 5-H), 4.00 (1 H, dd, J ^m
II Hz, Jypc  ^ Hz, 6-H), 4.30 (1 H, dd, Jg^m Hz, Hz,
6-H), 4.60 (1 H, d, Jgem Hz, 7-H), 4.68 (1 H, d, Jg^m
Hz, 7-H) and 5.86 p.p.m. (1 H, br s, 4-H); 5^ (50 MHz)
23.9, 24.0, 26.1, 26.4, 2 x 26.8 (C-11, -12, -13, -14, -15 
and -16), 33.9 and 34.3 (C-10 and -17), 41.8 (N-Me), 60.7 and
61.5 (C-5 and -6), 65.4 (C-7), 70.5 (C-2), 128.0 (C-4),
136.0 (C-3), 173.5 and 173.8 p.p.m. (C-9 and -18); m/z 309
206
(M*), 218, 124, 108 , 107, 94, 78 and 67. (Found: ,
309.1965. requires M, 309.1940). The picrolonate
salt could not be prepared.
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8.5 EXPERIMENTAL TO CHAPTER 6
8.5.1 Synthesis of synthanecine A dilactones - This was 
achieved as described in Chapter 3 .
8.5.2 Animal and Dosing - Male albino Wistar rats (Porton 
strain), bred at the Carshalton Laboratories, were used for 
all experiments. They were weanlings, aged 22 - 23 days, 
and had access to food (MRC diet) and water at all times.
The basic synthanecine A dilactones were dissolved in 
0.9% saline with an equivalent of HCl to give neutral 
solutions with conc. 15 or 30 mg/ml ; they were given as a 
single intra peritoneal (i.p.) injection. Some rats were 
predosed y^a a stomach tube, 4 h before the synthanecine A 
dilactone, with undilufed TOCP (0.5 ml/Kg body weight).
These animals were always caged separately from rats not so 
treated.
8.5.3 Measurement of pyrrolic metabolites - Rats were 
given a single dose of a synthanecine A dilactone, and 
killed (with CO2 ) 2 h later. Some were given TOCP 4 h before 
the synthanecine A derivative. Levels of pyrrolic metabolites 
in 3 portons (each 0.5 g) of liver and 1 portion of lung 
tissue were measured as follows.. The portions of tissue, 
liver or lung, were homogenised in ethanolic (5%) mercuric 
chloride (5 ml) for 15 - 30 sec. using a Nelco 10 blender.
The solids were separated by certrifugation (1 min.)-, washed 
once with ethanol (10 ml) and again centrifuged. The 
residues were resuspended in ethanol (2 ml) and Ehrlich's 
reagent (2 ml), heated in a water bath (90 - 100 °C) with
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continuous agitation for 1 min., and then cooled to room 
temperature. The suspensions were diluted to 5 ml with 
ethanol and centrifuged for 10 min., and the absorbances at 
56 5 and 6 25 nm were measured against an ethanol blank. The 
corrected absorance value was calculated using the formula 
shown below. Levels of pyrrolic metabolites are generally 
quoted as absorbances
5 6 5 6 2 5
Corrected Absorbance = 1.1 (Abs - Abs )
8.5.4 Alkaline Hydrolysis -. To the dilactone (0.1 mmol) 
dissolved in methanol (2. 0 ml) and water (2 .0 ml) was added
O.IM sodium hydroxide (1.0 ml) with thorough mixing. The 
initial pH (approx. 12) was measured (meter), then the 
mixture was kept at 23 °C in a closed flask and the time was 
noted for each decrease of 0.1 unit in the pH. This method 
was tested using ethyl acetate and then used for the 
synthanecine A dilactones (183 a), (183 b) and [(189 ) + (190)]
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8. 6 EXPERIMENTAL FOR CHAPTER 7
Emilia flammea Cass. (Syn. Cacalia coccinea) was grown at the
Botanical gardens in Glasgow, and cropped when flowering.
The fresh plant material (300 g) was finely chopped and
blended with methanol in portions. The blended extracts were
filtered and the methanolic filtrates were concentrated under
reduced pressure. The resulting green residue was extracted
with IM sulphuric acid (3 x lOO ml) and the combined acidic
extracts were washed with dichloromethane (10 x 20 0 ml) until
the washings became colourless. Zinc powder (5 g ) was added
to the aqueous solution and the mixture was stirred at room
temperature for 2 h. The acidic suspension was then filtered
through celite to remove the zinc powder. The filtrate was
basified with concentrated ammonia solution, and extracted
with dichloromethane (4 x 400 ml). The combined organic
extracts were dried, filtered and concentrated in vacuo
affording a crude alkaloidal mixture (50 mg). The crude
product was triturated with hexane (3 x 1 ml) and the
combined extracts were left at 0 ° C  overnight. A white
amorphous solid, which had crystallised, was collected and
further purified by trituration and recrystallisation from
hexane. The resulting white solid (25 mg) had m. pt. 103 -
\ oo
105 °C (Lit. 105 - 107 °C); Rp 0.34; [ alj^  “  ' ® =-17.5 ° 
(CHClg); (200 MHz) 0.85 (3 H, t, J 7 Hz, 21-Hg), 1.53
(2 H, m, 2 O-H2 ), 1.53 (3 H, s , I8-H3 ), 2.06 (3 H, s, NMe),
2.10 (1 H, m, 14-H^), 2.20 (1 H , m, 6 -H), 2.25 (1 H, m,
15-H), 2.43 (1 H, m, 6 -H), 2.65 (1 H, m, 5-H), 2.80 (1 H, m, 
14-H^), 2.85 (1 H, m, 5-H), 3.20 (1 H, br d, Hz,
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3-H), 3.44 (1 H, br d, 18 Hz, 3-H), 3.56 (1 H, br s,
0-H), 4.46 (1 H, br d, 11 Hz, 9-H^), 4.81 (1 H, t, J 3
Hz, 7-H), 5.09 (1 H, d, J 11 Hz, 9-H^), 5.10 (2 H, d, J 
6 Hz, 19-H%), and 6.02 p.p.m. (1 H, br s, 2-H). 5p (50 MHz)
12.0 (C-21), 26.5 (C-20), 28.5 (C-18), 36.1 (C-14), 37.5 
(C-6 ), 40.2 (NMe), 46.9 (C-15), 53.2 (C-5), 58.6 (C-9), 6 6 . 6  
(C-3), 75.2 (C-12), 77.2 (C-7), 117.9 (C-19), 131.8 (C-2),
135.7 (C-l),146.5 (C-13), 174.7 and 177.6 (C-11 and -16) 
and 191.5 p.p.m. (C-8 ); m/z^  365 (M^) 337 , 321 , 306 , 168 , 
151, 125, 110, 96, 53 and 43. (Found: M'*’, 365.1825.
requires M , 365.1838).
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